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The thesis entitled "Preparation and Characterization of Inclusion Compounds of 
Pharmaceuticals with Cyclodextrin" is comprised of an introduction, a general 
discussion and 'H NMR spectroscopic study of inclusion complexes of five 
pharmaceutical compounds with p-cyclodextrin 0-CD). 
The introduction describes a brief historical background, structures of CDs and its 
derivatives, examples of various industrial applications of CDs inclusion complexes with 
the main emphasis in the area of pharmaceuticals, chiral recognition by the CDs and the 
forces involved in the host-guest complexation. The general discussion deals with the use 
of 'H NMR spectroscopy in the study of CD-inclusion complexes. There are five chapters 
on the study of inclusion complexes of pharmaceutical compounds with p-CD. The 
objective of the study was to characterize the structures of the complexes formed in 
aqueous solution because the use of these complexes for pharmaceutical purposes 
requires the establishment of their structures. 
CDs are doughnut shaped molecules composed of glucose units joined through a-(l-4) 
linkage. Three most common, industrially important, a, P, and y-CDs are composed of 6, 
7 and 8 glucose units, respectively. The primary hydroxyl groups (n) are located at the 
narrow rim while wider rim is lined with secondary hydroxyl groups (2n). The outer 
surface of the CDs is highly hydrophilic due the presence of large number of hydroxyl 
groups while the CD cavity is relatively hydrophobic. Considering the presence of 18(a-
CD), 21 (P-CD) and 24(Y-CD) substitutable hydroxyl groups and involving cleavage of 
either 0-H, C-0 or C-C bonds, the number of possible derivatives of CDs are unlimited. 
Functionalization of CDs can concern complete or partial functionalization of hydroxyls. 
By virtue of their shape and hydrophobic nature of cavity, CDs accommodate a variety of 
hydrophobic molecules, or part of it, inside their cavity through non-covalent interactions 
to form inclusion complexes. Inclusion of the guest into the CD cavity results in altered 
physicochemical properties of the guest, like solubility, stability and volatility etc., which 
have found numerous applications in the field of pharmaceuticals. 
Biological systems are largely constructed from chiral molecules such as L-amino acids and 
D-sugars. In this highly chiral environment it is not surprising that drugs which possess 
asymmetric center/s exhibit a high degree of stereoselectivity in their interactions with 
biological macromolecules. It may be highly desirable to have all the activity in one 
enantiomer of the drug so as to avoid the unwanted activity and/or toxicity that may reside in 
the antipode but examples where this has been proven to be true are uncommon. The 
separation of enantiomers and their characterization are, therefore, of great importance for 
the pharmaceutical industry. CDs are chiral molecules and exhibit chiral recognition, i.e., 
they differentiate between enantiomeric species, forming diastereomeric complexes. 
Enantioselectivity of recognition is a thermodynamic quantity correlating in some way with 
the separation factor of enantiomers in separation techniques. It must be noted that among 
presently applied chiral selectors only CDs are effectively used in all enantioseparation 
techniques. A better understanding of the inclusion complex formation and the chiral 
recognition mechanism of CDs is, therefore, a subject of great importance. 
Multiple forces involved in guest-CD interactions make understanding of guest binding and 
chiral recognition mechanism by CDs extremely difficult. The understanding of the driving 
forces in the inclusion complexation of CDs is fundamentally important not only for CD 
chemistry but also for supramolecular chemistry as a whole. A large number of studies have 
been carried out on the subject and have been reviewed earlier. Nevertheless, it is often 
claimed that the driving forces leading to CD complexation still remain a controversial 
subject. 
NMR spectroscopy is an important technique to study inclusion complexes. The formation of 
an inclusion complex between a guest and CD results in the chemical shift changes in both 
the host and guest protons. The highfield shift changes in the CD cavity protons confirm the 
penetration of the guest into the CD cavity. The guest protons generally show downfield shift 
changes upon complexation but all the protons and not only the part included in the cavity 
display these changes. Sometimes highfield shift changes in the guest proton signals are also 
observed. Determination of stoichiometry of the complex is required, for any further 
investigation of the complex, which is usually achieved by NMR titrations studies. Nuclear 
Overhausser Effect (NOE) studies can be used to fully characterize the inclusion complex. It 
gives information about the part of the guest included inside the CD cavity, the mode of 
penetration, i.e. either from narrower or wider rim side, the depth of penetration and 
orientation of the guest. 
H NMR spectroscopic studies of complexation of roxatidine acetate hydrochloride, 
cilalopram, hydroxyzine hydrochloride, cnalapril malcale and fexofenadine hydrochloride 
with P-CD were carried out. In all the cases, the chemical shift changes in the proton 
resonances of studied compounds and P-CDs were observed in the spectra of mixtures of 
pharmaceutical compound and p-CD compared to pure component. P-CD cavity protons, 
namely H-3' and H-5', showed significant highfield shift changes in the presence of drug 
while other protons generally showed insignificant chemical shift changes. Stoichiometry 
and overall binding constant of the inclusion complexes were determined by 'H N M R 
titration methods. The mode of penetration and orientation of the guest molecule into the P-
CD cavity were established by ROESY/NOESY spectral data in all the studied cases. 
• ? Q V \ Q / "CH2OH 
P-Cyclodextrin 
Hydroxyzine Enalaprii 
Fexofenadine Model showing shape of 3-cyclodextrin 
Roxatidine acetate hydrochloride (RAH) forms one 1:1 RAH-P-CD complex in aqueous 
solution by the shallow penetration of the aromatic ring, due to the presence of two bulky 
groups in the meta position, from wider rim side of the P-CD cavity. The structure for the 
RAH-P-CD complex has been proposed. 
(RS)-Citalopram (CT) contains a F-substituted and a cycno-substituted aromatic rings. It 
forms 1:1 inclusion complexes with P-CD in aqueous solution involving both the 
aromatic rings. The modes of penetration of both the rings were identical i.e. from wider 
rim side of the cavity. There was chiral discrimination by the P-CD between the two 
enantiomeric forms and the mechanism of chiral recognition seems to be different 
modes of binding of two enantiomers in the complexes involving cyano-containing ring. 
The structures of all the complexes formed in solution between citalopram and P-CD 
have been characterized. 
(RS)-Hydroxyzine hydrochloride (HYZ) has two aromatic rings and both of these rings 
were confirmed to be involved in the inclusion complex formation with p-CD. Four 1:1 
HYZ-p-CD complexes were characterized, two formed by the entry of the phenyl ring 
and two by the penetration of the p-chloropheny! ring from both the sides of the P-CD 
cavity. The structures for all the complexes present in solution have been proposed. There 
was no clear evidence for the chiral discrimination by the P-CD between two 
enantiomers. 
It was confirmed by the detailed 'H NMR spectroscopic study that (SSS)-enalapril 
maleate (EN) exists in two geometrical forms in solution and an unambiguous 'H NMR 
assignment of the signals, which appeared separately for two isomers, was made. 
Enalapril maleate formed 2:1 EN-P-CD complexes in aqueous solution, it was confirmed 
that both, the aromatic as well as heterocyclic, rings are involved in complexation. 
ROESY confirmed that p-CD cavity is occupied by an aromatic and a heterocyclic ring at 
the same time. It was also evidenced that aromatic ring approached the cavity from 
narrower rim side while heterocyclic entered from wider rim side. Four 2:1 (EN-P-CD) 
diastereomeric complexes must, therefore, be present in solution. There was a significant 
change observed in the ratio of two geometrical isomers in one sample in the presence of 
P-CD which suggests some catalysis by the P-CD but this needs further confirmation. 
(RS)-Fexofenadine (FFN) has two phenyl and one para substituted aromatic rings. 
Complexes involving all the aromatic rings were found to be present in solution. The 
modes of penetration of phenyl and p-substituted aromatic rings into the P-CD cavity 
were different. The phenyl ring entered the cavity from wider rim side while p-substituted 
ring approached the cavity from narrower rim side. It was found that FFN forms 1:1 
inclusion complexes when the concentration of p-CD is less than or equal to that of FFN 
([P-CD]<[FFN]) and as the concentration of P-CD increases the 1:2 FFN-p-CD 
complexes are favoured. The structures for all the possible inclusion complexes present 
in solution have been proposed. There was some evidence of chiral discrimination 
between two enantiomers by P-CD. 
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AIM ANDOB.IECTIVE 
The objective of the work embodied in this thesis was to study the complexation of 
various pharmaceutical compounds with p-cyclodextrin in aqueous solution. 
Complexation of a pharmaceutical compound with cyclodextrins, to form a host-guest 
complex, resuhs in ahered various physicochemical properties of the guest, hke 
solubility, stability, volatility and masking of undesirable properties etc.. which are 
desirable for their use as pharmaceuticals. Moreover, these host-guest complexes are 
considered as new entities and are required to be characterized for their approval as a 
drug. CDs are chiral molecules and differentiate between enantiomeric species. 
Enantioselectivity of recognition is related in some way to the separation factor of 
enantiomers in separation techniques. The separation of enantiomers of a racemic drug is 
of great importance to the pharmaceutical industry because in a racemic drug one 
enantiomer is usually unwanted. NMR spectroscopy is a very useful tool to understand 
the mechanism of chiral recognition and a better understanding of the subject will help in 
the use of cyclodextrins as chiral selectors in various separation techniques. 
L Historical Background 
Supramolecular chemistry is the discipline which involves all kinds of interactions where 
covalent bonds are not formed between the interacting species. The majority of these 
interactions are of the host-guest type. Among all the potential hosts, the cyclodextrins (CDs) 
are the most important. 
In 1891 Villiers isolated a crystalline substance, which later proved to be a cyclodextrin 
(CD), by digesting starch with Bacillus amylobactor and determined its composition to be 
(C6Hio05)2.3H20. He named this substance as "cellulosine" simply because it resembled 
cellulose.' Twelve years later, Schardinger observed the same substance and was able to 
isolate and examine it. Schardinger was the first to extensively study CDs and for this reason 
CDs are also referred to as Schardinger's dextrins. However, it was not until the 1930s that 
Freudenberg and coworkers established the structure of CDs, based partly on their own 
studies and partly on the observations published by Miekeley,"* and others.^ In the 1950s, the 
chemical process for the production of CDs was thoroughly investigated by French and 
coworkers^ and the existence of larger CDs was confirmed. Also, during this time Cramer 
et. al. first began to uncover the CDs potential as complex forming agents. They examined 
the ability of CDs to complex with a variety of drug molecules, and noted the stabilization, 
volatility reduction, and solubility changes that occurred as a result of complex formation of 
drugs with CDs. They subsequently obtained a patent in 1953 that covered practically all of 
the most important aspects of applications of CDs in drug formulations.^ The number of 
patents and papers on CDs have increased exponentially since then. In 1981 the first 
International Symposium on Cyclodextrins^ was organized. Since then onward, symposia 
have been held every second year and presentations have increased both in quantity and 
quality. Moreover, while in 1970 the price of 1 Kg of p-CD was around US$ 2000, and it 
was available only as a rare fine chemical, it is a relatively inexpensive material and an 
important industrial commodity now in many ways. Also, a-, p- and y-CDs, as well as 
several of their derivatives are produced industrially and used in various chromatographic 
methods, or are studied as potential drug carriers, stabilizers, catalysts, etc. 
Structure of Cyclodextrins 
The three most common a-, p- and y-CDs, consisting of 6, 7 and 8 glucopyranosyl units, 
respectively, are linked through a-(l—»^4) glycosidic bonds (Fig. 1). The internal diameter of 
the three CDs increases with the number of glucose units while the height remains constant at 
7.9 A. The glucose units are in the rigid ^C\ chair conformation giving them a toroidal shape 
with all the secondary hydroxy! groups, 0(2)-H and 0(3)-H (2n), located on the wider rim 
while all the primary hydroxyl groups, 0(6)-H (n), on the narrower rim. The primary 
hydroxyls on the narrow side of the cavity can rotate, thus partially blocking the cavity, in 
contrast to the secondary hydroxyls, which are attached by relatively rigid chains and thus 
caimot rotate. 
The interior of the cavity is lined with (from the secondary hydroxyl rim inwards) a row of 
CH groups (the C-3 carbons), then a row of glycosidic oxygen, and then a row of C-5 CH 
groups. Intramolecular hydrogen bonds 0(3)-H 0(2)-H or 0(3) H-0(2) exist between the 
secondary hydroxyl groups of adjacent glucose units, forming a complete secondary belt in 
p-CD. This hydrogen bond belt is incomplete in a-CD molecule due to the presence of one 
glucose unit in distorted position. The y-CD has a non-planar and more flexible structure. 
The non-bonding electron pairs, of the glycosidic oxygen atom, are directed towards inside 
of the cavity producing a high electron density and giving the cavity some Lewis base 
character. The interior of the cavity is hydrophobic while the exterior is hydrophiiic."^''^ 
Table 1 gives some of the physical properties of the a-, p- and y-CDs. 
HOKjC 
Jf^ "^' 
OH H o ^ I o-irr°" 
' \ ^ ^ 
CHjOH 
a-Cyclodextrin p-Cyclodextrin y-CycIodextrin 
17,5 A° 
7.9 A" 
Fig. 1 Structures and sizes of cyclodextrins. 
Table 1 Characteristics of a-, p-, and y-CDs. 
Property a P 
No. of glucose units 
Appearance 
Molecular weight 
Water solubility (%) 
Cavity diameter, A 
6 
White crystalline 
powder 
972 
14.5 
4.9 
7 
White crystalline 
powder 
1135 
1.85 
6.2 
8 
White crystalline 
powder 
1297 
23.2 
7.9 
Cyclodextrin Derivatives 
Today, a number of derivatives of CDs are formed and being used in various ways. Various 
functional groups can covalently be attached to the hydroxyl groups.'^" '"^  The complexation 
behaviour of CDs is altered when the hydroxyl groups are modified. 
Considering the presence of 18(a-CD), 21(P-CD) and 24(Y-CD) substitutable hydroxyl 
groups and involving cleavage of either 0-H, C-O or C-C bonds, the number of possible 
derivatives of CDs are unlimited. All the known CDs derivatives can be classified as carriers 
(solubilizers, stabilizer) for biologically active substances, enzyme models, separating agents 
(for chromatography) and catalysts and additives (as detergents, viscosity modifiers etc.)."' '^  
Actually, methylated CDs (randomly methylated-p-CD), hydroxyalkylated-CDs 
(hydroxypropyl-p-CD and hydroxypropyl-y-CD) and branched CDs (glycosyl- and maltosyl-
p-CD) are produced due to cost/benefit ratio. Complexation with such functionalized CDs 
can also take place in organic solvents since many of the ftinctionalized CDs are soluble in 
organic solvents. Functionalization of CDs can concern complete sets of hydroxyls or partial 
functionalization. Commercial derivatives of cyclodextrins are shown in Table 2. 
Table 2 Chemical structures of cyclodextrin derivatives. 
R,0 
N' 
Compound 
Hydroph 
Methylated cyclodextrins 
3-Mono-O-melhylcyciodextrins 
2, 6-Di-O-methylcyclodextrins 
2, 3, 6-Tri-O-methylcyclodextrins 
Randomly methylated cyclodextrins 
Hydroxylalkylated cyclodextrins 
2-Hydroxyethylcyclodextrins 
2-Hydroxypropylcyclodextrin 
3-Hydroxypropylcyc!odextrin 
2, 3-Dihydroxypropylcyciodextrin 
Branched cyclodextrins 
6-0-Glucosylcyclodextrins 
6-O-MaUosylcyclodcxtrins 
2, 6-O-Dimahosylcyclodextrins 
Hydroph 
Alkylated cyclodextrins 
2, 6-Di-O-ethylcyclodextrins 
2, 3, 6-Tri-O-ethyicyclodextrins 
Acylated cyclodextrins 
2, 3-Di-O-hexanoylcycIodextrins 
2, 3, 6-Tri-O-acetylcyclodextrins 
2, 3, 6-Tri-O-propanoylcyclodextrins 
2, 3, 6-Tri-O-butanoylcyclodextrins 
2, 3, 6-Tri-O-valerylcyclodextrins 
2, 3, 6-Tri-O-hexanoyIcyclodextrins 
2, 3, 6-Tri-O-octanoy(cyclodextrins 
Ri Rz 
ilic Derivatives 
H CH3 
CH3 H 
CH3 CH3 
Ri, ^2, R3 "= H 
R3 
H 
CH3 
CH3 
orCH3 
R,,R2, R3 = HorCH2CH20H 
R,, R2, R3 = H or CH2CH (OH) CH3 
Ri, R2, R3 = H or CH2CH2CH2OH 
R,, R2, R3 = H or CH2 CH (OH) CH2OH 
H H 
H H 
maltose H 
obic Derivatives 
C2H5 H 
C2H5 C2H5 
C O C S H M COCsHn 
COCH3 COCH3 
COC2H5 COC2H5 
COC3H7 COC3H7 
COC4H9 COC4H9 
COC.Hi, COCsHn 
C O C T H I S COC7H15 
lonizable Derivatives 
Anionic cyclodextrins 
6-0-{Carboxymethyl)cyclodextrins 
6-0-(Carboxymethyl)-
2,3-di-O-ethylcyclodextrins 
Cyclodextrin sulfates 
Sulfobulylcyclodextrins 
H H 
C2H5 C2H5 
RIJ R2) R 3 ~ 
Ri, R2» R3 -
"N = 6, a-CDs; N = 7, p-CDs; N - 8, y-CDs; N = 9, 6-CDs. 
glucose 
maltose 
maltose 
C2H5 
C2H5 
H 
COCH3 
COC2H5 
COC3H7 
COC4H9 
COCsHu 
COC7H15 
CH2COONa 
CHjCOONa 
H or S03Na 
= Hor(CH2)4S03Na 
2 Industrial Applications of Cyclodextrins 
Today in industry, CDs and their derivatives are incorporated into a variety of items. CDs 
ability to form inclusion complexes with a variety of compounds has found usefulness in a 
multitude of areas. CDs are already in use in cosmetics, chewing gum, detergents, shampoo 
and toothpaste and for the formulation of drugs. Due to their nontoxic and non-hazardous 
nature, CDs have found applications in usually all kinds of everyday products. At present 
CDs have general approval for use as food additives in Japan and Hungary and for specific 
applications in France and Denmark. This section will include a broad but brief introduction 
into the different ways CDs and their derivatives are being used today in industry due to their 
ability to accommodate guest molecules in their cavity. The industrial applications of CDs 
have been divided into two parts: general applications and pharmaceuticals applications. 
Fig. 2 shows the structures of some compounds that have been utilized recently for the 
formation of complexes involving p-CD derivatives. 
Acridtne Red 
HO3S " f ^ v ^ ^ U 
8-Anilino-1 -naphthalenesulfonJc acid 
COOH 
Rhodamine B 
2-(p-tolutdmo)naphthalene-6-sulfonicacid 
O 
6 
4-amJnosulfonyl-7-fluoro-2,1,3-benzoxadiazole 
Me- NMe, 
Homocysteine 
(2)-4,4-Bis(dimethyarrrinomethyl)stilbene 
2,5-Norbomadiene 
NO; 
OH 
4-Nitrophenol 
COOH 
HN N 
^ ^ ^ ^ / ^ : ^ ^ C O O H 
H O O C ^ ^ ^ " ^ ^ 
2,6-Naphthalenedicarboxylic acid 
Ciprofloxacin 
Fig. 2 Names and structures of some typical pharmaceutical compounds utilized recently 
in the formation of host-guest complexes with p-CD derivatives. 
A. General Applications of Cyclodextrins 
Solubility 
The solubility of a compound can be altered by complexation with a CD.'^ The guest 
molecule in the cavity of the CD does not come in contact with the solvent. The outer surface 
of the CD interacts with the solvent, which contributes to the solubility of the complex and 
not the portion of the guest included in the CD cavity. Modification of the hydroxy! group of 
the outer surface of the CD markedly affects the solubility properties. Substitution of the 
hydroxyl groups with hydroxypropyl, carboxymethyl, tertiary amine or quaternary amine 
increases water solubility upto 60% or more. On the other hand, substitution of-OH groups 
with aliphatic groups such as hexyl or acetyl results in increased solubility in organic 
solvents. 
The cloudiness and bitter taste in the orange juice was discovered due to the presence of 
hespiridine. Addition of p-CD resulted in clearing the syrup and masking the bitter flavour of 
hespiridine.'^ Triterpenes which are water insoluble, such as oleanoic acid, ursolic acid and 
gederogenin, could be solubilized upto 400 //g/ml or more using CDs.'^ Phenylalanine, 
tyrosine and tryptophan units of the peptides complex well with CDs resulting in the 
formation of CD-peptide complex. Ovine growth hormone is water insoluble, except at high 
pH such as 11.5, which is not useful for pharmacological purposes. It can be solubilized at 
pW 7.5 to 8.5 when complexed with hydroxypropyl p-CD."* Some plant oils cause a rash and 
irritation when they come in contact with skin. Washing can result in spreading of the oils 
and increased irritation. These oils can be removed from the skin by complexation with 
10 
19 
cyclodextrins especially y-CD and hydroxypropyl p-CD. Large lipids such as ear wax can 
also be solubilized by complexation with y-CD. 
Glycolic acid is used for superficial peeling of the skin but is irritating to the skin. When 
applied complexed with cyclodextrins, it was found to be non-irritating and due to prolonged 
release of glycolic acid there was increase in efficiency of exfoliating action and cellular 
removal. 
CDs have also been used for dying fabrics. Using CDs, more dye was absorbed on the fabric 
reducing the amount of dye left in the waste water. The solubility of the dye in water also 
increased and no auxiliaries were needed to solubilize the dye. A 3-fold increase in the 
binding of the florescent dye to polyester fiber was achieved using hydrophobic tosyl 
derivatives of p-CD.^^ 
Viscosity of water-based paints during their manufacture can be controlled using CDs. 
Thickeners are added to paints to impart desired viscosity properties. By complexing CD 
with the thickener during the manufacture of the paints, the viscosity is reduced, making 
mixing easier. Viscosity is restored upon addition of paint components which displace the 
thickener from the cavity of the CD to give the paints its deshed viscosity properties. 
Process Aids 
CDs have found invaluable roles as processing aids in industry. CD has been used in the 
removal of cholesterol from animal products. ^ In one case, aqueous solution of CD was 
stirred with heated lard and tallow from which cholesterol was to be removed. The CD forms 
11 
complex with cholesterol which is insoluble in water or fat. The complex is removed by 
filtration or centriftigation. The CD-cholesterol complex is then suspended in water and 
heated which results in decomposition of complex causing CD to be solubilized in water and 
cholesterol to float on the surface. This way upto 80% of cholesterol has been removed from 
some treated material and CDs and cholesterol are obtained as pure products. CD 
complexation of cholesterol has also been found useful in reducing dietary cholesterol 
intake.^^ 
Fruit and vegetable juices were treated with a p-CD polymer to remove polyphenolics 
responsible for enzymatic browning. ^ Naringen and limonene, the bitter components of 
citrus fruits, have been removed using a polymer of p-CD.^^ Organic compounds need to be 
solubilized in water for bioconversions and therefore surfactants or solvents are used but 
these can be used in limited quantities because they affect the organism as well. By the use of 
methylated p-CD, a 6-fold increase in the bioconversion rate of podophyllotoxin was 
achieved compared to bioconversion in the absence of CD. 
Stabilization 
Compounds capable of making complexes with CDs are stabilized as a result of 
complexation, because they cannot interact with other molecules. Moreover, there is steric 
hindrance, which prevents approach by a molecule to the exposed portion of the guest at the 
open cavities. Unsaturated fatty acids, for example in fish oil, are easily oxidized resulting in 
unpleasant taste and odor. These oils can be protected from oxidation by complexation with 
CD. Peroxyacids are used as bleaching agents and their thermal stability and storage are a 
12 
matter of concern. Complexation with CDs not only improves storage and thermal stability 
but odour is also reduced and complex is stable without using dilutants. Explosives can also 
be stabiHzed by complexation with CDs. ' 
Masking of the Guest Effects 
A guest molecule in the CD complex gets isolated, resulting in the masking of its various 
properties. This technique has been used in masking the unwanted flavour in food and skin 
irritation effects. Lotions have been developed in which a fragrant but irritation causing 
component is complexed with CD in order to limit its direct physical contact with skin but 
still allowing evolution of the desired fragrance. The irritating or toxic effects of insecticides 
can also be reduced or eliminated by complexation \\dth CDs. Azinophos-methyl forms an 
odourless complex with p-CD.^^ No toxic effects were observed when the insecticide was 
administered dermally at a dose of 4000 mg/kg as CD-complex while free insecticide shows 
dermal toxicity at a dose of 18 mg/kg. 
Reduction of Volatility 
Reduction of volatility and controlled release of chemicals are other important applications of 
CDs. Menthol, for example, forms an odourless complex with P-CD which can be dried at 
100 **C while free menthol will be completely volatilized under these conditions. The release 
of fragrance from laundary dryer sheets can be controlled by complexing the fragrance with 
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Moreover, all the components of the fragrance have different volatility and some of the more 
highly volatile components are easily lost changing the composition of the fragrance. 
However, when these components are complexed with CDs, their volatility is reduced so that 
the character of the fragrance is not changed. CDs can also be used to prevent odour in the 
skin tanning and hair care preparations. A dry powder of CD can be used in products such as 
menstrual products, diapers, tissues, paper towels etc. ^ making them effective scavengers of 
unwanted odours. Perfumes can also be complexed to CDs to be released upon dissolution of 
the complex and displacement by odiferous compounds. 
Directing of Chemical Reactions 
CDs are also used for the mediation of specific organic reactions. The formation of 
host/guest complex, not only alter the parameters such as solubility, but inclusion of the part 
of the guest molecule into the CD-cavity offers significant steric shielding. This concept has 
been utilized in many ways for highly selective syntheses.^^ 2, 6-Naphthalenedicarboxylic 
acid is an important monomer for liquid crystalline polymer synthesis. Synthesis of 
2, 6-naphthalenedicarboxylic acid is difficult due to several reactive sites on the naphthalene 
ring leading to a range of products. It was found that when naphthalene was first complexed 
with CD then the yield of the desired 2, 6-product was greatly improved. The host CD 
sterically shielded the undesirable reaction sites on the naphthalene ring. 
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B. Pharmaceutial Applications of Cyclodextrins 
Of all the industrial applications of CDs, a large portion of their uses is devoted to their 
applications in the field of pharmaceuticals. The most common pharmaceutical applications 
of CDs are to enhance the solubility, stability and bioavailability of drug molecules. Each CD 
has its own ability to form inclusion complexes with specific guests, an ability which 
depends on a proper fit of the guest molecule within the hydrophobic CD cavity. At present, 
some 30 or so drug formulations are approved and marketed worldwide as CD complexes, 
generally natural CD complexes (Table 3). The structures of some of the pharmaceutical 
compounds marketed as CD complexes are shown in Fig. 3. 
The principal advantage of natural CDs are their (1) well defined chemical structures 
yielding many potential sites for chemical modification (2) easy availability and low cost (3) 
low toxicity and pharmacological activity (4) some water solubility and (5) protection of 
included drug molecules from biodegradation. However, natural CDs have relatively low 
solubility, both in water and organic solvents which limit their uses in pharmaceutical 
formulations. P-CD, the most common natural CD, has 21 hydroxyl groups, i. e. 7 primary 
and 14 secondary, which are available as starting points for structural modifications and so a 
variety of CD derivatives have been prepared so as to extend the physicochemical properties 
and inclusion capacity of the parent host molecule. Typical examples of the pharmaceutically 
usefiil p-CD derivatives are listed in Table 2, classified into hydrophilic, hydrophobic and 
ionic derivatives. 
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When mono- or disaccharides are attached to one or two primary hydroxyl groups of CD 
through 2 ,6-glycosidic linkage, their water solubility markedly increases: the solubility of 
6-0-glucosyl-P-CD, 6-O-maltosyl-P-CD in water is over 50% (w/v) at 25 '^C."'^  The 
complexation ability of branched CDs against hydrophobic guests is comparable to parent 
CDs and decreases only slightly with increase in the glucose number and the degree of 
substitution. However, the solubilizing ability of branched CDs is much greater than that of 
parent CDs. Branched CDs have higher affinity towards steroidal drugs such as progesterone, 
testosterone, dehydrocholic acid, digitoxin etc.''^' ^^  Due to their high solubilizing effect, 
branched CDs may be useful for parenteral preparations such as injections because of their 
weak hemolytic activity and high bioadaptability. 
The solubility of CDs can significantly be affected by water miscible cosolutes and 
cosolvents. For example, urea is known to increase solubility of a variety of polar and 
non-polar organic solutes in water. The solubilities of p- and y-CD were significantly 
enhanced in the presence of urea while that of a-CD decreased. Such solubility changes were 
observed for cosolvents such as alcohols, acetonitrile, dimethyl sulfoxide, dimethyl 
formamide. acetic acid and ethylene glycol etc.^ '"^^ 
The cosolubilization method has been found useful for the preparation of solid 
2-hydroxypropylated CD complexes with unstable drugs such as steroids, peptides and 
antibiotics. The synergetic effect of CD derivatives (methylated, hydroxy alkylated, 
carboxymethylated and branched forms) and water soluble polymers (polyvinyl pirroridone, 
hydroxypropylmethyl cellulose and carboxymethyl cellulose) on the solubility of various 
poorly water soluble drugs were studied. It was found that the solubilizing effect of 
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2-hydroxypropyl-p-CD is enhanced on an average by 27% by carboxymethyl cellulose and 
49% by polyvinyl pirroridone. ^ Table 4 summarizes the solubility enhancement studies of 
variety of pharmaceutical compounds in the presence of CDs. 
Table 4 Examples of CD enhanced solubility of pharmaceuticals. 
CD PrusCs) Ref. 
p-CD 
a-CD 
y-CD 
Hydroxypropyl-p-CD 
Dimethyl-p-CD 
SuIfobutylether-p-CD 
Randomly methylated p-CD 
Randomly acetylated 
amorphous-P-CD (Ac-P-CD) 
Nimesulide, Sulfomethiazole, Lorazepam. 56-68 
Ketoprofen, Griseofulvin, Praziquantel, 
Chlorthalidone, Etodolac, Piroxicam, 
Itraconazole, Ibuprofen 
Praziquantel 
Praziquantel, Omeprazole, Digoxin 
Albendazole, DY-9760e, ETH-615, 
Levemopamil HCL, Sulfomethiazole, 
Ketoprofen, Griseofulvin, Itraconazole, 
Carbamazepine, Zolpidem, Phenytoin, 
Rofecoxib 
Naproxen. Camptothesin, 
Dy-9760e, Danazol, Fluasterone, 
Spiranolactone 
ETH-615, Tacrolimus 
Naproxen 
62 
62, 68, 69 
70-73, 57, 59, 
61,66,74-77 
85,86 
71,80-82 
72,83 
84 
Stabilization 
The drugs must retain sufficient stability not only during storage but also in the 
gastrointestinal fluids, since reactions which result in a product that is pharmacologically 
inactive or less active will reduce the therapeutic effectiveness. The main concern in the 
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pharmaceutical field is, therefore, the rate of deceleration. CDs have been used to stabilize 
pharmaceutical compounds. ' 
Thymopentin is a peptide which blocks the stimulation of smooth muscle contractions 
induced by (+)-anatoxin-a, which is produced by blue green algae. Thymopentin is unstable 
in aqueous solution and can not be stored in a ready to use form. The activity was retained 
over 14 months of storage at 25 ^C when the drug was complexed with 2-hydroxypropyl-p-
CD in aqueous solution. In the absence of the CD, all the activity was lost within 1 week. 
Erythropoeten is a glycoprotein hormone which induces an increase in red cell mass. 
Complexed with 2-hydroxypropyl-p-CD, 100% of the activity was maintained for 10 days 
compared to only 50% of the activity in the absence of CD. The complexed erythropoeten 
retained 62% of the activity after 20 days compared to only 24% in the absence of CD.^ ^ 
Nicardipine is light sensitive and decomposes if exposed to light. The rate of 
photodegradation was reduced by complexing the drug with CDs. CD complexes of 
nicardipine were irradiated by UV light. Photodegradation was slowed by a factor of 10 with 
methylated-P-CD, 8 with 2-hydroxypropyl-P-CD, 6.5 with a-CD and 5 with y-CD.*^ 
Digoxin, one of the potent cardiac glycosides, is susceptible to hydrolysis in acidic media. 
The acid-catalyzed hydrolysis of the glycoside bonds in digoxin is decelerated by the 
addition of CDs. The hydrolysis of the glycosidic linkage connecting the A-ring of digoxin 
and the sugar was completely inhibited by p-CD.^ When the catalytic hydroxyl groups of the 
CD are blocked by substituents, their stabilizing effect is enhanced. The p-hydroxyketo-
moiety of the E-type prostaglandins is extremely susceptible to dehydration under acidic or 
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alkaline conditions. Parent CDs showed a positive catalytic effect but the use of methylated 
p-CD significantly decelerated the degradation reaction. Prostaglandin Ei has been stabilized 
by 6-0-(carboxymethyl)-0-ethyl-p-CD in a fatty alcohol propylene glycol ointment, because 
prostaglandin Ei is most stable in acidic conditions.^' Carmofur is extremely susceptible to 
base and water catalyzed hydrolysis to 5-fIuorouracil, which irritates the gastrointestinal 
tracts. The carmoftir can be stabilized by complexing with 6-0-(carboxymethyl)-0-p-CD. 
An antitumor drug, 0-6-benzyl guanine, undergoes hydrolysis under acidic conditions to form 
guanine and benzyl alcohol. The hydrolysis at/?!! 4.8 was decelerated by a factor of 220 by 
complexing the drug with sulfobutyl-p-CD with an average degree of substitution of 4.^ ^ The 
results of stability enahancement of pharmaceuticals in the presence of CDs are summarized 
in Table 5. 
Absorption Enhancement 
The enhanced water solubility of the drug upon complexation with CDs has been found to 
result in the enhanced bioavailability of the drug.'^^' The rate and extent of bioavailability 
of a poorly water-soluble drug from its CD complex is optimized by adjusting factors 
affecting the dissociation equilibria of the complex both in the formulation and in the 
biophase in which the complex is administered. Only a free form of the drug, which is in 
equilibrium with the complexed one in solution, is capable of penetrating the lipophilic 
barriers consisting of either mucosal epithelia or stratified cell layers and eventually entering 
the systemic circulation. Practical formulations usually contain a large quantity of 
pharmaceutical excipients, which may compete with the drug for the CD cavity. Moreover, 
the endogenous substances existing at the absorption site may also compete for the CD 
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Table 5 EtTect of cyclodextrins on drug stability. 
Effect 
Photostability 
Shelf life with unaffected 
dissolution rates for 4 years 
Thermal stability in solid state 
Stability against intramolecular 
cyclization in solid stale 
Stability to acid hydolysis and 
photodecomposition 
Stability against hydrolysis 
Deacetylation or degradation 
Photoreactivity 
Drug 
Promethazine 
DY-9760e 
2-EthyIhexyl-p-dimethy! 
aminobenzoate 
Glibenclamide 
Diclofenac sodium 
Quinaril 
Doxorubicin 
Acyl ester prodrugs 
of Ganciclovir 
Digoxin 
Rofecoxib 
Cam plot hes in 
Melphalan 
Carmustine 
Paclitaxel 
S pi rano lactone 
Flutamide 
CD 
Hydroxypropyl-p-CD, 
EHmelhyl-P-CD 
Suifobutyiether-P-CD 
Hydroxypropyl-p-CD 
P-CD 
P-CD 
p-CD, Hydroxypropyl-
P-CD 
Hyd roxy propy 1 - P-C D, 
Hydroxy propyl- y-CD 
Hydroxypropyl-p-CD 
y-CD 
Hydroxypropyl-p-CD 
Randomly dimethylated 
P-CD 
Sulfobutyl-P-CD, 
Hydroxypropyl-p-CD 
y-CD Hyd roxy propy l-y-CD 
Hydroxypropyl-p-CD 
Sulfobutylether-a-CD, 
Sulfobutylether- P-CD, 
Hydroxypropyl-p-CD, 
y-CD, p-CD 
P-CD 
Ref. 
72 
71 
94 
95 
96 
97 
98 
59 
69 
70 
79 
99 
100 
101 
102 
cavity. The displacement of the drug from the CD cavity by exogenous and endogenous 
substances is responsible for acceleration of the drug absorption. Some recent findings on the 
enhanced drug absorption by hydrophilic CDs administered via different routes are discussed 
here. 106 
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Oral Delivery 
The commercial viability of the CD-based oral formulations has been established with the 
marketing of more than 10 products.'*'^' "' Rapidly dissolving complexes of drugs with 
hydrophilic CDs are best suited for sublingual or buccal administration. This type of drug 
delivery not only gives a rapid rise in the systemic drug concentration but also avoids 
intestinal and hepatic first-pass metabolism of the drug. A water soluble complex of digoxin 
with y-CD can be formulated into a sublingual tablet to enhance bioavailability and to avoid 
acid hydrolysis of the drug by gastric juices. Other examples are sublingual administration 
of tablets containing complexes of steroids with CDs. 2-Hydroxypropyl-p-CD and p-CD 
polymer supported the absorption of testosterone from the oral cavity and not from the 
gastrointestinal tracts."^''" 
Rectal Delivery 
The release of drugs from suppository bases is one of the important factors in the rectal 
absorption of the drug. In general, hydrophilic CDs enhance the release of poorly water-
soluble drugs from oleaginous suppository bases. In comparison to parent CDs, the 
methylated CDs are found to significantly enhance the rectal absorption of hydrophobic 
drugs such as flurbiprofen," carmafur"^ and biphenylylacetic acid""* from the oleaginous 
suppository. 2-Hydroxypropyl-p-CD was also found particularly useful for the enahancement 
of rectal absorption of the above drugs. The most striking effect of 2-hydroxypropyl-p-CD 
was observed for the rectal absorption enhancement of the anti-inflammatory drug ethyl 
4-biphenylylacetate, a lipophilic prodrug of biphenylylacetic acid. ' There is a great clinical 
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need for the development of long-active types of rectal preparations for the potent opioid, 
morphine, in the treatment of intractable chronic pain in advanced cancer patients. Some 
hydrophilic CDs have been found to enhance the rectal absorption of morphine from the 
hollow-type oleaginous suppository in rabbits."^ 
Ocular Delivery 
One of the pre-requisite for a new vehicle to be used in ophthalmic preparations is that it is 
not irritating to the ocular surface, because irritation causes reflex tearing and blinking, 
which results in a fast washout of the instilled drug. The major problem with eye drops is its 
inability to sustain high local concentrations of drug. The administration of ophthalmic drugs 
in gels and in polymer matrixes has been shown to increase the contact time of the drug with 
cornea, a situation which increases their bioavailability. However, the patient's acceptance of 
such delivery systems is unsatisfactory. The possible advantages in the use of CDs are 
increase in solubility and/or stability and avoidance of incompatibilities of drugs, such as 
irritation and discomfort."^ 
Hydrophilic CDs, especially 2-hydroxypropyl-p-CD and sulfobutyl-p-CD have been shown 
to be nontoxic to the eye and are well tolerated in aqueous eye drop formulations. These 
hydrophilic CDs do not penetrate tight biological barriers such as the eye cornea but enhance 
the ocular bioavailability of lipophilic drugs by keeping the drugs in solution and increasing 
their bioavailability at the surface of the corneal barriers."*" "^ For example, dexamethasone 
acetate-2-hydroxypropyl-p-CD complex can be made as an ophthalmic solution. Recent 
studies have demonstrated that water soluble polymers such as hydroxymethylcellulose and 
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polypyrroridone stabilize the complex of dexamethasone with 2-hydroxypropyl-p-CD 
probably through the formation of a ternary complex, a situation which increases the aqueous 
solubility in eye drops and enhances the drug penetration into the aqueous humor in 
humans.'^^ A combination of 2-hydroxypropyl-p-CD with hydroxypropyl-methyl-cellulose 
has also been shown to unprove the topical delivery of carbonic anhydrase inhibitors to the 
^ . «^ 121,122 
eyes. ' 
Dermal Delivery 
CDs have a significant safety margin in dermal applications and can be used to optimizing 
the transdermal delivery of drugs intended either for local or systemic use. A suitable 
vehicle must be selected so that CDs fully exert their functions. For instance, the in vitro 
release rate of corticosteroids for water containing ointments (hydrophilic, absorptive or 
polyacrylic base) is markedly increased by hydrophilic CDs, whereas in other ointments 
(a fully alcohol propylene glycol or macrogol base) the CDs retard the drug release.'^'* When 
the hydrophilic ointment containing ethyl 4-biphenylylacetate or its CD complexes was 
applied to the skin of rats, the release of ethyl 4-biphenylylacetate from the ointment into the 
skin was enhanced by heptakis(2,6-di-0-methyl)-p-CD or 2-hydroxypropyl-p-CD, while 
p-CD had no appreciable effect. In addition, the p-CDs assisted the bioconversion of ethyl 
4-biphenylylacetate to biphenylylacetic acid in the skin and consequently facilitated the 
delivery of active biphenylylacetic acid to subcutaneous tissues, where its action is most 
desired.'^''^^ 
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Alleviation of Local and Systemic Toxicity 
The molecular entrapment of a drug into the CD cavity prevents its direct contact with 
biological surface as well as the entry of the drug into the cells of non-targeted tissues and 
thus reducing the local irritation.'^^ Pilocarpine was administered as a prodrug, 
0,0'-dipropionyl(l,4-xylene)bipilocarpine acid diester, with 2-hydroxypropyl-p-CD. The 
amount of irritation decreased as the amount of CD was increased. At a concentration of 
15%, the irritation was reduced to the same level as that with the commercial formulation and 
the ocular delivery was substantially improved. A complex of diclofenac was compared to 
a commercial preparation. Voltaren. Lysis of red blood cells was used to evaluate cellular 
lysis. The amount of complex needed to lyse the red blood cells was four times higher than 
for diclofenac alone. The results indicated the suitability of the hydroxypropyl-p-CD to 
optimize the ophthalmic application of the drug for improved transcomeal permeability and 
in vivo tolerance based upon the haemolysis studies.'^^ CDs also alleviate muscular tissue 
damage following intramuscular injection of drugs. For example, the intramuscular 
administration of chlorpromazine in the absence as well as presence of p-CD derivatives to 
rabbits showed reduced chlorpromazine-induced muscular damage.'^^ CDs diminish the 
ulcerogenic potency of several acidic antiinflammatory drugs and mask their disgusting 
smells and tastes when they are administered orally. A similar protection by hydrophilic CDs 
after rectal and ocular administration of drugs was also described. For example, 
2-hydroxypropyl-p-CD significantly reduced the irritation of rectal mucosa in rats caused by 
biphenylylacetic acid both for single and multiple administrations of the complex of ethyl 
4-biphenylylacetate with 2-hydroxypropyl-p-CD in oleaginous suppositories.'^' 
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Systemic Detoxification 
A study has demonstrated that the addition of p-CD to dialysis fluids accelerated the removal 
of phenobarbital by peritonea! dialysis, thereby proving effective in the treatment of drug 
overdose.'^^ A retinal-dextran conjugate solubilized by p-CD was reported to be less 
cytotoxic and retained the ability to inhibit the growth of cancer cells.'^^ CDs can be used not 
only as an enabling exipients in pharmaceutical formulations, but also as artificial carriers, 
for either exogenous or endogenous lipophiles, in the body.'^'' Some natural lipophiles are 
changed into toxic agents when the organism lacks the ability to transport and redistribute 
them properly by carrier proteins and their receptor systems. Furthermore, various exogenous 
lipophiles enter the body and accumulate in fat tissues. Consequently, these exogenous 
lipophiles may exert toxic action for a very long period. In such cases CDs act as an artificial 
circulating carrier for the lipophiles in order to redistribute them in extracellular space. 
When heptakis(2,6-di-0-methyl)-p-CD was administered parenterally to mice under retinoid 
induced hypervitaminosis A, the survival rate of poisoned animals was significantly 
improved.'^^ This preliminary result was the impetus for the use of 2-hydroxypropyl-P-CD to 
rescue a patient with familial hypervitaminosis A caused by overloading retinal esters in the 
liver.*^^ 
Gentamicin, an aminoglycoside antibiotic, is widely used in the clinical treatment of 
gram-negative infections, but its use is sometimes complicated by the development of 
drug-induced acute renal failure. CD sulfates, when given intraperitoneally, protected rats 
against renal impairment due to gentamicin. The protection probably occurs through 
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interfering with tiie intracellular events leading from the drug accumulation to 
nephrotoxicity.'^^ 
CD Based Delivery Systems 
Due to their multifimctional characteristics, CDs have also been found useful in oral drug 
delivery, peptide and protein delivery, and site-specific delivery. Drug release should be 
controlled in accordance with the therapeutic purpose and the pharmacological properties of 
active substances. There has been a growing interest in developing the rate- or 
time-controlled type oral preparations, because an appropriate drug release from the dosage 
forms is of critical importance in realizing their therapeutic efficacy. Various CD derivatives 
have been used for controlled drug release in oral preparations. The hydrophilic and 
hydrophobic CDs are useful for the immediate release'^^ and prolonged release'^^' ''*^  type 
oral formulations, respectively. The delayed release type oral formulation can be obtained by 
the use of 6-0-(carboxymethyl)-0-ethyl-p-CD.'^' 
Advances in biotechnology have accelerated the economical, large scale production of 
therapeutically active peptide and protein-based drugs tised to combat poorly controlled 
diseases, making them more readily available for therapeutic use. The progress in molecular 
biology, however, has not been matched by the progress in the formulation and development 
of delivery systems for peptide and protein drugs. There are considerable hurdles to be 
overcome before practical use can be made of therapeutic peptides and proteins because of 
chemical and enzymatic instability, poor absorption through biological membranes, rapid 
plasma clearance and immunogenicity. Many attempts have been made to address these 
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problems by chemical modifications or by coadministration of adjuvants to eliminate 
undesirable properties of peptides and proteins. CD complexation is an attractive alternative 
to the above approaches.'''^ 
Recently, intensive efforts have been made to design systems able to deliver drugs more 
efficiently to specific organs, tissues, and cells, etc.^ '* '^'*^ The CD complexes are in 
equilibrium with guest and host molecules in water, the degree of the dissociation being 
dependent on the magnitude of the stability constant. This property of the complex is a 
desirable quality, because the complex dissociates to free CD and drug at the absorption site, 
and only the drug in free form enters into systemic circulation. A typical example is the 
application of 2-hydroxypropyl-p-cyclodextrin to the chemical delivery system developed by 
Bodor'^'' which was used to deliver the polar drugs targeted on the brain. 
3, Chiral Recognition by Cyclodextrins 
Enantiomerism has always been treated as a rather "special" type of isomerism, probably 
because the only difference between the enantiomers is the marmer in which they interact 
with polarized light. One enantiomer is therefore rarely regarded as an impurity when present 
in a sample of the other enantiomer, in contrast to, say, a mixture of two aromatic positional 
isomers or a mixture of E- and Z-alkenes. In fact, this lack of any difference other than 
optical activity, only holds in a truly achiral situation and as soon as any chirality is 
introduced into the environment of a chiral molecule the enantiomers are differentiated. This 
will clearly be the case when a chiral drug interacts with an enzyme or a receptor, as such 
biomolecules will typically represent a chiral environment. Furthermore, processes such as 
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drug absorption, distribution, excretion and metaboUsm are all potentially subject to 
enantioselection. 
It is important to realize that the other enantiomer of a chiral drug, usually present as a 50% 
admixture, as the result of chemical synthesis, may be more than just an ineffective version 
of its mirror image, and may have dramatically different (and potentially undesirable) 
pharmacological effects in its own right. 
L-Dopa (1), a-dextropropoxyphene (2) and S-(-) timolol (3) are commercially available 
drugs that are marketed as single enantiomer because the antipode produced unwanted side 
effects. For L-dopa, it was noted during early development that many of the serious side 
effects, such as granulocytopenia, were due to the D-isomer: the racemate is no longer used 
in humans."*^ In contrast to flecainide (4) where both enantiomers have been reported to have 
very similar activity, the isomers of propoxyphene appear to have completely different 
activities. D-Propoxyphene has analgesic properties whereas hs optical isomer 
L-propoxyphene has antitussive properties but is devoid of analgesic properties.'''^ 
Indacrinone (5) is an interesting drug that has both diuretic and uricosuric activity. Preclinical 
and clinical studies showed that R-(-)-5 and its active metabolite are responsible for the 
diuretic activity, whereas S-(-)-5 promotes uric acid excretion.^^^ Each enantiomer seems to 
possess very little of the antipode's activity. Similarly, S-(-) enantiomer of 3 was selected for 
development as a p-blocking agent because the R-(+)-3 was found useful for the treatment of 
glaucoma. S-(-)-3 has been reported to cause fatal P-blockade induced bronchoconstriction 
when applied topically to treat glaucoma. It becomes obvious from these examples that each 
enantiomer needs to be evaluated separately before being regulated for use as a drug. The 
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separation of enantiomers and their characterization are, therefore, of great importance for 
the pharmaceutical industry. )5I 
HOOC 
CHg 
C2H5OCO-C—CHCHt-N(Chb)2 
Cf-t 
OH 
N 0CI-t-CH-CtiN(Chb)2 
w 
OCH^CFj 
HOO' 
Chiral recognition, also often termed as enantiorecognition, refers to the ability of one chiral 
molecule to recognize the chirality of another molecule. CDs are chiral molecules and exhibit 
chiral recognition, i.e., they differentiate between enantiomeric species, forming 
diastereomeric complexes. The magnitude of the enantiorecognition in guest-CD interactions 
can be characterized by enantioselectivity. Enantioselectivity of recognition is a 
thermodvTiamic quantity correlating in some way with the separation factor of enantiomers in 
separation techniques. 
It must be noted that among presently applied chiral selectors only CDs are effectively used 
in all enantioseparation techniques.'^^ In fact, widespread industrial applications of CDs are 
primarily due to their two properties: complex formation and their chiral recognition ability. 
A better understanding of the inclusion complex formation and the chiral recognition 
mechanisms of CDs is, therefore, a subject of great importance. 
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The basic mechanism of the interactions between CDs and other molecules is known but 
there are still questions to be answered. The most critical questions in CD chemistry are: 
(a) is the inclusion complex formation a prerequisite for chiral recognition by CDs? (b) Does 
any correlation exists between the binding strength and enantiorecognition power by CDs? 
(c) What sites of the CDs are primarily responsible for binding and enantiorecognition? 
(d) What are the major forces responsible for binding, and what factors are responsible for 
chiral recognition. 
Of all the techniques used to study chiral recognition, chromatographic techniques and NMR 
spectroscopy are the most frequently used methods. In chromatography, the separation of 
enantiomers is usually studied while spectroscopic techniques are used to study differences in 
other physicochemical parameters of the diastereomeric complexes involving CDs. 
NMR spectroscopic studies have provided some of the most detailed information concerning 
the nature of these interactions and the structure of the diastereomeric complexes involved. 
The most distinct advantage of the NMR spectroscopy is that it allows the application of 
racemic samples or non-racemic mixtures of enantiomers for the enantioselective 
determination of the stoichiometry and equilibrium binding constants of the diastereomeric 
CD-complexes. Besides, the easier availability of racemic mixtures compared to pure 
enantiomers offers the possibility of competitive binding studies. This means that the 
interaction of one of the enantiomer of a racemic mixture with a chiral selector may be 
studied in the presence of the other enantiomer, which mimics closely the real condition in 
chiral chromatographic separations. 
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NMR spectra of enantiomers in an achiral medium are identical because enantiotopic groups 
display same chemical shifts.'^ '* Enatiodifferentiation in the spectra require the use of a chiral 
medium that converts the mixture of enantiomers into a mixture of diastereoisomeric 
complexes. The simplest application of the chiral discrimination by CDs is an observation of 
the separation of signals of diastereomeric forms. Such experiments enable a simple 
estimation of optical purity of the guest molecules and rely on evaluation of relative signal 
intensities belonging to respective species. Most of the observations of splitting signals due 
to chiral recognition pertain to 'H spectra. There are very few examples describing the effect 
in "C spectra'"-'" and other nuclei, " N , " * '"F "' and^'P.'*"' 
Evidence of chiral recognition is usually the first step for flirther structural, thermodynamic 
or theoretical studies. Although the chemical shifts of such species are generally different, 
the magnitude of the expected effect is not always large enough to be observed. Moreover, it 
depends on the chemical shift differences between the free and complexed forms of the 
guest, the actual binding constant and finally on the kinetics of host/guest exchange. Hence, 
in order to increase the separation of the signals, an excess of CD is usually used and an 
analysis of the guest spectra is made. In practice, the observation of the separation of 
H signals due to chiral recognition is easiest and straightforward in the case of relatively 
strong and narrow signals but may be very difficult for complicated multiplets or broad 
signals. The observation of other nuclei provides several advantages, which include a larger 
chemical shift scale and a lack of multiplet structure as in ^H-coupIed spectra. 
The spectra of (+)-pinene (6) complexes'^' with a-CD in D2O present a typical example of 
the differentiation in ' H and '^C signals due to chiral recognition.'" The corresponding 
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A5=6(+) - 6(-) values are given in Table 6. The H signal separations were observed for 
almost all protons except H-7 and H-9, whereas, due to their larger chemical shift scale, the 
A5 (^ C^ ) values were larger by atleast 1 order of magnitude. 
10 10 
6 
5 
a-(+)-6 
f6 
5 
a-(-)-6 
Table 6 Differences between ' H and ^^ C complexation induced shifts (CIS) (ppm) of 
enantiomeric guest signals for the complexes of enantiomeric a-pinene with a-CD in D2O 
andDMSO. 
Atom 
1 
3 
4a 
4b 
5 
7a 
7b 
8 
9 
10 
A8 CIS (D2O) 
^H 
-0.04 
-0.05 
-0.02 
0.00 
0.04 
-0.02 
0.01 
-0.02 
0.00 
0.04 
"c 
-0.5 • 
-0.2 
1.2 
0.3 
-1.3 
-0.3 
-0.4 
0.2 
A6 CIS (DMSO) 
" C 
0.01 
-0.01 
0.01 
0.01 
-0.01 
0.00 
-0.02 
-0.02 
The influence of the magnitude of bindmg constants on the apparent signal separation is 
exemplified by the spectra observed for the same system in DMSO solution. In this case, 
due to greater solubility of free pinene, the binding constant should substantially decrease, 
consequently the differentiation of the ' H signals was too small to be observed and the 
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difference in the magnitude of the ^^ C chemical shifts were reduced.'^ ^ Thus, as a resuh the 
differentiation of the signals of the enantiomeric guest was seen only in the C 
^«««t«,«, 157,163 
spectrum. 
Spin-spin couplings, another NMR parameter, can also exihibit enantiodifferentiation. 
Since spin-spin coupling cannot be directly read out from the spectra of tightly coupled 
spin systems, it has seldom been used in chiral recognition studies, Lipkowitz and 
coworkers'^ ^ determined complexation mduced differences in apparent couplings in.the 
range of 0.01-1 Hz for tryptophan (7) enantiomers complexed by a-CD. The observation of 
enantiodifferentiation of coupling constants is expected to be more reliable for couplings 
mvolving heteronuclei, owing to their usually larger magnitude. 
^ ^ - '^ °° 
+NH3 
The relaxation rates of nuclei are even more difficult to determine than spin-spin couplmg. 
Special experimental techniques and appropriate data reduction have to be applied in order to 
obtain then* values.^^ On the other hand, relaxation rates of many magnetically active 
isotopes can provide valuable information on the dynamics of the system under study.^^' '^ ^ 
Few relaxation studies for the complexes of CDs with enantiomeric guests have been 
reported. Interestingly, not all these works exhibit the differentiation of relaxation rates due 
to chiral recognition. The observations of differences in the relaxation rates of CD 
diastereomeric complexes are scarce and all but one is devoted to the studies of longitudinal 
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relaxation rates. The first systematic study of this effect was carried out for 7-CD complexes 
in D20.'^ Longitudinal relaxation rates for all protons of host and guest molecules were 
determined in free 7 (0.26-2.3 s-'), free a-CD (1.4-5.0 s'') and both diastereomeric 
complexes at a host-to-guest ratio of 1:1. The relaxation rates of 7 increased on complexation 
but were smaller than those for a-CD protons. These results were interpreted in terms of 
larger motional freedom of the guest molecules than that of the host. According to authors, 
larger differential changes in relaxation rates of protons of 7 in the complex with 
R-enantiomer, as compared to those with the S-enantiomer complex, indicated that the latter 
enantiomer binds less tightly to a-CD. The cooperative effects of Coulomb interaction and 
inclusion were assumed to be essential for chiral recognition of anionic phenylacetic acid 
derivatives by several aminated CDs (8, 9).'^^ 
M 
d -IN 
(8) N-6, Ri=R2=H 
(9) N-7, R|=R2=H 
Likewise, the importance of electrostatic interactions for chiral discrimination was proved for 
complexes of charged, cationic and anionic p-CD with various a-aminoacids.'**^ It was 
demonstrated that protonated heptakis(6-amino-6-deoxy)-p-CD favoured the complexation 
with (S)-enantioners of N-acetylated tryptophan (10), phenylalanine (11), leucine (12) and 
valine (13) in their anionic form while the native a- and p-CD did not. Enantiodiflferentiation 
was also found for cations of methyl esters of a-aminoacids interacting with the anionic form 
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of heptakis(6-(thioglycolic acid)-6-deoxy)-p-CD where the (R)-enantiomers were preferred 
guests. 
10 
COOH 
NHCOCH3 
CH, 
HiC COOH 
H X 
11 
CH3 NH2 
12 
COOH 
NH, 
13 
Enantiodifferentiation of anionic tetrahelicene (14) by native CDs was studied using binding 
constants and thermodynamic parameters determined by variable temperature 'H N M R 
titration.'" The binding constant for the (M)-14 was found to be much higher than that for 
the corresponding (P)-14. However, the 2D ROESY measurements indicated a somewhat 
deeper insertion of the (P)-form into the CD cavity. The results were attributed to a 
domination of enthalpy effects in the process of complexation. 
• 0 0 c COO' 
•00c coo~ 
(P)-14 (MH4 
The binding constants and enthalpy change (AH) and entropy change (AS) values were 
determined for both the enantiomers of binaphthyl derivatives (15, 16) with native and 
heptakis(2,3,6-tri-0-methyl)-p-CD.'^ The results revealed that the complexation is 
entropically driven. They also showed that the entropically driven complexation by the 
permethylated derivative differentiated the enantiomers more effectively. 
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Several studies'^*' '^ ^ reported the stoichiometry of CD complexes of enantiomers in 
combination with chemical electrophoresis (CE) enantioseparations, but a distinct difference 
in the stoichiometry of the complexes was observed in only few cases. Thus for example, 
Kano and coworkers'^^ observed different stoichiometrics for the complexes of S- and 
R-l,r-binaphthyl-2,2'diol (17) with heptakis(2,3,6-tri-0-methyl)-P-CD. The stoichiometry 
of S-guest complex was determined to be 2:1 while for R-guest a 1:1 stoichiometry was 
found. 
17 
An article on the structure determination of CD complexes, using NMR spectroscopy in 
relation to CE, was published by Yamashoji et al. in 1992.'^' Subsequently, several studies 
were reported''^' '^ ^ in which the authors tried to explain the quantitative differences 
observed in the behaviour of chiral selectors based on the structure with guest molecules. All 
these studies contributed significantly to a better understanding of CD-guest interactions. 
However, at present it is difficult even with very sophisticated powerful NMR techniques to 
define the structure and dynamics of the complexes on a level providing the key for the 
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explanation of sometimes very fine quantitative differences in the enantioselective 
recognition by different cyclodextrins. 
The ' H N M R titration and ROESY studies of inclusion of l-(4-quinolyl) ethanol (18) by 
per-O-methylated-a-CD evidenced the formation of equatorial and axial complexes of 
(R)- and (S)-enantiomers, respectively.'^'* In addition to the determination of the binding 
constants for both the enantiomers, the fi-ee energy changes (AG) were also determined. 
HO /r^ \ / ' V ' OH 
18-(per-0-methylated)-a-CD complexes 
The screening of the affinity patterns of a wide range of chiral guests towards CD-type chiral 
selectors using CE revealed that the affinity pattern may change depending on the type and 
position of the substituents on the CD rim and on the CD cavity size.'^^ These studies help in 
elucidation of possible structural mechanism of qualitatively different behavior of the CD 
type chiral selectors in CE, in particular, for examples in which the affinity of the 
enantiomers is opposite towards given chiral selectors. 
The enantiomers of the anesthetic drug ketamine (19) possesses an opposite affinity pattern 
towards native a- and p-CD.'^^ ROESY spectroscopy indicated that there are no dramatic 
differences in the structures of the corresponding intermolecular complexes. The enantiomers 
are just more deeply included in the cavity of p-CD compared to a-CD.'^^ Similar to this, no 
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clear differences besides the extent of intermolecular inclusion could be observed between 
the structures of complexes of dimethinden (20) and chlorpheniramine (21) with p-CD and 
heptakis(2,3,6-tri-0-methyl)-p-CD although the enantiomer affinity patterns were opposite 
for all three analytes towards these two CDs.'^^' '^ .^ 
0 ^ v ^ ^ ' 
CI 
19 20 21 
In other examples, however, significant differences in the structures of intermolecular 
complexes could be observed. The enantiomers of clenbuterol (22) showed opposite affinity 
toward native p-CD and heptakis(2,3-0-diacetyl)-p-CD in CE experiments. The splitting of 
the resonance signals due to complexation induced chemical shifts of the protons of the 
enantiomers was primarily observed for the aromatic protons in the case of p-CD and for the 
protons of the tert-butyl moiety of 22 in the case of heptakis(2,3-0-diacetyl)-p-CD. These 
data indicate that the aromatic part of 22 is mainly involved in the interaction with p-CD 
while tert-butyl moiety is involved in the interaction with heptakis(2,3-0-diacetyl)-p-CD.'^^ 
H 
N XH3 
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The chiral cholinergic drug aminoglutethimide (23) shows opposite affinities in CE towards 
p- and y-CD.'^^ The detailed NMR spectroscopic study confirmed the deep inclusion of the 
p-aminophenyl moiety of 23 into the p-CD cavity entering from the wider secondary side 
while the p-aminophenyl ring enters the y-CD cavity from the narrower primary side. The 
glutarimide ring is apparently less involved in the complex formation. However, the 
involvement of the methyl group in complex formation carmot be completely ruled out. 
23 
The complexation of antihistamine drug brompheniramine (24) with p-CD and 
heptakis(2,3,6-tri-0-methyl)-p-CD was studied by ID-ROESY experiments in solution.'^ ** 
For the complexes of (+)-24 with both CDs unambiguous confirmation was obtained 
indicating the inclusion of the 4-bromophenyl moiety of the drug into the CD cavity. In 
addition, in the case of (+)-24 complex with p-CD, the inclusion of the maleate counter ion 
into the p-CD cavity was also indicated, but this contradicts simple geometric considerations 
and the assumption that the stoichiometry of the complex is 1:1. The contradiction was 
solved by the X-ray crystallographic study performed on the monocrystals obtained from a 
1:1 aqueous solution of (+)-24 maleate and p-CD. The stoichiometry of the complex was 
found to be not 1:1 but 1:2 and the brompheniramine maleate is sandwiched between two 
molecules of p-CD. The 4-bromophenyl moiety of the drug enters the cavity of one of the 
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P-CD molecules whereas the cavity of another p-CD molecule is occupied by the maleate 
counter anion. 
24 
In a recent study, 27 cationic chiral analytes were resolved by CE using native p-CD and 
heptakis(2-0-methyl-3,6-di-0-sulfato)-p-CD, having both primary and secondary CD rims 
with 14 bulky sulfate substituents. The bulky substituents on both sides of the cavity entrance 
may hinder inclusion complex formation between chiral analytes and heptakis(2-0-methyl-
3,6-di-0-sulfato)-p-CD. For 12 of 16 chiral analytes resolved with both chiral selectors the 
enantiomer migration order was opposite. Analysis of the structures of analyte-CD 
complexes in solution indicated that, in contrast to mainly inclusion type complexation 
between chiral analytes and p-CD, external complexes were formed between the chiral 
analytes and heptakis(2-0-methyl-3,6-di-0-sulfato)-P-CD.'^^ 
The enantiomers of 23 enantioselectively bind to heptakis(2-0-methyl-3,6-di-0-sulfato)-p-
CD and are resolved with this chiral selector in CE. In addition, significant complexation 
induced chemical shift differences were observed for the protons of 23 enantiomers in NMR 
spectrum of the complex. It was established by ID ROESY experiments that 23 most likely 
does not form an inclusion complex with heptakis(2-0-methyl-3,6-di-0-suIfato)-p-CD. Thus, 
inclusion complex formation between CDs and their chiral guests does not seem to be a 
necessary prerequisite for chiral recognition. 
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In conclusion, multiple forces involved in guest-CD interactions make understanding of guest 
binding and chiral recognition mechanism by CDs extremely difficult. Molecular modeling 
studies when used in combination with instrumental techniques, especially with ROESY 
experiments in NMR spectroscopy and X-ray crystallogr^hy may significantly contribute to 
the understanding of the nature of the intermolecular forces responsible for guest-CD 
interactions and chiral recognition. 
4. Forces Involved in Cyclodextrin Complexation 
The understanding of the driving forces in the inclusion complexation of CDs is 
fundamentally important not only for CD chemistry but also for supramolecular chemistry as 
a whole. A large number of studies have been carried out on the subject and have been 
reviewed earlier.'^' Nevertheless, it is often claimed that the driving forces leading to CD 
complexation still remain a controversial subject. Here we will only discuss the interactions 
between the substrates and the cavity wall of the CD. 
Electrostatic Interactions 
Electrostatic interactions include all kinds of electrostatic forces between permanent charges, 
dipoles and higher dipoles, present in the system. Three types of electrostatic interactions are 
usually most important namely ion-ion, ion-dipole and dipole-dipole interactions. As native 
CDs are neutral molecules, the ion-ion interaction does not occur in CD complexation, unless 
the CD is appropriately substituted. 
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The ion-dipole interaction, on the other hand, is expected to take place in CD complexation 
since CDs are polar molecules though the occurrence of this interaction is difficult to 
establish. The ion-dipole interaction should increase with increasing ionic charge of the 
guest. It can be expected that dianions such as SO4 and CO3 will bind more tightly with 
CDs than ions such as CIO4" and NO3". However, though the complexation of CD with CIO4" 
and NO3' has been observed experimentally, no complexation could be detected for SO4" or 
COs'^'^'The ion-dipole interaction, in aqueous solution, is not necessarily favourable since 
interaction between substrate and water is also strong. Chujo et. al. '^ first calculated the 
dipole moments of CDs, from the published X-ray crystal structures, in the range of 10-20 D 
suggesting that CDs are highly polarized. Later studies showed that dipole moments of CDs 
1 O f 
are highly susceptible to the chemical environment. Smaller dipole moments in the range 
of 2-4 D were obtained for the CDs optimized by various theoretical methods. Since CDs 
have modestly large dipole moments, this must play an important role in their complexation. 
Dipole-Dipole Interaction 
Model studies for the complexation of a-CD with several substituted benzenes such as 
I Ctf. 1 OT 
benzoic acid, p-hydroxybenzoic acid and p-nitrophenor ' were carried out and h was 
found that dipoles of the guest are antiparallel to that of the host. Interestingly, as the 
magnitude of the guest dipole increases, so does the value of the CD dipole but in opposite 
direction. Thus it was concluded that dipole-dipole interaction plays an important role in 
stabilizing the complex as well as determining its orientation. 
The free energy relationship analyses also prove the importance of dipole-dipole interaction 
in CD complexation. The correlation studies between the binding constants of a-CD with 
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4-substituted benzoic acids and the Hammett cr constants of the substituents were carried 
out.'^^ The resuhs showed that as the -COOH group always stays at the positive end of the 
dipole of the host, it is readily understandable that binding is enhanced by electron release 
from the para substituents. However, in the case of complexation of a-CD with benzoate 
anions, it is the electron withdrawing para substituent that favours the binding. This is 
again caused by the dipole-dipole interaction, because in the anion complexes, the 
carboxylate group stays at the negative end of the dipole of the CD. Davies et. al. also 
pointed out the importance of the dipole-dipole interaction in CD complexation based on the 
correlation studies. The Hammett cr values were used to reflect the electronic effects of the 
substituents in the 1, 4-disubstituted benzenes. It was observed that for neutral 
1, 4-disubstituted benzenes, the group with a larger a value is bound in the narrower end of 
the CD cavity because of the favourable dipole-dipole interaction energy. The conclusion 
has been successfully applied to a number of systems'^ and it was found that the exceptions 
to the rule such as complexation of a-CD with para substituted aromatic sulfides, sulfoxides, 
sulfones and ketones are caused by steric hinderance.'^' 
Hamai et. al.'^^ studied the effect of CD complexation on the acidities of several phenol 
derivatives such as 4-nitrophenol, 4-cyanophenol, 4-bromophenol and 4-methoxyphenoI 
which also supported the above results. It was found that, except for 4-methoxyphenol, the 
acidities of phenols were enhanced as a result of CD complexation. The behaviour was 
thought to be due to the dipole moments of the phenols, which are usually directed from the 
hydroxy! group to the para substituent. Thus, the dipole-dipole interaction was concluded to 
be an important factor in CD complexation. 
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Yasuda et. al.'^^ recently performed scanning tunneling microscopy studies on 
self-assembled a-CD inclusion complexes with water, methanol and 4-nitrophenol. The 
observed structures of a-CD-water and a-CD-methanol complexes were different from that 
of a-CD-4-nitrophenol complex. It is believed that the difference reflects the important role 
of the dipole-dipoie interaction in CD compiexation. 
van der Waals Interactions 
The presence of van der Waals forces, which seems to mean either the induction and 
dispersion forces combined or the dispersion force alone, in CD compiexation is reasonable. 
The involvement of van der Waals interaction in the CD compiexation has been claimed by 
many workers. It is generally believed that the hydrophobic interaction between two non-
polar molecules is with a positive enthalpy, the observation of a negative enthalpy change in 
CD compiexation is often considered to indicate the dominance of van der Waals interaction 
instead of hydrophobic interactions.'^ However, as CD compiexation is a complicated 
process, the above argument is not always correct. 
The correlation analysis between the binding strength and structural feature of the substrate is 
a reasonable method to show the involvement of van der Waals interaction in CD 
compiexation. For instance, both the induction and dispersion forces depend on 
polarizability, which in turn is related to molecular size and electron density, and so to the 
correlation variables like molar refraction, molecular volume, surface area, molecular weight 
etc. Thus the correlation between the strength of binding and the above parameters is atleast 
indicative of the importance of van der Waals interaction in CD compiexation.'^^ 
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The involvement of van der Waals interaction in CD compiexation can also be shown by the 
structure of the complexes. In fact, numerous studies have revealed that bulky guest 
molecules are in close van der Waals contact with the CD cavities.'^ Interestingly, 
sometimes van der Waals interaction might be so strong that the hydrophobic but bulky side 
of the guest molecule can enter the CD cavity. Moreover, the fact that CDs can form stable 
complexes with the guest molecules in pure organic solvents such as DMF, DMSO and even 
heptanes evidently demonstrates that van der Waals interaction is essentially important.'^^' '^ ^ 
The involvement of van der Waals interaction in CD compiexation has also been shown by 
molecular modeling'^ which is usually performed with molecular mechanic and molecular 
dynamic calculations. Most of the modeling studies were performed in the gas phase so that 
the solvent effect plays no role in the results. Many authors concluded, from these 
calculations, that van der Waals interaction makes the major contribution to the formation of 
CD complexes. This conclusion is not unexpected because in the calculations the energetic 
contributions from the dehydration and hydration of the host, guest and their complex, and 
from the reorganization of the solvent molecules were not taken into consideration. Whether, 
or not, van der Waals interaction plays a major role in CD compiexation in solution in not 
clear. 
It should be mentioned that van der Waals interactions also exist between the solvent 
molecules and the substrates of CD. Thus, in the CD compiexation the substrate is 
exchanging one set of van der Waals interaction (with the solvent molecules) for another set 
(with the CD cavity). In fact, this type of exchange is the reason why the ion-dipole 
interaction is not significant in CD compiexation. However, as the polarizability of water is 
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much lower than that of the organic substrate lining the CD cavity, it is expected that van der 
Waals interaction should be stronger between CD and the substrates than between water and 
the substrates. As a result, van der Waals interaction has a positive contribution to complex 
stability. This effect can be shown by the complexation of CDs with inorganic ions such as 
CIO4' and NOa'.^^ Apparently, hydrophobic interaction cannot make a contribution in these 
systems. As the ion-dipole interaction might be stronger between water and the ions than 
between CD and the ions, the only possible driving force leading to complexation is van der 
Waals interaction. 
Hydrophobic Interaction 
The role of hydrophobic interaction in CD complexation is a controversial problem. 
Traditionally, hydrophobicity was considered to be the result of the enhanced structure of the 
water molecules in the near vicinity of the non-polar solute, which would bring about a 
usually large entropy loss during the hydration.^ * '^ However, neither the neutron scattering 
measurements nor the computer simulations indicated any evidence that the structure of the 
water of hydration close to a non-polar solute was more ordered than that of water in the 
bulk.^ "^ 
In the experimental studies, however, the association of non-polar molecules in water is 
usually foimd to be with positive enthalpy and positive entropy change. This has long been 
taken as the experimental signature of hydrophobic interaction. The fact that most of the 
experimental enthalpy and entropy changes of CD complexation are negative seems to 
indicate that the hydrophobic interaction is not an important driving force in CD molecular 
recognition/complexation. It was suspected that the above experimental observation was not 
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representative enough, possibly, because all the guest molecules that had been studied were 
not sufficiently hydrophobic. Thus, the a-CD complexation with 1-adamantanecarboxylate 
was studied, and the observed positive entropy was believed to settle the issue. 
Unfortunately, a reinvestigation of the system showed that the entropy change is still 
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negative. 
The above problem can be settled if we notice that in CD complexation many interactions 
other than the hydrophobic interaction are also involved. For example, unlike that in the 
aggregation of two small non-polar molecules, the van der Waals interaction between CD 
and the guest is quite strong. As the interaction is attractive in nature and it tends to restrict 
the conformational freedom of the complex, it is possible that the total enthalpy and entropy 
of the complexation are both negative in spite of the presence of the hydrophobic interaction. 
Moreover, it is well known that the transfer of non-polar gases into water is associated with a 
large positive heat capacity change. Therefore, the fact that CD complexation is often 
accompanied with a large negative heat capacity change also demonstrates that the 
hydrophobic interaction is important in association.'^ *' 
In addition to using the thermodynamic criteria, there are several other methods to show the 
involvement of hydrophobic interactions. In CD chemistry, the most compelling evidence in 
favour of the presence of hydrophobic interaction is the repeated observation that in the CD 
complexes the most non-polar portions of the guest molecules are usually enclosed in CD 
cavities. 
The involvement of the hydrophobic interaction in CD complexation can also be shown by 
the correlation analyses as, in general, increasing the hydrophobicity of the substituents of 
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the guest enhances the complexation.^^ Parameters of hydrophobicity including the partition 
coefficient log P and the hydrophobic surface area are frequently chosen. Sometimes, the 
correlation between the binding strength and the number of the carbon atoms of a 
homologous series of substrates is also taken as evidence of hydrophobic mteraction. As an 
increment of -3,0 KJ/mol in the standard free energy of complexation for each methylene 
group is observed, which is close to the value in the transfer of homologous organic 
compounds from water to hydrocarbon solvent, it is repeatedly suggested that the binding 
mechanism of CD is of a hydrophobic nature.^^^ 
Another evidence of the hydrophobic interaction is that the strength of the CD complexation 
is usually weakened upon the addition of organic co-solvent. Addition of inorganic salts, 
on the other hand, tends to strengthen the binding, simply because it makes the bulk solution 
more polar. The binding constants of CD complexes also increase when D2O is used as the 
solvent instead of H2O which might be caused by the fact that hydrophobic interaction is 
stronger in D2O than in H20.^^ 
Hydrogen Bonding 
The role of the hydrogen bonding in CD complexation has been well established for the 
complexes in solid state.^ ^*' The study of a number of crystal structures of CD complexes 
have clearly shown the well defined hydrogen bonding between the substrates and the 
hydroxyls of CDs. Usually, the host-guest hydrogen bonding is restricted to the primary 
0(6)-H groups of CDs because they are flexible and can rotate, in contrast to the secondary 
0(2)-H and 0(3)-H groups which are rigid due to the preferred ^C\ form of the glucose units. 
52 
However, it should be mentioned that sometimes there are also C-H....O , C-H....N and 
C-H..../?/^'^ interactions between the cavity wall of CDs and the guest molecules. 
On the other hand, the role of the hydrogen bonding in CD complexation in aqueous solution 
is still controversial. The primary reason for the problem is that water can compete with CDs 
to form the hydrogen bonds with the substrate molecules. For example, molecular dynamic 
calculations on the complexation of a-CD with p-chlorophenol and p-hydroxybenzoic acid in 
water clearly indicated that the hydrogen bond is rarely formed between CD and the 
substrates. '^"* Thus, it was concluded that hydrogen bonding plays a minor role in 
complexation. Besides, it has been demonstrated that although in the solid complex of a-CD 
with 4-fluorophenol the OH group of phenol is hidden inside the CD cavity,^'^ in aqueous 
solution the F atom remains inside and OH group outside the CD cavity.' 216 
Nevertheless, examples of hydrogen bonding in CD complexation in aqueous solution have 
been shown by some authors. For instance, in the study of the complexation of y-CD with 
pamoic acid, the large observed binding constants were thought to indicate the occurrence of 
hydrogen bonding between the carboxylate of the guest and a secondary OH of CD.^'^ 
Sometimes, the occurrence of hydrogen bonding in CD complexation can be detected with 
spectroscopic methods. For example, Takahashi et. al.^'^ used the ' H and '^ N NMR 
techniques to study the interaction of aspartame with p-CD in aqueous solution. It was 
concluded that the amide part of aspartame was hydrogen bonded in CD complexation in 
aqueous solution. Recently, Chen et. al.^'^ studied thepH dependance of the complexation of 
3-hydroxynaphthalene-2-carboxylic acid with P-CD. It was found that with increasing pH 
07H<11), the binding constant decreases probably because the deprotonated substrate is more 
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hydrophilic. However, at pH > 11 the binding constant increases as the pH value rises. The 
behaviour was thought to be due to the hydrogen bonding between the deprotonated 
secondary OH of CD and the hydroxyl group of the guest at the pH range. After p-CD is 
permethylated, there is a Httle change in the binding constant atpH > U with increasing/?H 
value, presumably because permethylated p-CD cannot be deprotonated under the same 
conditions. Thus it was concluded that hydrogen bonding plays an important role in the CD 
complexation. 
Relief of Conformational Strain 
The conformation of a CD in the solid state is usually less symmetrical than that in solution. 
The crystalline packing and the presence of water molecules in the solid state are, probably, 
responsible for this behaviour. Saenger and coworkers^^^ assumed that the deviation from the 
symmetrical conformation of the CDs in the solid state constitutes a store of energy whose 
relief upon complexation is a driving force for the complexation. This was identified as an 
"induced fit" mechanism. However, p- and y-CDs exist in nearly symmetrical conformations 
in solid state, yet their complexes tend to be stronger than those of a-CD rendering the 
doubts about the strain relief hypothesis. Actually, the hypothesis is not relevant to the 
complexation of CDs in solution. Though it is possibly true that a CD in the solid state has a 
higher conformational energy than that in solution, the thermodynamics of the CD 
complexation in solution does not involve the energy of a solid state CD. Eftink et. al.^^' 
pointed out that conversion of the a-CD from its distorted to symmetrical conformation must 
cost energy, the process cannot be a source of energy for the complexation. Thus there seems 
no support for the relief of conformational strain as a driving force for the CD complexation. 
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Release of Cavity-Bound High-Energy Water 
Two water molecules are present in the a-CD cavity in the solid state. As the CD cavity is 
relatively non-polar, the water molecules included in the CD cavity should lack the 
complement of stabilizing hydrogen bonds that would be available to them in the bulk 
aqueous solution. Thus the water molecules in the CD cavity are energy-rich than those in the 
bulk solution whose release upon complexation was postulated as a driving force leading to 
the complex formation.^^ This hypothesis was largely developed around the observations on 
a-CD. 
Takagi et. al.^ ^^ have tried to estimate the thermodynamics of inclusion separately from 
solvation effect which supports this hypothesis but the problem with the high energy water 
hypothesis is that it focuses on the water and neglects the CD or more generally it fails to 
consider the energetics of the entire system. The cavity bound water molecules may well be 
enthalpy rich but they should have more conformational freedom than the water molecules in 
the bulk solution because of the lack of hydrogen bonding. Although, the release of the 
cavity-bound water is accompanied with a negative enthalpy change, the free energy change 
of the process is not necessarily negative. The reorganization of the solvent molecules is 
actually a process of enthalpy-entropy compensation without any free energy contribution. 
As a result, the release of cavity-bound high-energy water is not considered a driving force 
for the complexation. 
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Charge-Transfer Interaction \- ^ ^  _ ^ ^ ' 
Charge-transfer interaction is usually considered a type of v S deFwaals interaction. It 
needs to be discussed separately, however, since in the area of CD chemistry the term van der 
Waals interaction usually refers to the combination of induction and dispersion forces. In the 
CD chemistry, in addition to the charge-transfer interaction between the substituent groups of 
CDs and the guest,^ ^^ charge-transfer interaction between the CD skeleton and the substrate 
has also been observed and it has been recently suggested to be a driving force in CD 
complexation. The role of charge-transfer interaction in the CD complexation can be shown 
by the fact that (1) the binding constant of a-CD complex of the 1, 4-dicyanobenzene radical 
anion is 45 times larger than that of neutral 1, 4-dicyanobenzene-a-CD complex^^^ (2) the 
binding constant of the p-CD complex of neutral 10-methyIphenothiazine is 35 times smaller 
than that of the 10-methylphenothiazine radical cation complex^^^ (3) the binding constant of 
a-CD with the singlet xanthone is much more stable than that with the triplet one.^ ^* 
Conclusion 
The driving forces leading to the inclusion complexation of CDs should include the 
electrostatic interaction, van der Waals interaction, hydrophobic interaction, hydrogen 
bonding, and the charge transfer interaction. However, enthalpy-entropy compensation, 
release of conformational strain and release of cavity-bound high-energy water are not 
energetically contributive to the complex formation. Furthermore, van der Waals interaction 
and hydrophobic interaction constitute the major driving forces for CD complexation 
whereas electrostatic interaction and hydrogen bonding can significantly affect the 
conformation of a particular inclusion complex. 
generaC (Discussion 
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NMR spectroscopy has become the most important tool for the structural elucidation of 
organic compoimds, particularly in the solution state. The method is of increasing 
significance for most CD application studies. There are few alternatives to NMR 
spectroscopy in the CD related studies. 
As with many carbohydrates, it is often difficult to obtain single crystals of CD 
derivatives and then to analyze them by X-ray crystallography, or by neutron diffraction. 
Other techniques such as fluorescence, UV/visible spectroscopy, calorimetry etc. play a 
major role in measuring complexation energetics with CDs but usually provide very 
indirect and qualitative information about inclusion modes and geometries. 
Structure determination is of particular importance for supramolecular host-guest 
complexes, which are the basis of most CD applications in medicine, catalysis, separation 
and sensor technology and also food chemistry. Pharmaceutical uses of CDs for drug 
protection or targeting now legally require structure determination of the administered 
compounds. NMR spectroscopy is also becoming an important tool for in vitro, in future 
perhaps even for in vivo, studies of CD interactions with biological macromolecules such 
as nucleic acids, proteins, or cell membranes. The most obvious incentive to use NMR 
techniques for the investigation of CD complexes is the interest to understand the driving 
forces and binding modes in these non-covalent associations, and then to make optimeil 
use of these factors for new applications. It should be remembered that the driving force 
for CD inclusion often is of solvophobic nature and that most CD applications involve 
action in a liquid matrix, which emphasizes again the role of NMR spectroscopy as the 
most important method applicable in solution. 
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After the first publication on the use of NMR spectroscopy to study inclusion 
phenomenon by Demarco and Thakkar,^^^ there has been a virtual explosion of such 
studies. The older work was restricted to the observation of few CD protons, mostly at 
the anomeric centers which were sufficiently separated from other strongly coupled 
signals. The advent of high-field instruments and in particular 2D methods has 
completely changed the situation, and the possibilities of now available NMR techniques 
are far from being exploited. Nuclear Overhauser Effects (NOEs) have already become a 
major tool in structural studies of complex biomolecules. 
The spectacular advances of NMR techniques, have led to much more detailed structural 
information of CDs and their complexes. These tasks represent a fascinating challenge 
for the NMR spectroscopist in view of the high complexity of the underlying 
cycloamylose ' H NMR spin systems.^^'*'^^ These are characterized by signals which, 
apart from the anomeric proton, absorb in a range of only 0.5 ppm and are strongly 
coupled. In addition, the shielding effects of the CD cavity on the included guest 
molecules are limited to a few tenths of a ppm at most, as a consequence of a host 
framework being buih up entirely of single, less polar and polarizable bonds and thus 
weak shift tensors. 
The aim of the present discussion is not to discuss or even to mention all the work on the 
study of the CD complexes using NMR spectroscopy. Instead we will illustrate the use of 
NMR techniques in the structure elucidation of CD inclusion complexes with some 
representative examples, yet without a special focus on this method. 
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Demarco and Thakkar first noticed the highfield chemical shift changes in the p-CD 
cavity protons, namely H-3' and H-5', in the presence of a variety of aromatic substrates 
in aqueous solution and envisaged from these observations that the aromatic ring is 
positioned in the [3-CD cavity. This observation later became the basis for NMR 
spectroscopic study of the CD inclusion complexes. He used 100 MHz instrument for 
these studies which is actually not suited for this type of work because all the CD 
protons, except H-T, resonate in the 0.5 ppm range and are not easily distinguished. He 
established the assignment for each proton on the basis of analysis of individual splitting 
patterns and coupling constants at 220 MHz, decoupling experiments and expected 
chemical behaviour i.e. H-3' and H-5', being 1, 3-diaxial to the Cj axial oxygen should 
resonate at lower fields than the H-2' and H-4' protons. 
At magnetic fields above 9.4 T, corresponding to 400 MHz for the 'H NMR spectra, the 
dispersion is high enough to locate, in conventional one dimensional spectra, most of the 
CD protons, eased by the high symmetry of the macrocycles. The 'H NMR spectrum of 
p-CD in aqueous solution has already been assigned in detail. It has been established that, 
on the NMR time scale, all the seven glucose units have identical conformations and the 
molecule is highly symmetrical. Furthermore, the magnitude of the vicinal coupling 
constants J], 2 through to J4,5 are consistent with the C| chair form for the glucose units of 
CDs.^" 
It is now well accepted that the signals of the cavity protons move highfield when the 
guest molecule or a part of it enters the CD cavity. The chemical shift change data 
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obtained from ' H N M R titration experiments can be used to determine stoichiometry, 
binding constant and is thus helpful in the determination of structure of the complex. 
The magnitude of the chemical shift changes for the protons positioned in the CD-cavity, 
A5H-3' and A5H-5', increases with an increase in the concentration of the guest while that 
for guest protons increases with an increase in the concentration of the CD.^'^ The 
magnitude of the A8H-3' and A5H-5' also depends on the nature of the guest. The chemical 
shift changes are high in the case of aromatic guests while these are relatively small if the 
aliphatic guest enters the CD cavity. Salbutamol (25) forms a 1:1 inclusion complex with 
p-CD whose structure has been confirmed by detailed NMR spectroscopic and molecular 
modeling studies (Fig. 4).^ "'^  It has been established that aliphatic part of the guest enters 
the CD cavity. Fig. 5 shows very small shift changes in the p-CD cavity protons in the 
presence of salbutamol. On the other hand these shift changes are quite large when 
aromatic ring of (IS, 2R)-(+)-ephedrine (26) enters the P-CD cavity.^ '^ ^ 
H3C,,, J., 
r^ 'OH 
.NH 
HaC^ 
Salbutamol-p-CD complex (1S, 2R)-(+)-Ephedrine-P-CD complex 
Fig. 4 Structures of mclusion complexes of salbutamol and (IS, 2R)-(+)-ephedrine. 
(B) 
H-3' H-6' 
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, H-4-
H-2' H-4' 
P-CD H_3 
H.2' H-4' 
i .C 3.S 
Fig. 5 Comparative chemical shift changes in the p-CD cavity protons upon inclusion of 
an aromatic guest (A) and an aliphatic guest (B). The [H]/[G] is same in both the cases. 
The CDs generally act as one site ligand and the guest enters the cavity from wider rim 
side. This is always true for a-CD but in the case of p- and y-CDs, complexes formed by 
the penetration of the guest from the narrower rim side have also been reported."" The 
relative chemical shift change data for the cavity protons (ASH-J- and A8H-S*) is sometimes 
taken as an evidence for the mode of penetration of the guest, ft has been suggested that 
in the cases where A6H.3->A6H.5' the guest entry is from wider side'^ ** and vice versa.^ "*^  
This statement may be true only when the guest is bulky but can not be generalized. 
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Kano'^^ studied the complexation of pure enantiomers of binaphthyl derivatives with 
various CDs. The chemical shift changes observed for H-3' of heptakis(2, 3, 6-tri-O-
methyl)-P-CD (TMe-p-CD) were quite high compared to those for H-5' (A8H-3'>ASH-5-) 
in the presence of 1, r-binaphthyl-2, 2'-diyl hydrogen phosphate (27). It was estabHshed 
that 27 is shallowly bound to the wider side of the TMe-p-CD cavity. The guest being 
bulky cannot penetrate deep into the cavity. Moreover, the mode of penetration of the two 
enantiomers was found different. (Fig. 6) 
\ / 
A 
•o o 
(R)-27-TMe-p-CD complex (S)-27-TMe-P-CD complex 
Fig, 6 Modes of penetration of two enantiomers of 27 into the p-CD cavity. 
He also studied the complexation of several helical metal complexes with modified CDs. 
A-Ru(phen)3^^ ion (28) forms a 1:1 complex with heptakis(6-carboxymethylthio-6-
deoxy)-p-CD (per-C02"-p-CD) (Fig.7). It has been shown that the guest approaches the 
cavity from narrower rim side and for this complex the chemical shift for H-5' was quite 
high compared to that for H-3' (A6H-5>A8H-3).^'*^ These examples show that the relative 
values for A5H-3' and A6H-5' can be used in support of the mode of penetration of guest 
into the CD cavity.^ "*^  
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ooc. 
28 Model of 28-(per-C02')-p-CD complex 
Fig. 7 Mode of inclusion of 28 into the (per-C02")-p-CD cavity. 
Rekharsky,^ '*^ however, made a detailed ' H N M R study of the CD inclusion complexes of 
a variety of guests and showed that while the magnitude of the chemical shift changes for 
H-3' and H-5' protons is a quantitative measure of the stability of the complexes, their 
ratios, A5H-5'/A8H.3', are related to the depth of penetration of the guest into the CD cavity. 
In all the studied cases, the guest approached the p-CD cavity from wider rim side though 
A5H-5'>A5H-3'. He showed that higher magnitude of A5H-3' and A5H-5' values is due to 
higher stability of the complex. On the other hand, their ratios, A6H-5'/A5H-3'. which were 
found as high as 1.2-3.0 for P-CD indicate a deep penetration of the guest into the host 
cavity. It becomes obvious from these examples that the use of relative magnitude of 
chemical shift changes for cavity protons as an evidence in support of the mode of 
penetration of guest into the CD cavity cannot be generalized (Table 7). In fact the mode 
of penetration can better be determined by the NOE experiments. 
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Table 7 Chemical shift changes (A5) of H-3' and H-5' of P-CD protons upon 
complexation with selected ligands in buffered aqueous solutions at pD = 7.0 and 
7'=298.15 K. The mode of penetration of the guest into the p-CD cavity is from wider 
rim side in all the cases. 
Ligand 
Phenethylamine 
L-a-0-Benzylglycerol 
1-Benzylimidazole 
4-Benzylpiperidine 
]-Butylimidazole 
(IS, 2S)-(+)-Pseudoephedrine 
(lS,2RH+)-Ephedrine 
(IR,2SH-)-Ephedrine 
Hydrocinnamate 
Phenyl-(3-D-glucopyranoside 
3-Phenyl-1 -propylamine 
»Gi/rH! 
0.94 
0.59 
0.77 
0.94 
0.95 
0.98 
1.00 
0.97 
0.92 
0.81 
1.03 
H-3' 
0.03 
0.03 
0.09 
0.14 
0.05 
0.07 
0.07 
0.06 
0.04 
0.02 
0.10 
H-5' 
0.06 
0.09 
0.18 
0.22 
0.09 
0.12 
0.12 
0.10 
0.10 
0.05 
0.12 
H-5'/H-3' 
2.0 
3.0 
2.0 
1.6 
1.8 
1.7 
1.7 
1.7 
2.5 
2.5 
1.2 
The formation of the CD inclusion complex also results in the concomitant chemical shift 
changes for the guest protons and generally all the guest protons, and not only the part 
included in the CD cavity, show downfield shift changes, but sometimes upfield changes 
are also observed.^'^ These changes have mostly been found to be of qualitative 
significance though these may also provide important information regarding the structure 
of the complex. 
Due to low water solubility of the guest, sometimes it is not possible to use high 
concentration of the guest in the NMR titrations and in such cases the chemical shift 
changes observed for the CD cavity protons may be very insignificant while large 
chemical shift changes are observed for guest protons. The chemical shift change data for 
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guest protons can be used for determining stoichiometry and binding constant of the 
complex but whether guest enters the CD cavity or not can only be said on basis of 
chemical shift changes in the cavity protons. ROESY experiments may be required in 
such cases to ascertain whether guest has actually entered the CD cavity. 
Nuclear Overhauser Effect (NOE) 
Beside the chemical shift changes, observed for hosts and guests, upon complexation 
relative to unbound state, detection of the through-space dipole-dipole interactions 
(NOE and/or ROESY) between the CDs and the guests is another important probe of the 
structure of complexes. NOEs have been used for the study of CD complexes in solution 
since the pioneering work of Bergeron and Rowen?'*^ Though the advent of high magnetic 
fields has greatly enhanced the dispersion of signals; at the same time, however, the 
unfavourable correlation times of complexes with molecular weights around 10^  lead to a 
drop of the observed NOEs, e.g. fi-om 34% at 90 MHz to 9% at 250 MHz. To obtain 
sizeable NOEs on a 400 or 500 MHz instrument, application of spin-lock techniques such 
as ROESY are required.^ '*^ In the ROESY spectra, artifacts which possess phase 
properties different than genuine NOE cross peaks are fi-equently observed between 
resonances within a common J-coupling network, thus being easily distinguishable. 
Intermolecularly, as in the case of CD complexes, these COSY-type peaks are not 
observed; however, false cross peaks with the same phase as genuine interactions may 
arise from scalar transfer fi-om H-3' and/or H-5', the cavity protons being most prone to 
interact dipolarly with the guest. 
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The use of NOEs in the structure elucidation of CD complexes is exemplified by few 
representative examples. A typical NOE application is illustrated with a-CD complexes 
with phenol derivatives. Fig. 8 describes different inclusion modes for the cyclodextrins 
complexes with phenol derivatives and, obviously, all three modes should lead to quite 
different NOEs and should be distinguishable this way. 
Mode t Mode II Mode III 
Fig. 8 Various possible modes of penetration of phenol derivatives into the CD cavity. 
For Mode I with no or little immersion of the phenyl ring into the cavity there is a 
sizeable contact only between the guest Hm and H-3' of a-CD and one can expect only 
small ROE at Hm upon irradiation of H-3'. For Mode II irradiation at H-3' should lead to 
ROE of both Ho and Hm signals, at H-5' only of the m-proton. In contrast, no effect on 
the Hm signal upon irradiation of H-5' can be expected for Mode III. The 2D ROESY 
spectrum of the p-iodophenolate with a-CD (Fig 9) shows only those cross peaks 
discussed for Mode II.^ '*^  
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II., H„ H-r H-5' H-3' 
i 44^ 
-^ 
Fig. 9 Part of the ROESY spectrum showing intermolecular cross peaks between the p-
iodophenolate and a-CD cavity protons supporting the inclusion Mode II. 
Another interesting example is structure elucidation of a 1:1 complex between benzoic 
acid and p-CD.^ **^  1D ROESY experiments were performed to confirm the structure of 
the complex. The NOEs on the CD protons were studied on saturation of various 
aromatic protons. The irradiation of Hp did not show any NOE on the CD cavity protons. 
However, intermolecular NOEs were observed on saturation of Ho, Hm, H-3' and H-5'. 
Almost equal NOE values were observed on both the cavity protons when Ho was 
irradiated, while the NOE value for H^ to H-3' was larger than for H^ and H-5'. These 
results clearly suggest an inclusion geometry with the aromatic Hp proton located at the 
68 
CD equatorial plane, Hp on the chiral vertical axis, and Ho at similar distances from both 
the cavity protons. Both the geometries are compatible with this NOE data. However, 
NOEs on both the cavity protons upon saturation of Hm can only be explained when a fast 
equilibrium exists between the two inclusion complexes (Fig. 10). 
V-H-3 
VH-S 
1 ^ 
[-Hm / 
COOH / 
VH-3 
VH-5 
\ 
COOH / 
^ Hm / 
Fig. 10 Structures of two 1:1 p-CD-benzoic acid inclusion complexes. 
The use of ROESY in the study of chiral recognition mechanism is exemplified by the 
following example. Chiral recognition of an anionic tetrahelicene (29) has been studied 
by native CDs. Fig. 11 shows the ROESY spectra of p-CD-(M)-29 and P-CD-(P)-29 
systems in D2O which show the different connectivities of the cavity protons with the 
protons of two enantiomers. It was interpreted from these results that both the CO2' 
groups of 29 are placed near the rim of the secondary OH group side of p-CD and ring A 
of the 29 penetrate the p-CD cavity. It was shown that there was somewhat deeper 
penetration of the ring A of (P)-29 compared to that of (M)-29 into the CD cavity.^ ^^ 
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H-6 
fig. 11 ROESY spectra of (P)-29-P-CD and (M)-29-p-CD complexes. 
Stoichiometry and Binding Constant of the Complex 
The most commonly claimed stoichiometric ratio for CD complexes is 1:1 which is 
usually justified. Nevertheless, other ratios are known, most common of these probably 
being 2:1 (H/G) while the ratios 1:2 and 2:2 have also been reported. 237 
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Before any structural or association constant determination is performed, it is always 
essential to determine the stoichiometry of the host-guest complex which is readily 
achieved from NMR titration data. There are several methods used to determine the 
stoichiometry, namely continuous variation method (Job's Plot), molar ratio method and 
several modified Benesi-Hildebrand methods. 
Job's Plo^*'' 
The method of continuous variations involves preparing a series of solutions containing 
both the host and the guest in varying proportions so that a complete range of mole ratios 
is sampled (0> [H]/[H]+[G] <1) and where the total concentration [H]+[G] is kept 
constant for each solution. The experimentally observed parameter is a host or guest 
chemical shift that is sensitive to complex formation. The data are plotted in the form 
[H]A6obs verses [H]/[H]+[G]. The position of the maximum indicates the stoichiometry of 
the complex (Fig. 12). 
50 The Mole-Ratio Method 
In this method a series of solutions is prepared in which the formal concentration of one 
of the components is held constant while that of the other is varied. A plot of the 
chemical shift change (A6) verses mole ratio of the components is then prepared. If the 
formation constant is reasonably favourable, two straight lines of different slopes are 
obtained; the intersection occurs at a mole ratio corresponding to the combining ratio in 
the complex (Fig. 13). 
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0.08 
Fig. 12 A typical Job's plot for 1:1 complex. 
D,2D 
Fig. 13 A typical molar ratio plot showing 1:1 stoichiometry of the complex. 
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Modifications of Benesi-Hildebrand Method 
The stoichiometry and stability constant of the inclusion complex can also be 
determined by any of the following methods. Assuming that the composition of the 
complex is 1:1, the following expression can be written: 
G + H ^ GH 
The association constant of the complex {K^ is given by 
[GH] 
K,= [H] [G] 
where [H], [G] and [GH] are equilibrium concentration of host, guest and complex, 
respectively. Benesi-Hildebrand studied the complexation of iodine with aromatic 
hydrocarbons by UV-visible spectroscopy and derived the following linear equation 
(equation 1) for the calculation oi Kg^\ 
max (1) 
where Sobs is the extinction of a layer of solution 1 cm deep containing m moles of I2 and 
Gmax is the molar extinction coefficient of the complex at the wavelength of maximum 
absorption. NMR version of the Benesi-Hildebrand equation was independently derived 
by Mathur et. al. ^ and Hannah and Ashbaugh^^^ (equation 2). 
1/A8„b, = l/(iS:.A8„,,|H|) + 1/A5 
max (2) 
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where A5obs = (Sc-^obs) and ASmax =(6ci-SGH )• 
A plot of 1/A6„bs against 1/[H] (often referred to as a double reciprocal plot) should be 
linear for a 1:1 complex, with a slope l/ZCaASmax and intercept l/ASmax allowing the 
determination of stability constant (K^). This expression is valid when observing one 
species in presence of a large excess of the other species. 
An alternative solution of Benesi-Hildebrand equation has been proposed by Foster and 
Fyfe (equation 3)? '^* 
A6obs/|Hl = K^ ASobs + K, A8„„ (3) 
This is a special form of the more general Scatchard plot.^ ^^ In the Foster-Fyfe procedure, 
a plot of A6obs/[H] against A6obs (referred as an x-reciprocal plot) should be linear for a 1:1 
complex. The gradient is equal to -K^ and the intercept gives ASmax- This modification 
requires an extrapolation to infinitely dilute solution and the Ka is not dependent on the 
extrapolation. 
Another modification of Benesi-Hildebrand equation is Scott equation (equation 4).^ *^ 
[H]/A6oi« = IH1/A6„„ + Aa^^/iTa (4) 
In the Scott procedure, a plot of [H]/A5obs is plotted against [H] (referred to as a y-
reciprocal plot) which should be linear for a 1:1 complex with a slope 1/A8max and 
intercept A6max/Ka allowing the estimation of stability constant (Ka). 
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The stoichiometry and stability constant of the 1:1 tetramethrin and p-CD inclusion 
complex were determined by spectrofluorometry^" through double reciprocal plot 
(equation 5).^ ^^ 
1/AFob, = l/(/:aAFn,3,|H|) + 1/AF^,, (5) 
where AFobs denotes the change in fluorescence intensity of tetramethrin in the presence 
of p-CD compared to pure tetramethrin and AFmax change in fluorescence intensity of 
tetramethrin, when all of its molecules are complexed with p-CD, compared to pure 
tetramethrin while other symbols have their usual meaning. The equation is identical to 
the Hannah and Ashbaugh modification (equation 2) except that a different property of 
the complex is studied. 
Now, assuming the complex to be 1:2, the following expression can be written: 
G + 2H ^ GH2 
if [H]»[GH2l»[GH] then the following linear expression (equation 6) is obtained for 
calculating stability constant by fluorospectrometry. 
l/AF,bs = V{K,A¥^,Am^) + 1/AF„,, (6) 
where symbols have their usual meaning. A plot of 1/AFobs against 1/[H] gives a straight 
line for a 1:2 complex. Thus, the NMR version of this equation can t>e written as: 
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1/A6,bs=l/(^.A6„„IH|') + 1/A6 
max (7) 
A plot of l/A5obs verses 1/[H]^ should be a straight line for 1:2 complex with a slope 
l/A'aA8maxand intercept 1/A6max allowing the determination of stability constant. 
These are conditional values in which activilv coefficients are not considered. 
Throughout the above discussion it is assumed that the guest molecule is the observed 
species. It does not matter which species is observed and the most readily observed and 
responsive molecule would normally be chosen. The data treatment for observed host is 
identical, with host and guest symbols switched. 
Throughout discussion the CD protons are numbered as H-l ' to H-6'. 
^^KWd^Spectroscopk Study of 
Compkj^ation of ^ ^ticCine Acetate 
HydrocfiCoride witfi ^ -CydJodej^ttin 
Roxatidine acetate hydrochloride (RAH), chemically known as N-{3-[(a-piperidino-m-
toIyl)oxy]propyl} glycolamide acetate mono hydrochloride, is a histamine H2 receptor 
antagonist.^ ^^ The drug is recommended for the management of benign and post operative 
ulcer, as it does not appear to affect cytochrome P450 and is therefore considered to have 
little effect on metabolism of other drugs.^^ 
0 
'' N06 . '-^  
0 18 XH3 
19 
Roxatidine acetate 
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Experimental 
'H N M R spectra of pure RAH (Fig. 14) and five mixtures of RAH and p-CD 
(Figs. 15-19) were recorded in D2O at room temperature and the chemical shift values 
were recorded in 6 (ppm). 'H NMR spectra for pure RAH and two mixtures (A, B) were 
recorded on a 200 MHz instrument while those for three mixtures (C-E) were recorded on 
a 300 MHz instrument. The chemical shift change data for p-CD protons was obtained, 
relative to reported data, by keeping the concentration of P-CD constant while varying 
the concentration of RAH. The molar ratios ([RAH]/[p-CD]) were calculated by direct 
integration of appropriate signals. Alt the spectra consisted of one set of concentration 
dependent resonances for each proton or group of equivalent protons indicating a fast 
reversible exchange between free and complexed RAH on the NMR time scale. 
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Fig. 14 'H NMR spectrum (200 MHz) of pure roxatidine acetate hydrochloride. 
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Fig. 15 'H NMR spectrum (200 MHz) of a mixture of roxatidine acetate hydrochloride and 
P-CD having a molar ratio ([RAH1/[P-CD]) equal to 0.77. 
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Fig. 16 'H NMR spectrum (200 MHz) of a mixture of roxatidine acetate hydrochloride and 
3-CD having a molar ratio (fRAHl/fP-CD]) equal to 1.19. 
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Fig. 17 'H NMR spectrum (200 MHz) of a mixture of roxatidine acetate hydrochloride and 
P-CD having a molar ratio ([RAHl/fP-CDD equal to 1.96. 
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Fig, 18 'H NMR spectrum (200 MHz) of a mixture of roxatidine acetate hydrochloride and 
P-CD having a molar ratio (f RAH1/[P-CD]) equal to 3.50. 
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Fig. 19 'H NMR spectrum (200 MHz) of a mixture of roxatidine acetate hydrochloride and 
3-CD having a molar ratio ([RAHyrP-CDD equal to 4.55. 
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Result and Discussion 
^H NMR Chemical Shift Change Data ofP-CD 
The protons situated in the p-CD cavity, namely H-3' and H-5', exhibited significant 
highfield shift changes in the presence of RAH which increased with the increasing 
concentration of RAH while other P-CD protons did not show any significant chemical 
shift changes. Fig. 20 shows changes in the chemical shifts of p-CD protons in the 
presence of RAH compared to pure p-CD while the ' H NMR chemical shift change data 
for all the p-CD protons is given in Table 8. The highfield shift changes in the p-CD 
cavity protons confirmed the inclusion of the RAH into the p-CD cavity resulting in the 
formation of RAH-p-CD complex, as reported earlier.^^^'^^'^^'-^^^ 
h 
3.5 3.0 3J 3.0 3.50 3.25 
k 
3.50 3.25 
Fig. 20 Part of the H NMR spectra of mixtures of RAH and p-CD showing p-CD protons. 
(Temperature = 25 "C, Solvent = D2O) 
A 
B 
C 
D 
E 
0.77 
1.19 
1.96 
3.50 
4.55 
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Table 8 'H NMR chemical shift change data (A5) of p-CD protons, in the presence of RAH. 
(Temperature - 25 "C. Solvent - D^O) 
[RAH]/ A W 
Sample [p-CD] H-2' H-3' H-4' H-5' H-6^ A5H-3 
0.0141 -0.0176 0.0093 -0.0182 -0.0075 1.03 
0.0107 -0.0276 0.0079 -0.0281 -0.0095 1.01 
0.0060 -0.0495 0.0095 -0.0505 -0.0135 1.02 
0.0140 -0.0985 0.0145 -0.0995 -0.0135 1.01 
0.0170 -0.1455 0.0185 -0.1535 -0.0255 1.05 
Negative values indicate highfield shift 
Stoichiometry of the RAH-fi-CD Complex 
The stoichiometry of the RAH-p-CD complex was determined by the Scott 
modification^^^ of Benesi-Hildebrand method.^^' The ' H NMR shift change data for 
p-CD protons was obtained, in the presence of RAH, by keeping the concentration of 
p-CD constant while varying the concentration of RAH. A plot of the chemical shift 
change data for H-3' of p-CD against [RAH] in the form of ([RAH]/[P-CD])/A6 verses 
([RAH]/[p-CD] gave excellent linear fit (Fig. 21) supporting the 1:1 stoichiometry of the 
RAH-p-CD complex. 
^H NMR Assignment ofRoxatidine Acetate Hydrochloride 
The signals of RAH and p-CD did not interfere with each other in any of the spectrum. 
The signals for aromatic protons appeared as a singlet (H-6), a doublet (J - 8.1 Hz, 
H-2, 4) and a triplet (J = 8.0 Hz, H-3) in all the cases except in the spectrum of pure drug 
in which the doublet for H-2, 4 and singlet for H-6 were found partly overlapping. The 
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assignment of the non-aromatic protons could not be done due to poor resolution of the 
signals and these were therefore not studied. 
1 2 3 
[RAH]/[p-CD] 
Fig. 21 Scott plot showing 1:1 stoichiometry for RAH-p-CD inclusion complex. 
^H NMR Chemical Shift Change Data of Roxatidine Acetate 
Hydrochloride 
As expected, changes in the shapes as well as chemical shifts of RAH protons were 
observed in the presence of P-CD. AH the protons, except the aromatic proton H-6, 
exhibited downfield shift changes. There were no significant changes observed in the 
chemical shift values for RAH in the spectra of samples C, D and E. The chemical shift 
change (A6) data for all the aromatic protons of RAH is given in Table 9. 
Table 9 'H N M R chemical shift change (A6) data for RAH aromatic protons in the 
presence of p-CD in D2O. (7'emperature = 25 Xj 
Sample 
A 
B 
C 
D 
E 
IRAHl/IP-CDI 
0.77 
1.19 
1.96 
3.50 
4.55 
H-2,4 
0.0214 
0.0155 
0.0100 
0.0070 
0.0050 
H-3 
0.0302 
0.0220 
0.0120 
0.0082 
0.0041 
H-6 
-0.0388 
-0.0322 
-0.0130 
-0.0087 
-0.0037 
Negative values indicate highfield shift 
It can be concluded on the basis of chemical shift changes in the proton resonances of 
p-CD and RAH compared to those of pure samples, in solution, in conjunction with the 
1:1 stoichiometry of the complex that RAH forms a 1:1 inclusion complex with p-CD by 
the shallow penetration of probably aromatic ring, due to the presence of two bulky 
groups, into the p-CD cavity. It can not be said with certainty, however, which part of the 
guest is entering the p-CD cavity and also whether the penetration of the guest is fi-om 
wider or narrower rim side of the cavity. The structure for the RAH-p-CD complex could 
not, therefore, be confirmed. 
We studied the complexation of RAH with p-CD again because the resolution in the 200 
MHz spectra was not good and there was some element of doubt in the calculation of 
chemical shift changes. 
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Experimental 
Ail the NMR spectra were recorded on a 500 MHz instrument. ' H N M R spectra of RAH, 
in the absence (Fig. 22) as well as in the presence of p-CD (Figs. 23-28), were recorded 
in D2O at room temperature. The chemical shift values are reported in 8 (ppm) with 
reference to HDO peak. To determine the stoichiometry and binding constant of the 
complex the chemical shift change data for p-CD protons was obtained by keeping the 
concentration of p-CD constant at 10 mM while varying the concentration of RAH from 
2.11 to 36.7 mM. COSY spectrum was recorded for pure RAH (Fig 29) while ROESY 
and NOESY spectra were obtained for a mixture of RAH and p-CD. All the spectra 
consisted of one set of concentration dependent resonances for each proton or group of 
equivalent protons indicating a fast reversible exchange between free and complexed 
RAH on the NMR time scale. 
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Fig. 29 2D COSY spectrum of pure RAH. 
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Result and Discussion 
^HNMR Chemical Shift Change Data ofp-CD 
All the signals for p-CD protons were easily identified by their characteristic shapes and 
chemical shifts values. In the presence of RAH, p-CD cavity protons positioned inside 
the p-CD cavity, namely H-3' and H-5', exhibited highfield shift changes which 
increased with the increase in the concentration of RAH while other protons remained 
more or less unaffected. The chemical shift change data for all the p-CD protons is given 
in Table 10 and the gradual highfield shifts of the p-CD cavity protons with the increase 
in the concentration of RAH are shown in Fig. 30. These shift changes in the H-3' and 
H-5' protons of p-CD can only be explained in terms of ring current effect of aromatic 
ring included in the cavity, thus confirming the formation of inclusion complex between 
RAH and P-CD as reported earlier. 
Table 10 'H N M R chemical shift change data (A8) for p-CD protons in the presence of 
RAH. {Temperature - 25 "C, Solvent - D2O) 
I3-CD1/IRAH1 
2.367 
1.503 
1.366 
0.808 
0.436 
0.272 
H-r 
0.008 
0.006 
0.007 
0.004 
-0.001 
-0.003 
H-2' 
0.121 
0.011 
0.013 
0.013 
0.011 
0.012 
H-3' 
-0.014 
-0.027 
-0.032 
-0.051 
-0.069 
-0.089 
H-4' 
0.009 
0.008 
0.012 
0.010 
0.006 
0.006 
H-5' 
-0.004 
-0.015 
-0.018 
-0.046 
-0.062 
-0.089 
H-6' 
0.002 
-0.001 
-0.003 
-0.008 
-0.011 
-0.023 
Negative values indicate highfield shift. 
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B 
D 
H-6' 
" H-6' 
H-3' 
US' 
lknP{_ 
H-2' H-4' 
>W ^ ^ 
H-2' H-4' 
/J^ ' lj^\ KA 
H-4' 
H-2' . 1 . 
w 
H-4' 
H-2' 
i 
H-2- JE:^ 
I . , — I 
H-2 
- 1 — , r 
, H-4' 
3 . 8 3 . 6 
Fig. 30 Part of ' H N M R spectra (500 MHz) showing p-CD 
proton signals of mixtures of p-CD and RAH having molar 
ratios ([p-CD]/[RAH] (A) 2.367 (B) 1.503 (C) 1.366 (D) 
0.808 (E) 0.436 (F) 0.272. 
(Temperature - 25 ''C, Solvent = D2O) 
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Stoichiometry of the RAH-p-CD Complex 
The stoichiometry of the RAH-P-CD complex was determined by the Scott equation for 
1:1 complex. 256 
[G]/A5obs = [G]/A5n,^ + A5„,ax/^a 
The ' H N M R chemical shift change (A5) data for P-CD protons was obtained, in the 
presence of RAH, by keeping the concentration of p-CD constant while varying the 
concentration of RAH. The plot of A6H-5' against [RAH] in the form of [RAH]/ASH-5' 
verses [RAH] gave a linear fit (Fig. 31) confirming 1:1 stoichiometry for the RAH-p-CD 
complex. The slope of the plot is thus equal to l/ASmax and the intercept with the vertical 
axis to A6niax/^a, allowing the estimation of K^ to be 49 M"'. 
I 
O 
[RAH] 10-^ M 
Fig. 31 Scott's plot of [RAH]/A6H-5- verses [RAH] showing 1:1 
stoichiometry for RAH-p-CD complex. 
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^HNMR Assignment ofRoxatidine Acetate Hydrochloride 
The assignment of all the signals in the ' H N M R spectrum of pure RAH was made with 
the help of COSY spectrum (Fig. 29). The signals for RAH did not interfere with those of 
p-CD in the spectra of mixtures of RAH and ^-CD. The assignment for all the proton 
signals of RAH is shown in Fig. 22. The aromatic protons were observed as a singlet at 
6.980 (H-6), a multiplet for two protons at 7.023 (H'2, 4) and a triplet at 7.362 (H-3). 
^H NMR Chemical Shift Change Data of Roxatidine Acetate 
Hydrochloride 
In the presence of p-CD, changes in the chemical shifts and shapes of the aromatic proton 
signals indicated the involvement of aromatic ring in complexation. The signal for H-6 
exhibited highfield shift while those for H-2, 4 and H-3 displayed downfield shift 
changes. Aliphatic protons of RAH also exhibited chemical shift changes in the presence 
of p-CD but their chemical shift changes were not calculated because complexation 
involved only the aromatic ring of RAH. Fig.32 shows the changes in the aromatic region 
of the spectrum of RAH in the presence of p-CD compared to pure RAH. 
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Fig. 32 Part of the 'H N M R (500 MHz) spectra 
showing aromatic protons of RAH (A) 1:2.367 
[P-CD]/[RAH] mixture (B) pure RAH. 
NOESY/ROESY Data o/RAH-fi-CD Mixture 
ROESY spectrum was recorded for a mixture of RAH and p-CD which did not show any 
cross peak between aromatic protons of RAH and p-CD cavity protons. The NOESY 
spectrum (Fig. 33) of the same mixture was then recorded which proved helpful in the 
structural characterization of the complex. As expected the H-2, 4 protons of RAH 
displayed through space interaction with H-3' and H-6' of p-CD but not with H-5' 
proving the shallow penetration of the aromatic ring into the p-CD cavity from the wider 
side of the cavity. No aliphatic proton of RAH showed cross peak with p-CD cavity 
protons. 
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H-3' H-6' -rr y H-4' 
3,8 36 3,4 
Fig. 33 A Partial NOESY spectrum (500 MHz) of a 
mixture of RAH and p-CD showing dipolar 
interactions between aromatic protons of RAH and 
p-CD cavity protons. 
{Mixing time -^ 0.5 sec, Delay Time - 3.90 sec) 
The proposed structure for the complex formed between RAH and p-CD in aqueous 
solution is shown in Fig. 34. 
10 
_I3 15 II , 9 
/ O 
3 
Fig. 34 Proposed structure for 1:1 RAH-p-CD complex. 
^HWii^Spectroscopic Study of 
Compko^ation of Citabpram 
witfi P-Cyc[6de3(trin 
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Cilalopram (CT), chemically known as (+)-l-[3-(dimethylamino)-propyl]-l-(4-
fluorophenyl)-5-isobenzofurancarbonitrile, is a selective serotonin-reuptake inhibitor. Its 
ability to potentiate serotonergic activity in the central nervous system, via inhibition of 
the neuronal reuptake of serotonin, is thought to be responsible for its antidepressant 
action."^ ^^  It is marketed as racemic mixture though 5-enantiomer of CT (escitalopram) has 
been found about 30-folds more potent than its /J-counterpart.^^ 
NC. 1 
Citalopram 
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Experimental 
All the ^H NMR spectra (Figs. 35-40) were recorded on an Inova 500 MHz instrument in 
D2O at 25 °C. The chemical shift values, reported in 6 (ppm), were calculated with 
reference to HDO peak at 4.780. To determine the stoichiometry of the complex, ' H NMR 
shift data for CT and p-CD was obtained by keeping the overall concentration of the two 
components constant ([CT]+[p-CD] = 10 mM) while the molar ratio (r = [CT] or 
[P-CDK[CT]-t-[P-CD]) was varied from 0 to 1. To determine the binding constant, ' H 
NMR shift data for another set of six mixtures of CT and p-CD was obtained in which the 
concentration of CT was kept constant at 5 mM while that of p-CD was varied from 0.8 
mM to 12 mM. COSY (Fig. 41) and ROESY (Fig. 42) spectra were recorded for a mixture 
of CT and p-CD. All the spectra consisted of one set of concentration dependent 
resonances for each proton or group of equivalent protons, indicating a fast reversible 
exchange between the free and complexed drug on the NMR time scale. 
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H-1.2 H-3 
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H-2 l'^ I TT*,ft 
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Fig. 41 2D COSY spectrum for a mixture of CT and p-CD. 
I ' ' ' ' I ' ' ' ' I • • • • I • • • • I • • • • I • ' ' ' I ' • ' ' r ' ' ' I ' ' ' ' I ' ' ' ' I ' ' ' ' I ' 
7 . 5 7 . 0 5 . 5 5 . 0 5 . 5 5.0 4 . 5 4 . 0 3 . 5 3 . 0 2 . 5 2 . 0 1 . 
Fig. 42 2D ROESY spectrum for a mixture of CT and p-CD. 
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Result and Discussion 
^H NMR Chemical Shift Change Data ofp-CD 
The assignment of p-CD cavity protons was made with the help of COSY spectral data 
(Fig. 41). The signal for H-T appears separate from rest of the p-CD protons at 4.995 and 
can easily be identified. It shows cross peak with H-2' and thus all p-CD protons are 
easily recognized by studying the cross peaks between various protons in the COSY 
spectrum (Fig. 43). 
4.0 3.5 3.0 
Fig. 43 Part of COSY spectrum (500 MHz) of a 
mixture of CT and p-CD showing p-CD signals. 
The p-CD cavity protons, namely H-3' and H-5\ displayed significant highfield shift 
changes in the presence of CT which increased with the increasing concentration of CT 
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while other p-CD protons exhibited negHgible shifts. Fig. 44 shows changes in the 
chemical shifts of p-CD protons in the presence of CT. The chemical shift changes for all 
the p-CD protons in the presence of CT are given in Table 11. The highfield shift 
changes in the p-CD cavity protons can only be attributed to the penetration of the guest, 
most probably aromatic ring, into the p-CD cavity resulting in the formation of p-CD-CT 
inclusion complex/es, in analogy to previous studies.^^ '^^ ^ '^ ^'' ^ 
H - 6 >^ f7 y 
M..> A/U. 
H-5' 
I 
^ 1l T y 
D 
H-6' H-3' t H-2' H-4' 
1 I ' l l 11/ 
JMI'I'L 
B 
H-6' ii-I- I H.4'5' A 
3.8 3.6 3.4 
Fig. 44 Part of 'H N M R spectra (500 MHz) 
showing p-CD proton signals of mixtures of p-
CD and CT having molar ratios ([P-CD]/[CT] 
(A) 1.609 (B) 1.245 (C) 0.702 (D) 0.384 (E) 
0.150. (Temperature - 25 °C, Solvent - D2O) 
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Table 11 'H NMR chemical shift change (A6) data for P-CD protons, in the presence of CT. 
I3CD|/|CT1 H-r H-2* H-3* H-4* H-5* H-6' 
1.609 
1.245 
0.702 
0.384 
0.150 
0.002 
0.008 
0.016 
0.018 
0.018 
0.043 
0.048 
0.048 
0.049 
0.053 
-0.150 
-0.198 
-0.262 
-0.266 
-0.269 
0.009 
0,000 
0.006 
0.007 
0.007 
-0.213 
-0.313 
-0.405 
-0.410 
-0.413 
-0.027 
-0.043 
-0.062 
-0.063 
-0.063 
Negative values indicate upfield shift 
(Temperature = 25 "C, Solvent = D2O) 
^H NMR Assignment ofCitalopram 
An unambiguous H NMR assigrmient of the guest, especially aromatic protons, is 
important for the study of p-CD inclusion complexes. The assignment of all the CT 
protons was made with the help of COSY (Fig. 41) and ROESY (Fig. 42) spectral data of 
CT in the presence of P-CD because some of the protons, which appeared completely 
merged in the spectrum of pure CT, separated in the presence of p-CD helping in 
assignment. The ' H NMR spectral data of CT in the absence as well as in the presence 
of P-CD is given in Table 12. The signals for H-9 and H-11 were observed as triplets at 
2.313 (J=8.0 Hz) and 3.086 (J = 7.5 Hz) in the spectnim of pure CT but appeared as 
multiplets in the presence of p-CD due to splitting of signals. The signals for H-10 
appeared as a pair of multiplets in the presence as well as in the absence of p-CD. The 
assigrmient of these signals is supported by the cross peaks between H-9/H-10 and 
H-lO/H-11 and no H-9/H-11 cross peaks in the COSY spectrum. The signal for H-12 was 
observed as a singlet in the absence as well as presence of p-CD. A pair of doublets at 
5.228 (J=.15 Hz) and 5.265 (J=17.4 Hz), each integrating for one proton, in the spectrum 
of pure CT was ascribable to only H-8. Each of these doublets splitted into a pair of 
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doublets in the presence of p-CD. The aromatic protons were observed as a triplet at 
7.106 (J=I0.5, 2H) and multiplets centered at 7.483 (3H) and 7.654 (2H). As the 
fluorine-containing ring (A) protons are expected to appear relatively highfield compared 
to cyano-containing ring (B), the triplet at 7.106 could only be ascribed to ring A protons 
while the signal at 7.654 could be assigned to ring B protons. The protons H-5, 6 should 
interact with H-4, 7 and adjacent fluorine atom and appear as triplet. The signal at 7.106 
was, therefore, ascribed to H-5, 6. The signal at 7.654 was assigned to H-1, 2 of ring B 
because protons ortho to cyano group should appear downfield. The multiplet at 7.483 
can only be due to H-4, 7 (A) and H-3 (B). These assignments are well supported by the 
COSY and ROESY spectral data. The H-4, 7, being in close proximity to H-8 and H-9, 
showed cross connection peaks with these protons in the ROESY spectrum. Similarly, 
cross peaks between H-1 and H-8 were observed in the ROESY spectrum. In the 
presence of p-CD, the signals for H-2 and H-3 of one enantiomer separated completely 
while those for other enantiomer remain merged with H-1 and H-4, 7 signals, 
respectively. That the separated signals belong to same enantiomer is evidenced by the 
presence of cross peaks between these signals in the COSY spectrum (Fig. 45). 
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Fig. 45 Part of the COSY Spectrum (500 
MHz) of a mixture of CT and p-CD showing 
cross peaks of aromatic protons of CT. 
^HNMR Chemical Shift Change Data ofCitalopram 
All the CT protons exhibited significant chemical shift changes in the presence of p-CD 
which increased with the increase in concentration of the P-CD. The signals for the ring A 
protons, H-9 and one of the H-8, for one enantiomer, displayed highfleld chemical shift 
changes while rest of the proton resonances moved downfield. The magnitude of the 
chemical shift changes for ring B protons was much larger compared to protons of the ring 
A. Moreover, all the proton signals of the CT splitted in the presence of p-CD because of 
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the chiral discrimination by the p-CD between the two enantiomers. The separation of the 
enantiomeric signals was highest for H-2, 3 and H-8 protons. The chemical shift change 
data for all the CT protons in the presence of p-CD is given in Table 12 while Fig. 46 
shows the shift changes and splitting of the CT proton resonances in the presence of p-CD 
compared to pure CT. 
Table 12 ' H N M R (500 MHz) chemical shift change (A8, ppm) data for CT and 
[p-CD]/[CT] mixtures for all the protons of CT in the presence of p-CD in D2O. 
(Temperature = 25 "0 
Proton 
H-10 
H-9 
H-12 
H-11 
H-8 
H-5,6 
H-4,7 
H-3 
H-1 
H-2 
[CT] 
1.500 
1.680 
2.313 
2.744 
3.086 
5.228* 
5.265" 
7.106 
7.483 
7.483" 
7.654 
7.654" 
IP-CD|/[CT] 
=1.609 
0.099 
0.128 
-0.054 
0.020 
0.085 
-0.029 
0.038 
0.079 
0.106 
-0.040 
-0.028 
-0.028 
0.030 
0.180 
0.180 
0.279 
|P-CD|/[CT] 
=1.245 
0.085 
0.125 
-0.051 
0.019 
0.080 
-0.023 
0.031 
0.034 
0.073 
-0.039 
-0.025 
-0.025 
0.028 
0.172 
0.172 
0.268 
ip-CD|/|CT| 
=0.702 
0.058 
0.089 
-0.041 
0.011 
0.057 
-0.044 
0.010 
0.040 
0.069 
-0.032 
-0.022 
-0.022 
0.024 
0.118 
0.118 
0.184 
[p-CD]/[CT] 
=0«384 
0.048 
0.044 
-0.026 
0.003 
0.028 
-0.032 
-0.003 
0.013 
0.039 
-0.018 
-0.016 
-0.016 
0.006 
0.055 
0.055 
0.097 
[P-CDl/lCT] 
N».150 
0.010 
0.009 
-0.018 
-0.004 
0.000 
-0.039 
-0.015 
-0.016 
0.010 
-0.005 
-0.010 
-0.010 
0.001 
-0.013 
-0.013 
0.012 
Negative values indicate highfield shift 
"The signal splitted in the presence of p-CD 
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Fig. 46 Parts of ' H N M R spectra (500 MHz) of mixtures 
of p-CD and CT showing CT proton signals in 
comparison to pure CT. ([P-CD]/[CT] (A) 1.609 (B) 
1.245 (C) 0.702 (D) 0.384 (E) 0.150). 
{Temperature = 25 "C, Solvent = D^O) 
Stoichiometry of the p-CD-CT Complex 
To establish the stoichiometry of the p-CD-CT complex, the continuous variation 
.249 
method^^^ (Job's) was used to follow the changes in the chemical shifts of H-1, 2 of CT 
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(Fig. 47 A) and H-3' and H-5' of p-CD (Fig. 47 B). Although the shapes of the curves are 
not highly symmetrical, the maxima corresponds to a molar ratio (r) of 0.42indicating that 
there is one molecule of CT for each f3-CD molecule in the complex i.e. 1:1 
stoichiometry of the p-CD- CT complex/es. 
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Fig. 47 Job's plot for the |3-CD/CT complex (A) plot of data 
corresponding to H-2 and H-1,2 protons of CT (B) plot for 
data corresponding to H-3' and H-5' protons of p-CD. 
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The overall stability constant (A^ a) of the complex/es was determined using Scott's 
modification^^^ of Benesi-Hildebrand equation.^^' 
[H]/A5obs = [H]/A5^^+ A^mJK, 
The plots of A5H-2 or A8H-I, 2 against [p-CD] in the form of [p-CD]/A5obs vs [p-CD] gave 
excellent linear fits (Fig. 48) confirming 1:1 p-CD-CT complexation. The slope of the 
plot is thus equal to l/ASmax and the intercept with the vertical axis to A5n,ax/^a, allowing 
the estimation ofKa, to be 436 M" which is the mean value of the K^ determined from two 
plots. 
2 4 6 
[p-CD] 10"^ M 
Fig. 48 Scott's plot of [P-CD]/A6obs verses [P-CD] showing 
1:1 stoichiometry for p-CD-CT complex. 
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ROESYSpectral Data of P-CD-CTMixture 
There are two aromatic rings present in the CT and NOE studies were carried out under 
rotating frame conditions (ROESY) to establish beyond doubt the involvement of these 
rings in the complexation and to determine the actual structure of the complex. ROESY 
spectral data of a mixture of CT and p-CD confirmed that both the aromatic rings are 
incorporated into the p-CD cavity (Fig. 49). Moreover, the mode and depth of penetration 
of the two aromatic rings could also be established with the help of ROESY spectral data. 
An expansion of a part of the ROESY spectrum showing interactions of various protons of 
CT with the p-CD cavity protons is shown in Fig. 49. 
H-1.2 H-3j H-3.4.7 H-5.6 
-30 
-3.5 
-4 0 
-5 5 
Fig, 49 A Partial ROESY (500 MHz) 
spectrum of a mixture of CT and p-CD 
showing dipolar interactions between CT and 
p-CD cavity protons. 
(Mixing time = 0.2 sec. Delay Time ^ 3.35 sec) 
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Cross connection peaks between both the aromatic rings protons with P-CD cavity 
protons were observed. The signal for H-5, 6 of F-containing ring (A) displayed cross 
peaks with H-5' and H-6' of p-CD, both positioned near the narrower rim of the cavity, 
while H-4, 7 exhibited cross peaks with H-3' (located near wider rim) and H-5'.^^'' These 
resuhs can only be explained by the mode of penetration of F-containing ring (A) as 
depicted below. 
Also, all the CN-containing ring (B) proton signals displayed cross peaks with p-CD 
cavity protons. The signals for H-2 and H-3, for the two enantiomers, completely 
separated in the presence of p-CD. The H-2 and H-3 of one enantiomer (the signals for 
these protons for the other enantiomer appeared merged with other signals) exhibited 
cross peaks with only H-3' of p-CD. Moreover, the H-2/H-3' interaction was very weak 
compared to H-3/H-3'. Of the various possible modes of penetration of aromatic ring B 
into the CD cavity (Modes I-VI), only the modes in which H-2 lies along the axis of the 
CD-cavity (Mode 11, V) can explain the interaction with only H-3' of p-CD and the 
difference in the intensity of peaks. Mode V can be ruled out due to steric factors^^* 
thus Mode II seems the most probable structure of one p-CD-CT complex. The 
interaction between nitrile group and cavity protons may be the reason for more 
downfield shift changes in the H-2, 3 signals of citalopram. But this mode can not explain 
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the interaction between H-8 of CT and H-3' of p-CD which means that the two 
enantiomers have different modes of penetration in the complexes involving ring B and 
the only plausible structure for the other p-CD-CT complex can be as shown in Mode I. 
H, 
\ NC' 
\ "^ ^ 
' v ' ] ^ ' 
W / 
Mode II 
H 
Mode 
Mode IV ModeV 
In conclusion, racemic CT forms four 1:1 inclusion complexes with p-CD in aqueous 
solution by the penetration of aromatic ring into the P-CD cavity. The mode of 
penetration of the F-containing ring of ^-and S-enantiomers seems identical and the 
mechanism of chiral differentiation by the p-CD between the two enantiomers of CT 
appears to be due to the difference in the mode of entry of the CN-containing ring (B) of 
the two enantiomers into the p-CD cavity. However, it is not possible to say with 
certainty which of the two structures belong to i?-enantiomer and which to ^-enantiomer. 
Fig. 50 shows all the 1:1 p-CD-CT complexes present in solution. 
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NMe2 
Racemic CT P-CD 
R- or S-CT-p-CD R- or S-CT-p-CD R- & S-CT-p-CD 
Fig. 50 Schematic representation of all the possible 1:1 inclusion complexes 
formed between CT and p-CD in D2O. 
^HW4.<SiSpectroscopic Study of 
Compiexation of Hydroxyzine 
HydrocfUbride witfi P-Cychde^rin 
29 
Hydroxyzine hydrochloride.^^^ (HYZ) chemically known as 2-(2-{4-f(RS) 
-(4-chlorophenyI)phenylmethyllpiperazine-l-yUethoxy)ethanol dihydrochloride, a 
piperazine derivative, belongs to antihistamine family. In addition to its antihistaminic 
effects, HYZ possesses antichlolinergic, sedative, antispasmodic, tranquilizing. 
bronchodilative and antiemetic activities,"^^ 
r ^ ^ 
Hydroxyzine 
30 
Experimental 
All the experiments were performed on a Varian 300 MHz Unity instrument at room 
temperature for pure HYZ (Fig. 51), pure p-CD and for mixtures of HYZ and p-CD 
(Figs. 52-56). The ' H N M R chemical shift data for p-CD cavity protons was obtained, by 
keeping the concentration of p-CD constant at 10 mM while varying the concentration of 
HYZ from 3.47 to 10 mM, to determine the stoichiometry and binding constant of the 
complex/es. The ROESY and COSY spectra of a mixture of HYZ and p-CD were 
recorded on a Bruker DRX 600 (600 MHz) instrument. All the spectra consisted of one 
set of concentration dependent resonances, for each proton or group of equivalent 
protons, indicating that the reversible exchange between free and complexed drug is rapid 
on the NMR time scale. The water signal at 4.800 ppm was used as intemal reference 
throughout this work. 
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Result and Discussion 
^H NMR Chemical Shift Change Data offi-CD 
The assignment of p-CD cavity protons was made with the help of COSY spectral data. 
The signal for H-l' appears separate from rest of the p-CD protons, helping in the 
identification of all the p-CD protons. The p-CD cavity protons, namely H-3' and H-5', 
displayed significant highfield shift changes in the presence of HYZ which increased 
with the increase in the concentration of HYZ. Small chemical shift changes were 
observed in the H-6' while other p-CD protons exhibited negligible shift changes. Fig. 57 
shows changes in the chemical shifts of p-CD protons in the presence of HYZ compared 
to pure p-CD. The chemical shift changes for all the p-CD protons in the presence of 
HYZ are given in Table 13. The highfield shift changes in the p-CD cavity protons can 
only be attributed to the inclusion of the HYZ into the p-CD cavity resulting in the 
formation of HYZ-p-CD complex/es, in analogy to earlier studies. ^ ^^ ' ^ ^^ ' ^ '^- ^ ^^  
Table 13 ' H NMR chemical shift changes (A6) for the p-CD protons upon complexation. 
Sample (P-CD| H-l' H-2' H-3' H-4' H-5' H-6' 
/[HYZ] 
A 2M 0.0164 0.0408 -0.0945 0.0211 -0.0905 -0.0121 
B 2.50 0.0164 0.0433 -0.1055 0.0161 -0.1012 -0.0136 
C 2.18 0.0134 0.0403 -0.1065 0.0131 -0.1130 -0.0196 
D 1.56 0.0064 0.0438 -0.1645 0.0071 -0.1467 -0.0226 
E 1.00 0.0032 0.0473 -0.2135 0.0021 -0.1977 -0.0266 
Negative values indicate highfield shift. 
(Temperature = 25 °C, Solvent = D2O) 
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Fig. 57 Part of H NMR spectra (300 MHz) showing signals 
for p-CD protons in the presence of varying amounts of HYZ 
([P-CD]/[HYZ] ratios (A) 2.88 (B) 2.50 (C) 2.18 (D) 1.56 
(E) 1.00. (Temperature = 25 "C, Solvent - D2O) 
Stoichiometry of the HYZ-P-CD Complex 
The stoichiometry and the association constant {Kg) of the complex/es were determined 
by Scott method. 256 
[G]/A6obs= [G]/A6niax+ A5n,a./^a 
The plot of A6H-5- against [HYZ] in the form of [HYZ]/A6obs verses [HYZ] gave excellent 
linear fit (Fig. 58) confirming 1:1 stoichiometry for the HYZ-p-CD complex. The slope 
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of the plot is thus equal to IMSmax and the intercept with the vertical axis equal to 
A8max/^ a^  allowing the estimation ofK^ to be 58 M''. 
o 
'X. 
[HYZ](10-^M) 
Fig. 58 Scott plot of [HYZ]/ASH-5 verses [HYZ] for 1:1 HYZ-P-CD complex. 
^H NMR Assignment of Hydroxyzine Hydrochloride 
The signal for benzylic proton was observed at 4.981 in the spectrum of pure HYZ while 
signals for all the remaining aliphatic protons appeared in the region 3.00-4.00. The 
signals for the five phenyl ring protons and four p-chlorophenyl ring protons appeared 
separately in the absence of p-CD. The phenyl ring protons appeared as a multiplet in the 
region 7.20-7.35 while p-chlorophenyl protons were observed as two partly merged 
doublets in the region 7.35-7.45 (Fig. 51). 
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^H NMR Chemical Shift Change Data of Hydroxyzine 
Hydrochloride 
In the presence of p-CD, the benzylic proton showed highfield shift and appeared partly 
merged with the HDO signal. The remaining aliphatic protons appeared merged with the 
p-CD protons and could not be studied. The signal for two protons of p-chlorophenyl ring 
moved highfield, in the presence of p-CD, and appeared merged with phenyl ring protons 
as indicated by the integration of the signals (Figs. 52-56). Moreover, there were 
significant changes in the shape of signal for phenyl ring protons, but the resolution of the 
peaks was not good on 300 MHz instrument. To clearly establish which of the two 
p-chlorophenyl ring protons moved highfield, a NOESY spectrum was recorded for a 
mixture of HYZ and P-CD ([P-CD]/[HYZ]=0,58) on a 600 MHz instrument (Fig. 59). 
The spectrum showed phenyl ring protons as a triplet at 7.322 (IH) and a multiplet at 
7.374 (4H) while the p-chlorophenyl ring protons were observed as two multiplets, each 
integrating for two protons, at 7.449 and 7.469. The signal at 7.469 exhibited cross 
connection peak with the benzylic proton, which appeared partly merged with HDO peak, 
in the NOESY spectrum and therefore was assignable to H-1, 4 while the signal which 
moved highfield in the presence of P-CD could only be assigned to H-2, 3. The changes 
in the shapes and chemical shifts of both the aromatic rings protons indicate the 
involvement of both these rings in the complexation with p-CD. Fig. 60 shows the 
aromatic region of the spectra of HYZ, in the absence as well as in the presence of p-CD. 
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Fig. 59 A part of NOES Y (600 MHz) spectrum of a mixture of HYZ 
and p-CD showing dipolar interactions between benzylic and H-1, 4 
protons of HYZ. 
Fig. 60 Part of the ' H N M R (300 MHz) spectra showing aromatic 
protons of HYZ (A) pure HYZ (B) mixture of HYZ and P-CD 
( [P -CD] / [HYZ]=2 .88 ) . 
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ROES Y Data of Hydroxyzine Hydrochloride-p-CD Mixture 
The ROESY^^^ spectrum of a mixture of HYZ and p-CD ([p-CD]/[HYZ]-0.58) on a 600 
MHz instrument (Fig. 61) exhibited strong cross correlation peaks between H-3' and 
H-5', positioned inside the p-CD cavity, and protons of both the aromatic rings of HYZ 
confirming the penetration of both the aromatic rings into the p-CD cavity. Moreover, 
strong cross peaks between H-6' of p-CD and phenyl ring protons were also observed. 
The equally strong interactions of H-1, 4 and H-2, 3 of p-chlorophenyl ring with H-3' and 
H-5' of p-CD are only possible if p-chlorophenyl ring penetrates the cavity from both the 
sides giving rise to two 1:1 inclusion complexes. Similarly, the interaction of all the 
phenyl ring protons with H-3', 5' and 6' at the same time can only be explained if phenyl 
ring approaches the p-CD cavity from both the sides. 
Ph-H 
H1,4H:23 
3 J -
3.4-
3.6-
3.8- oc^ 
r 1 — 
7.55 7.45 7J5 7.25 
Fig. 61 Part of the 2D ROESY (600 MHz) spectrum of a mixture of p-CD and HYZ 
showing cross peaks between aromatic protons of HYZ and cavity protons of p-CD. 
(Mixing time - 0.225 sec. Delay Time - 2.8 sec) 
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Thus, taking into consideration the ROESY spectral data and 1:1 stoichiometry, in 
conjunction with the chemical shift changes observed in the ' H N M R spectra, it can be 
said that HYZ forms four 1:1 inclusion complexes with P-CD, in aqueous solution, by the 
penetration of the aromatic rings from both the sides of the p-CD cavity. The highfield 
shift changes in the H-2, 3 can be explained in terms of hydrogen bonding between the CI 
atom and H atom of the rim hydroxyl groups. The structures for all the 1:1 HYZ-p-CD 
complexes are proposed as shown in Fig. 62. 
P-Cyclodextrin 
Fig. 62 Proposed model of the inclusion equilibria for all the 
1:1 HYZ-p-CD complexes. 
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^H9^M<SiSpectroscopic Study of 
Compk^tion ofT.nalapn[Ma[eate 
witfi J3-Cycl6dhctrin 
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Enalapril maleate (EN), chemically known as l-{N-[(S)-l-ethoxycarbonyl-3-
phenylpropyl]-L-alanyl} -L-proline maleate, and its analogs are highly effective 
antihypertensive agents which act as angiotensin converting enzyme (ACE) inhibitors. 
ACE inhibitors prevent conversion of angiotensin I to ii and act to widen the blood 
vessels resulting in easier pumping of blood by the heart. They are, therefore, used for the 
treatment of hypertension, congestive heart failure and to alleviate strain on heart 
damaged by heart attack.^ ^ '^ ^^ ^ 
^0 
Enalapril 
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Experimental 
All the 'H N M R spectra (Figs. 63-68) were recorded on a JEOL 400 MHz instrument in 
D2O at 25 "^ C. The chemical shift values are reported in 5 (ppm) with reference to HDO 
peak at 4.7846. ' H NMR chemical shift change data was obtained for p-CD protons, to 
determine the stoichiometry of the inclusion complex, by keeping the concentration of 
the p-CD constant at 10 mM while the concentration of EN was varied from 11.4 to 52.6 
mM. The molar ratios ([p-CD]/[ENl) were calculated by direct integration of appropriate 
signals. The COSY (Fig. 69) and ROESY (Fig. 70) spectra were recorded for a mixture 
of EN and p-CD. As expected, all the spectra consisted of one set of concentration 
dependent resonances for each proton or group of equivalent protons indicating a fast 
reversible exchange between free and complexed EN on the NMR time scale. 
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Fig. 63 'H NMR spectrum (400 MHz) of pure enalapril maleate. 
148 
SZPL-t 
SZ8L-r 
89ZS-t-
6CC0S 
S I S f i 
(SUOrilJMJ) 
Fig. 64 'H NMR spectrum (400 MHz) of a mixture of enalapril maleate and p-CD having a molar 
ratio ([|3-CD]/[EN]) equal to 0.875. 
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Fig. 65' H NMR spectrum (400 MHz) of a mixture of enalapril maleate and P-CD having a molar 
ratio ([P-CD]/[EN]) equal to 0.750. 
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Fig. 66' H NMR spectrum (400 MHz) of a mixture of enal^ril maleate and p-CD having a molar 
ratio ([P-CD]/[EN]) equal to 0.560. 
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Fig. 67 'H NMR ^ )ectnim (400 MHz) of a mixture of enal^ qjril maleate and p-CD having a molar 
ratio ([P-CD]/[EN]) equal to 0.335. 
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Fig. 68 'H NMR spectrum (400 MHz) of a mixture of enalapril maleate and P-CD having a molar 
ratio ([P-CD]/[EN]) equal to 0.190. 
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Fig. 69 2D COSY spectrum of a mixture of EN and P-CD. 
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Fig. 70 2D ROESY spectrum of a mixture of EN and P-CD. 
Result and Discussion 
^HNMR Chemical Shift Change Data ofp-CD 
The p-CD cavity protons were easily identified by their characteristic shapes and 
chemical shift values and the assignment is ftilly supported by COSY spectral data 
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(Fig. 71). Significant highfield shift changes were observed in the protons situated inside 
the p-CD cavity, namely H-3' and H-5', in the presence of EN which increased with the 
increasing concentration of EN. Other p-CD protons did not show any significant 
chemical shift changes in the presence of EN. Fig. 72 shows changes in the chemical 
shifts of p-CD protons in the presence of EN compared to pure p-CD while the ' H N M R 
chemical shift change data for all the p-CD protons is given in Table 14. The highfield 
shift changes in the p-CD cavity protons confirmed the inclusion of the EN into the p-CD 
cavity resulfing in the formation of p-CD-EN complex, as reported earlier.^ ^ '^^ ^ '^^ '^"^^^ 
H-2' 
H-T I f., H-6- H-4' 
m ^ 
. - « 
' \^^M 
Wr4M 3iPa 
''. -' 
Z ^ . . J 
:s XJ^ 
m 
/;''^ '.^ ;^ 
T I T T I I I I 1 r 42 4.0 38 3.6 3.4 
K 
- - ^ — w 
^ /W 
•w 
Fig. 71 A part of COSY spectrum (400 MHz) of EN and 
p-CD mixture showing region containing p-CD signals. 
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H-,V 
H-6' [p.CD]/tEN]=0.190 
H-5 , H-2' 
H-4' 
[P-CD]/tEN]=0.335 
J^JA.Mo. 
[p-CD]/[EN]=0.560 
[p-CD]/[EN]=0.750 
[p-CD]/[EN]=0.875 
y^^^WU 
,. H-6' [p-CD] H-2 
3.9 
H-4* 
1 1 I I I I • 1 1 I 
3.8 3-7 3.6 3.5 
Fig. 72 Partial ' H N M R (400 MHz) spectra showing signals for the protons of p-CD in 
the absence as well as in the presence of varying amounts of EN. 
(Temperature = 25 "C, Solvent - D2O) 
Table 14 ' H NMR (400 MHz) chemical shift change (A8) values for p-CD protons in the 
presence of EN in D2O. (Temperature = 25 "C; 
A/B** 
iy.ri 
60:40 
61:39 
59:41 
64:36 
IP-CDI/ 
[EN] 
0.875 
0.750 
0.560 
0.335 
0.190 
H-r 
-0.0055 
-0.0073 
-0.0091 
-0.0128 
-0.0201 
H-2' 
0.0100 
0.0064 
0.0046 
0.0046 
0.0037 
H-3' 
-0.0402 
-0.0403 
-0.0439 
-0.0567 
-0.0751 
H-4' 
-0.0019 
-0.0037 
-0.0055 
-0.0092 
-0.0147 
H-5' 
-0.0730 
-0.0738 
-0.0798 
-0.0998 
-0.1428 
H-6' 
-0.0073 
-0.0091 
-0.0128 
-0.0183 
-0.0311 
#cis /trans ratio of EN. 
Negative values indicate high field shift. 
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^H NMR Assignment ofEnalapril Maleate 
Two diastereomeric forms, (SSS)- and (RSS)-, of enalapril maleate (EN) are known of 
which only (SSS)-diastereomer is used as drug.^ ^^ ' H NMR spectra of EN 
(SSS-diastereomer), in the absence as well as in the presence of p-CD, showed that two 
geometrical isomers are in equilibrium in solution as some of the non-aromatic protons 
appeared separately for two isomers. Cis-trans isomerism is possible in the case of EN 
due to hindered rotation along amide bond.^ ^^ The spectral assignment for the major (A) 
and minor (B) isomers was made with the help of COSY (Fig. 69) and ROESY (Fig. 70) 
spectral data. The chemical shift data of the studied protons for pure EN is given in Table 
IS. 
^W p 
^^ ^ 
18 ^ / . tf ° 
19 
A: Enalapril maleate (Major) 
HOO<^ 
20 
B: Enalapril maleate (Minor) 
The signals for the protons of three methylenic groups, for two isomers, at C-8, 17, 18 
were found resonating as multiplets centered at 2.2700 (3HA+4HB), 1.9600 (3HA+1HB) 
and 1.7200 ( IHB). The signal for HA-19 was observed resonating at 3.5328 in the case of 
pure EN. In the presence of p-CD, HA-19 signal merged with p-CD protons and, 
therefore, its chemical shift changes could not be determined. The structures for the two 
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isomers could be established by comparative study of the H-13, 14 and 16 signals. The 
major isomer was assigned structure (A) since H-13 and H-14, being in close proximity 
of oxygen of -COOH group should appear downfield compared to signals for the same 
protons of the minor isomer (B) which is in good agreement with earlier observation."^ '^ 
As expected, the signal for H-16 for major isomer (A) appears relatively upfield 
compared to that of minor isomer. The ' H N M R assignment of major and minor isomers 
is also supported by the through space interaction between H-16 and H-13 signals, in the 
case of major isomer, in the ROESY spectrum. 
^H NMR Chemical Shift Change Data ofEnalapril Maleate 
As expected, changes in the shapes as well as chemical shifts of EN protons were 
observed in the presence of p-CD. All the protons, except H-11, exhibited downfield shift 
changes. The highfield shift in the H-11 signal may be due to hydrogen bonding between 
the hydrogen of the rim hydroxy 1 and -COOC2H5 group. The signal for H-11, which 
appeared as a quartet at 4.2321 in the spectrum of pure EN, became complex in the 
presence of p-CD making it difficult to calculate its chemical shift changes. The A5 
values for all the studied protons of the EN are given in Tablel5. 
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Table 15 'H N M R (400 MHz) data for EN and its chemical shift change (A6) data in the 
presence of p-CD in D2O. (Temperature - 25 "C, 
Proton 
HA-12 
HB-12 
HB-14 
HA-14 
HA,B-7 
HB-19 
HB-9 
HA-9 
HB-13 
HA-13 
HA-16 
HB-16 
HA.B-2,4,6 
HA,B-3,5 
[EN| 
1.2490 
1.2490 
1.4910 
1.5368 
2.7600 
3.4000 
3.8700 
3.9100 
4.0380 
4.2620 
4.3800 
4.4200 
7.2550 
7.3360 
IP-CD]/ 
[EN|=0.875 
0.0092 
0.0183 
0.0302 
0.0275 
0.0700 
0.0300 
0.0530 
0,0608 
# 
0.0360 
0.0436 
0.0130 
0.0250 
0.0140 
IP-CD]/ 
(EN|=0.750 
o.ono 
0.0202 
0.0284 
0.0257 
0.0620 
0.0200 
0.0476 
0.0517 
0.0290 
0.0333 
0.0300 
0.0100 
0.0200 
0.0140 
[p.CD|/ 
[EN1=0.560 
o.ouo 
0.0202 
0.0247 
0.0232 
0.0500 
0.0150 
0.0421 
0.0462 
0.0250 
0.0296 
0.0280 
0.0080 
0.0150 
0.0100 
IP-CD]/ 
(EN]=0.335 
0.0128 
0.0202 
0.0229 
0.0211 
0.0450 
0.0100 
0.0312 
0.0388 
0.0220 
0.0280 
0.0262 
0.0050 
0.0120 
0.0090 
(pCDl/ 
[EN|=0.190 
0.0092 
0.0147 
0.0174 
0.0156 
0.0350 
0.0020 
0.0310 
0.0278 
0.0170 
0.0220 
0.0230 
0.0015 
0.0080 
0.0040 
#could not be determined. 
Stoichiometry of the EN-P-CD Complex 
Scott plot of A8H-5' against [EN] in the form of [EN]/A5H-5' verses [EN] was found to be a 
nonlinear relationship which indicated that the stoichiometry of the complex is not 1:1. 
The stoichiometry of the EN-p-CD complex was then determined by the mole ratio 
method.^^^The ' H NMR shift change data was obtained for p-CD protons in the presence 
of EN by keeping the concentration of p-CD constant while varying the concentration of 
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EN. The plot of A6H-5- verses [P-CD]/[EN] (Fig. 73) shows maximum around 0.5 
suggesting a 1:2 stoichiometry for the p-CD-EN complex. The stability constant of the 
complex was determined by the modified Scott equation for 1:2 complex. 
[G] VA5obs = [G] ' /A5^ax + A5n,ax/^a 
A plot of A5H-5' against [EN] in the form of [EN] /ASH-S- verses [EN] gave a linear fit 
(Fig. 74) confirming 1:2 stoichiometry for P-CD-EN complex. The slope of the plot is 
thus equal to 1/A5max and the intercept with the vertical axis equal to AS^ax/^a allowing 
the estimation oiK. to be 340 M"' 
< 
-0.06 
-0.08 
-0.10 
-0.12 
-0.14 
-0-16 
0,0 0.2 0.4 0.6 0,8 
[p-CDJ/ lEnalapril maleate] 
1,0 
Fig, 73 Mole ratio plot of the chemical shift changes 
of H-5' of P-CD during titration with EN in DjO. 
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2 ^ 
[ENr*10'2mM 
Fig. 74 Scott's plot of [EN]^/A6H-5' verses [EN]^  showing 1:2 
stoichiometry for p-CD-EN complex. 
ROESY Spectral Data of P-CD-EN Mixture 
ROESY^^ ^ spectrum (Fig. 70) was recorded for a mixture of EN and p-CD to study the 
mode of penetration of two guest molecules into a p-CD cavity. Intermolecular cross 
peaks observed between the aromatic protons of the guest and H-5' of p-CD and no cross 
peaks observed between the aromatic protons and H-3' confirm the shallow penetration 
of the aromatic ring into the p-CD cavity from narrower rim side.'^ '*^  Moreover, Cross 
peak between H-I9 and H-2, 4, 6 of EN confirmed that aromatic ring of one guest 
molecule and 5-membered ring of another molecule share the same p-CD cavity which is 
in agreement with the 1:2 p-CD-EN stoichiometry of the complex. Cross peak between 
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H-17 (18) and H-3' was also observed which confirms that 5-membered ring enters the 
p-CD cavity from wider rim side. Fig. 75 shows an expanded region of the ROESY 
spectrum containing cross peaks between the p-CD and EN protons. Since EN exists as a 
mixture of two geometrical isomers in solution, there are several 1:2 p-CD-EN 
combinations possible. The general structure for the 1:2 p-CD-EN complex can be shown 
as in Fig. 76. 
H-18/H-5'-
H-17(18)/H3' 
H-18/H-19 
H-2.4.6 / H-5' 
H3 
•..4.6 I H-5' , H 2,4,6/H 19 
Fig, 75 Expansion of part of 2D ROESY spectrum 
showing cross peaks between EN and p-CD protons. 
(Mixing time ^ 0.25 sec, Delay Time = 2.35 sec) 
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Fig. 76 Proposed structure for 1:2 EN-p-CD complex. 
It is important to mention here that the cis-trans ratio for EN, as determined from the 
integration of M-CHa doublet, remained almost unchanged, in the presence of p-CD, in 
four samples. However, there was a significant change observed in one of the sample 
(Table 14). This can only be explained in terms of catalysis by the P-CD. However, this 
needs further investigation. 
^H9m^Spectroscopic Study of 
Compko^ation of Teo^pfenadme 
IfydrocfiConcte witfi P-CycCodej^tin 
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Fexofenadine hydrochloride (FFN), chemically known as (±)-4- {1 -hydroxy-4-[4-
(hydroxydiphenylmethyl)-l-piperidinyl]-butyl}-a,a-dimethylbenzene acetic add 
'J7T 
hydrochloride, is a second generation antihistamine that is used to treat allergies. It is a 
racemate and exists as zwitter ion in aqueous media at physiological pH. It belongs to the 
group of amine compounds bearing diphenylmethyl functionality. 
B 7 8 
Q f ^ = = ^ T OH 
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Fig. 76 'H NMR spectrum (500 MHz) of pure fexofenadine. 
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Experimental 
All the ' H N M R spectra (Figs. 77-83) were recorded on an Inova 500 MHz instrument in 
D2O at 25 ''C. The chemical shift values were calculated with reference to HDO peak at 
4.780 and are reported in 5 (ppm). To determine the stoichiometry of the complex 
' H NMR shift data was obtained for the FFN by keeping the concentration of the PEN 
constant at 3.7 mM while the concentration of the p-CD was varied from 2.5-9.1 mM. 
The molar ratios ([p-CD]/[FFN]) were determined by direct integration of the appropriate 
signals. ROESY spectrum (Fig. 84) was recorded for a mixture of FFN and p-CD. All the 
spectra consisted of one set of concentration dependent resonances for each proton or 
group of equivalent protons indicating a fast reversible exchange between free and 
complexed FFN on the NMR time scale. 
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y-<o 
Fig. 77' H NMR spectrum (500 MHz) of a mixture of fexofenadine and ^-CD having a molar 
ratio ([p-CD]/[FFN]) equal to 2.46. 
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Fig. 78 'H NMR spectrum (500 MHz) of a mixture of fexofenadine and p-CD having a molar 
ratio ([P-CD]/[FFN]) equal to 1.76. 
Fig. 79 'H NMR spectrum (500 MHz) of a mixture of fexofenadine and p-CD having a molar 
ratio ([p-CD]/[FFN]) equal to 1.27. 
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Fig. 80 'H NMR spectrum (500 MHz) of a mixture of fexofenadine and 3-CD having a molar 
ratio (fP-CDl/rFFNl) equal to 1.15. 
Fig. 81 'H NMR spectrum (500 MHz) of a mixture of fexofenadine and p-CD having a molar 
ratio ([P-CD]/[FFN]) equal to \A2. 
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Fig. 82 'H NMR spectrum (500 MHz) of a mixture of fexofenadine and p-CD having a molar 
ratio ([P-CD]/[FFN]) equal to 0.68. 
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Fig. 83 2D ROESY spectrum (500 MHz) of a mixture of fexofenadine and P-CD. 
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Result and Discussion 
^H NMR Chemical Shift Change Data ofp-CD 
All the p-CD proton resonances were easily identified by their characteristic pattern of 
signals. An examination of the p-CD proton signals in the ' H NMR spectra revealed 
significant highfield shift changes in H-3' and H-5' proton resonances, positioned inside 
the p-CD cavity, compared to pure p-CD. Negligible shift changes were observed in H-2' 
and H-4' proton signals while small highfiled shift changes were observed in H-6' signal. 
The induced highfield shift changes in the p-CD cavity protons upon addition of FFN 
confirmed the formation of FFN-p-CD complex in solution in analogy to previous 
reports.^^^' ^^ '^ ^ '^' ^^ ^ Fig. 85 shows complexation induced shift changes in the p-CD 
protons in the presence of FFN compared to pure p-CD. 
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Fig. 85 Part of the ' H N M R (500 MHz) spectra 
showing chemical shift changes in the p-CD 
protons (a) in the presence of FFN in 
comparison to (b) pure p-CD. 
^HNMR Assignment of Fexofenadine 
The assignment of all the FFN protons, especially the aliphatic protons, was not possible 
because separate signals were not observed for aliphatic protons. It was possible though 
to make an unambiguous assignment of all the aromatic protons and methyl protons, and 
therefore only these protons could be studied. The signal for methyl protons (H-I3) was 
observed as a singlet in all the spectra of FFN, pure as well as mixtures of FFN and 
p-CD. FFN is structurally related to terfenadine.^^^ in which the para substituent on ring 
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A is tertiary butyl group. The ' H N M R data of terfenadine and ROESY spectral data of 
FFN, in the presence of p-CD, proved very helpful in the ' H NMR assignment of FFN. 
The chemical shift change data for all the studied protons is given in Table 16. The 
spectral region between 1.498 and 1.809 totally integrated for 14 protons which contained 
a singlet for six protons assignable to two methyl groups (H-13) while remaining 8 
protons could be ascribed to H-7, 10 and 11 protons. Similarly, the region between 2.864 
and 3.225 integrating for 5 protons and a signal at 3.4 for two protons, in the spectrum of 
pure FFN, could be attributed to H-6, 8 (5H) and H-9 (2H) protons, respectively. The 
signal for H-9 merged with the p-CD protons in the spectra of mixtures. The signal for H-
12 can be expected around 4.5 but it was found merged with HDO signal as confirmed by 
the ROESY spectral data. The signal for H-1 at 7.736 was identified by its through-space 
interaction with methyl protons (H-13) in the ROESY spectrum (Fig. 84). The signal for 
H-5, most shielded aromatic proton, was observed as a triplet at 7.227 as in the case of 
terfenadine. The most deshielded aromatic proton signal at 7.481 has been assigned to H-
3 while this signal was ascribed to H-4 in the case of terfenadine. Our assignment is 
justified because this signal shows cross connection peaks, in the ROESY spectrum, with 
the signals at 2.909 and 1.714 which are attributable to H-6 and H-7 protons. These NOE 
peaks can not be explained if the signal at 7.481 is assigned to H-4. The proton 
resonances for H-2 and H-4 were found merged in the region 7.317-7.348. The signal for 
H-2 showed a cross peak with the signal for H-11 and H-12, which appeared merged with 
the water signal. 
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^HNMR Chemical Shift Change Data of Fexofenadine 
As already mentioned chemical shift change data for only aromatic and methyl protons 
could be obtained. All the aromatic protons and methyl signal exhibited shift changes in 
the presence of p-CD which increased with the increase in the concentration of p-CD. 
The magnitude of chemical shifts for H-3 was very high compared to other aromatic 
protons. The ring A protons exhibited highfield shift changes while downfield shift 
changes were observed for ring B protons. The changes in the shapes of the signals for H-
3 and H-5 suggest that there is some splitting, probably due to chiral differentiation 
between the two enantiomers by the p-CD. Part of the ' H N M R spectra, containing 
aromatic signals, of FFN in the absence as well as presence of p-CD are depicted in Fig. 
86 while chemical shift change data of all the studied protons is given in Table 16. 
Table 16 ' H NMR chemical shift change data of studied protons of FFN in the presence 
of p-CD. (Temperature - 25 "C, Solvent = D2O) 
[P-CD]/[FFN1 
2.46 
1.76 
1.27 
1.15 
1.12 
0.68 
H-1 
-0.060 
-0.058 
-0.042 
-0.040 
-0.044 
-0.030 
H-2,4 
-0.023 
-0.028 
-0.014 
-0.011 
-0.017 
-0.010 
H-3 
0.109 
0.089 
0.060 
0.052 
0.047 
0.026 
H-5 
-0.003 
-0.004 
0.001 
0.000 
-0.005 
-0.004 
CH3-I3 
0.068 
0.038 
0.053 
0.052 
0.039 
0.030 
Negative values indicate highfield shift changes 
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IP-CD1/[FFN1=2.46 1^ U H-5 
1P-CD1/(FFNJ=1.76 
[p-CDl/IFFNl=1.27 
[^-CDl/[FFNI=1.15 
[p-CDI/(FFN|=M2 
IP-CD1/[FFN1=0.68 
A 
H-3 
A
H-l }J^:^'^ H.5 
IFFNl 
7.60 7.50 7.40 7.30 7.20 
Fig. 86 A part of ' H N M R spectrum (500 MHz) 
showing aromatic protons of FFN in the absence as 
well as in the presence of varying amounts of p-CD. 
(Temperaiure = 25 "C, Solvent - D2O) 
Stoichiometry of the FFN-fi-CD Complex 
Scott plot^ ^^ of A6H-3 against [P-CD] in the form of [P-CD]/A5H.3 verses [P-CD] also gave 
a nonlinear relationship indicating that the stoichiometry of the complex is not 1:1. The 
stoichiometry of the complex was then determined by mole ratio method.^ '*^ Fig. 87 
illustrates plot of A6 verses mole ratio ([p-CD]/[FFN]) for H-3 of rings B because it 
showed maximum shift changes in the presence of p-CD. The plot shows that the 
A6 values increase in a linear fashion till [p-CD]/[FFN]=l suggesting 1:1 stoichiometry 
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but since A6 does not become constant and still keeps increasing even when 
[p-CD]/[FFN]>l implies that the stoichiometry is not simply 1:1 but a combination of 
1:1 and 1:2 (FFN/p-CD) complexes. The formation of 1:2 complex is favoured when 
[p-CD]/[FFN]>l. It was further confirmed by Scott method that the stoichiometry is 
neither simply 1:1 nor 1:2 but a combination of both. 
0.12-
0.10-
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< 0.06-
0.04-
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• I ' I ' I • I ' I '• r • I ' I ' » ' I 1 I • 
0.6 1.0 1.4 1.8 22 2.6 
[P-CD]/[FFNJ 
Fig. 87 Mole ratio diagram of the chemical 
shift changes of FFN proton during titration 
with P-CD in D2O. 
ROESYData ofFFN-fi^CD Mixture 
ROESY spectrum was recorded for a mixture of FFN and p-CD having molar ratio equal 
to 1.15 in D2O to ascertain the existence of multiple equilibria in solution and to have an 
insight into the mode of penetration and orientation of the aromatic ring into the p-CD 
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cavity. As shown in the Fig. 88, the ROESY spectrum displayed correlation peaks 
between all the aromatic protons with H-3' and H-5' of p-CD situated inside the cavity 
thus confirming beyond doubt the involvement of all the aromatic rings in the 
complexation. 
H-2' j_H-5' 
\ 
H-2.4 
H-4' 
0 0' 
P ^ 
Jj L» 
fi* 
lo iS iS 2^ xo 15 
-7.1 
-7.2 
;7.3 
-7.4 
-7.5 
-7.6 
Fig. 88 Expansion of the ROESY spectrum (500 
MHz) showing cross peaks of methyl and all the 
three aromatic ring protons with p-CD protons. 
(Mixing time "^- 0.2 sec. Delay Time ^ 3.05 sec) 
The cross peaks between H-3 of FF^ and H-2', 4' of P-CD, situated near wider rim 
clearly indicate that phenyl ring penetrates the cavity from wider rim side while 
p-substituted ring penetrates from narrower rim side since H-1 is showing cross peak 
with H-2', 4' of p-CD. Fig. 89 shows the proposed structures for all the possible 
FFN-p-CD inclusion complexes present in solution. 
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COOH 
COOH 
Fig. 89 Schematic representation of all the possible inclusion complexes formed in D2O 
between FFN and P-CD. 
In conclusion, ' H N M R titration studies of fexofenadine hydrochloride (FFN) with 
p-cyclodextrin (p-CD) in D2O confirmed the presence of several inclusion complexes 
involving all the three aromatic rings. The structures for all the possible 1:1 and 1:2 
complexes have been proposed taking into account the stoichiometry and ROESY 
spectral data. The mode of penetration has been clearly established. The stability 
constant could not be calculated but the complexation behaviour of fexofenadine seems 
very similar to that of terfenadine. 
Annexure 
vii) Conclusion and Suggestion for Further Work 
In conclusion, the complexation of five pharmaceutical compounds with p-cyclodextrin 
was studied, in aqueous solution at room temperature, by NMR spectroscopy which is 
one of the most acceptable techniques for the study of inclusion complexes in solution. 
The objective of our work was to establish the structure of the complex formed in 
solution. It was found, in all the cases, that aromatic part of the drug molecule 
preferentially enters the p-cyclodextrin cavity resulting in the formation of inclusion 
complex/es. Moreover, the aromatic ring generally enters the cyclodexlrin cavity from 
wider rim side but complexes involving entry of the guest from narrower rim have also 
been identified. The mode and depth of the penetration have been established, in an 
unambiguous manner, by advanced NMR techniques like ROESY and NOESY 
experiments. The mode and depth of penetration are supported by binding constants. The 
complexes identified were, in most case, 1:1 (Drug:p-CD) but in the case of enalapril 
maieate the complex was found to be 2:1 (Drug:p-CD). Fexofenadine forms both 1:1 and 
i :2 (drug:p-CD) complexes in aqueous solution. 
h can be concluded thai, in the cases where only one aromatic ring is present in the drug, 
1:1 complex is formed when the guest/host ratio is equal or smaller than one and as the 
concentration of guest further increases, the 2:1 (drug:p-CD) complex starts to appear 
and increases with the increase in the concentration of drug. In the cases where more than 
one aromatic ring was present in the drug molecule, more than one 1:1 complexes were 
formed. 
Furthermore, the penetration of the aromatic ring was shallow when the aromatic ring 
was meta-disubstituted resulting in the formation of weak complex as evidenced by 
smaller value of stability constant {Ka) in the case of roxatidine acetate hydrochloride 
where two bulky groups are present on the aromatic ring in the meta position. The 
presence of a subtituent in the para position may affect the stability of the complex in a 
favourable or unfavourable manner depending on the nature and size of the substituent. 
The significance of the work carried out lies in the fact that use of a pharmaceutical 
compound in the form of a cyclodextrin complex is permitted only after the structures of 
the complexes formed, in aqueous solution, are established because they have to work in 
aqueous medium. The effect of size of the cyclodextrin cavity on the complexation 
behaviour will be studied by studying the complexation of drugs with oC- and Y-CD and 
with other modified CDs to increase the solubility of drug in water. Further, efforts will 
be made to do X-ray studies on the purified drug-cyclodextrin complexes. 
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SHORT COMMUNICATIONS 
30 min) (Pharmakopea Polska 1993). It is interesting that 
an increasing propoition of xyiitol in model tablets is ac-
companied by an increase in measurable tablet diameter 
during storage. Average values of disintegration time of 
model tablets arc specified in Table 2. This property, re-
sulting ftom so called "crystallographic memory" of the 
xyiitol structure, described by the approximation equation, 
should be taken into consideration during design of packa-
ging (blisters) not only to reduce losses during blistering 
but also to provide the required practical stability of a pre-
paration. 
Experimental 
Sorbitol: Neotoiti P60 W (Roquette-Letunn. France; Xyiitol: Xylitoib 
300 (Roquette-Ldtrem, France); Hydroxypropylineihyl cellulow (HPMC): 
Phamucou 904 ^nnce); DitMsk calcium pboiphale - CaHPO^-211:0 
(Calcium ortho phoaphaie p.a.) ROCH Oliwlce (Poland), C>72-04 Buden-
heim: Magnesium ttearate 
2. liutniHunU amd mttiwds 
"EXACTA 21" numerical tabletiing machine with computer courol which 
enables monitoring of the compcestion proceu u pfognmmed morpholo-
gical panmeten of a model tablet TURBULA type T 2 C mixer with 
uandard glau contiinen V>3J)dm' in which tablet feed (powder) for 
direct tableiting was made. Etectioaie micromeier prothiced by Mituloyo 
(U.K.) Ltd; Patent £P 0053091. Meaturemeni of motpbological value* of 
a tablet (d « 2r, h) wa* made with u accuracy of ± 0.01 mm. Hardneaa 
tester. Schleuninger Type T 2 C ( Switzoiand ) and ERWEXA type I B -
M (Germany). ERW^CA inHtumenl to determine tablet di^ntegraiion 
time. 
The product for direct laUeitiag wai pnpind b a TIIRBULAT2C mixer 
by mixing N«OM>rfo P 60W, Xyliaorb 300. KPMC and CaHPO« 2H:0 for 
13 min. The comparative particle aiie of the mixed compooemi w u maii^ 
tained in a formulation. AJFIer introducing the r"g~' '"" iteania the com-
pooeou were mixed in altematiag planes for 3 min at a q)eed of 20 ipm. 
The cotnpretsioa process wu carried out in an "EXACIA 21" lahtfiwing 
machine using computer optimization of the morphological panmeten of 
model tablets. 
The dilTereot types of model tablcu were produced in quantities of 4.3-
5.0 thousand uniu. 
Tests were made according to the requirements of FPV (Pharmakopea 
Polska 1993). Tlie results obtained for each of the four model types, whi^ 
are chancteiized by dUfenni conienu of xyUtol, were eatimaied statisti-
caUy. 
The evaluation of hardneu of the model tableu was made with a Schleuni-
ger T 2 C hardness tester at umport and aAcr the fint (12 months) and 
second (24 months) year of storage. The measurements wen made for 
20 tableu selected at random and wen analysed statistically. 
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A NMR spectroscopic study of mixtures of varying rati-
os of roxatidine acetate hydrochloride (RAH) and p-cy-
clodextrln (p-CD) In D2O revealed the formation of a 
1:1 Inclusion compound. The aromatic ring of RAH se-
lectively penetrates the p-CD cavity in preference to 
the piperidlne ring. 
Cyclodextrins (CDs) hold a variety of guests into their hy-
drophobic cavitiics (Steed and Atwood 2000; Wlmioet 
et al. 2002) and serve as useful models for studying topo-
chemistry and catalytic mechanism of enzymes (Bender 
1988). CDs are widely used in pharmaceudcal applications 
as a vehicle for drug delivery of poorly water-soluble 
drugs (Aiibal and Shrinivas 1996; FrOmming and Szejtli 
1994). Extensive studies on inclusion complexes of various 
medicinally useful con^xHmds with p-CD have been re-
ported (Aithal and Shrinivas 1996; FrOmming and Szejtli 
1994; Menard etaL 1990). We report, herein, our results 
on the study of the inclusion complex of roxatidine acetate 
hydrochloride (RAH), a potent anti-ulcer drug (Murdoch 
1991), with p-CD in soludon by NMR spectroscopy. 
The 'H NMR spectra were recorded for five samples with 
[RAHJ^^D] molar rados varying from 0.77 to 4.55 as 
determined by direct integration of the NMR signals. The 
anomeric proton (H-1) of ^ D was used as internal refer-
ence throughout this work. 
The signals for RAH and ^ D {HOtons did not interfere 
with each other in any spectrum. Tlie signals for aromadc 
protons of th« RAH molecule appeared as a singlet (H-6'). 
a doublet (J ^ 8.1 Hz H-2'.4') and a triplet (J = 8.0 Hz H-
3') in all the cases except in the spectrum of the pure drug 
in which the doublet for H-2',4' and H-6' singlet were 
found pardy overiapping. 
The induced chemical shift change (A6i) for ^-CD pro-
tons were calculued relative to reported 'HNMR data 
(Schneider eial. 1998). Each sample spectrum denoted 
largest A6i for the H-3 and H-5 protons of the P-CD. The 
other ^ D ' s protons showed either much smaller or neg-
ligible deviations. The Adi data for various protons of ^-
CD in the presence of varying amount of RAH is given in 
the T^ble. In the presence of RAH, the peaks for H-3 and 
H-5 protons of the p-CD moved progressively upfield 
with the increase of concentration of RAH. The Fig. 
shows the part of the NMR spectra of samples A to E, 
containing signals for protons of p-CD. NMR spectra of 
samples A aiid B were recorded on a 200 MHz spectro-
meter while those of samples C. D & E were obtained on 
a 300 MHz ifistiument. The spectra of samples A and B 
Phamiazie 59 (2004) 8 653 
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Tbble: 'H NMR chemkal shift changes (^6i) of p-CD and RAH prolons upon complexation 
Stmpk 
A 
R 
C 
D 
E 
IGlAHl 
0.77 
1.19 
1.96 
3.50 
4.55 
g^yclodMir 
H-: 
0.0141 
0.0107 
0.0060 
0.0 J 40 
0.0170 
n 
H-3 
-0.0176 
-0.0276 
-0.0495 
-0.0985 
-0.1455 
HJ 
0.0093 
0.0079 
0.0095 
0.0145 
0.0185 
H-S 
-0.0182 
-0.0281 
-0.0505 
-0.0995 
-0.1535 
H-6 
-0.0075 
-0.0095 
-0.0135 
-o.om 
-0.0255 
lA (H-sy 
M,iH-3} 
1.03 
1.01 
1.02 
1.01 
1.05 
Rotalklinc KcUle hyUiwhloritle 
H-2'.4' 
0.0214 
0.0155 
0.0100 
0.0ff7Q 
0.0050 
H-3' 
0.0302 
0.0220 
0.0120 
0.0082 
0.0041 
H-e 
-0.0388 
-0.0322 
-0.0130 
-0.0087 
-0.0037 
Neiuive vtlu«i indicaiet upReU thift. 
arc very much aiike due to small change in [RAHJ/[P-CDJ 
molar ratio but the shift of signals for H-3 and H-S pro-
tons is obvious. The shift of signals for H-3 and H-5 pro-
tons in the spectra C, D and E is very prominent. 
The penetration of the less polar portion of the guest 
molecule into the ^-CD cavity from the wider side com-
prises the most common mode of complexation. Since 
the H-3 and H-S protons are positioned inside the cavity, 
the inclusion of guest into the p-CD cavity causes major 
upfield shifts of these pcotons. This is attributed U) the 
ring current of the aromatic ring of the guest molecule 
that is included in the cavity (Komiyama and Hirai 
1980a, 1980b). On the other hand, most of the guest 
protons Khow downfield shift changes but the A6i values 
for guest protons are much !>maller in magnitude com-
pared to host protons. Rekharsky etal. (199S) have de-
monstrated that the magnitude of ihe uptielj shifts of 
H-3 and H-5 protons of CDs, A5i(H-3) and A6i(H-5). 
and their relative ratios A&i(H-S)/A6i(H-3), can be used, 
respectively, as a quantitative measure of the stability of 
complex and the depth of inclusion of ligand into the 
cavity. 
The observed high field shifts in the H-3 and H-5 peaks 
of P-CD in the presence of varying amount of RAH thus 
clearly indicate the insertion of the aromatic ring of the 
RAH into the p-CD cavity. Moreover, the magnitude of 
the shifts for H'3 and H-S protons of p-CD increased as a 
function of an increasing ratio of [RAH]/[p-CD] giving a 
slightly curved line for A6i(H-3) vs (RAHJ/[p-CD] plot. 
A modified Hildebrand-Benesi plot (Benesi and Hilde-
brand 1949; Qi el al. 1991) of chemical shift change data 
for H-3 of p-CD in the form of ([RAH]/[p-CD])/A6i(H-3) 
vs [RAHJ/[p-CDl gave excellent linear fits supporting the 
1'. I complex formation. As expected, aU the protons of 
the RAH, except the aronmic proton CH-6'). showed 
downfield shifts on complexation. The A5i data for aro-
matic protons of RAH in the presence of varying amounts 
of P-CD is given in Ihe Tible. There was no significant 
change observed in the chemical shil'l values of proiun.vi ol 
RAH molecule in the spectra of samples C. D and E. Thi.s 
is in good agreement with the earlier observation that with 
the increase of concentration of guest, the Abi values (or 
guest protons decrease (Rekharsky etal. 1995). This phe-
nomenon indicated, in analogy to many previously re-
ported cases (Bergeron and Rowan 1976; Komiyama and 
Hirai 1980a. 1980b), that the phenyl ring of the RAH is 
selectively inserted into the p-CD cavity driven primarily 
by hydrophobic interactions. 
3J0 3.25 
,1, 
3.M 3J3 3.50 3.25 
Fig.: Typical 'H NMR ipcctra u a varieiy of gucsi to host [OMH] ratioi for the complexuioo of Roxitidine Acelale Hydrochlonde (RAHJ with ^cyclo-
dexmn in DjO. Note the Urge upCi^ ihifu of H-3 aiKl H-S in sharp coMiut u> the tmal) ifaift dtanga obieived for H-2, H-4 and H-6 
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The A5i values for H.2 and H-4 of p-CD and H-6' aro-
matic proton of RAH need special attention. Normally the 
signal for all the P-CD pTotons show upfield shifts (if any) 
while all the guest protons show downfield shifts. The 
downfield shifts of H-2 and H-4 of p-CD and upfield shift 
of H-6' of RAH may be attributed to their interaction 
through solvent The ratios A6i(H-5)/A6i(H-3) were calcu-
lated for all the samples. The relatively smaller values 
(1.01-1.05) for A6i(H-5)/A6i(H-3) ratios compared to 
those reported for other complexes (1.2-3.0) suggest that 
the penetration of the aromatic ring in the ^-CD cavity is 
not deep which is expected due to the presence of two 
bulky groups in the meu position of aromatic ring. 
FinaUy, the 'H NMR spectroscopic study of RAH in the 
presence of pMTD shows tiiat a 1:1 RAH-p-CD complex 
is fonned in solution which is in rapid equilibrium witii 
free P-CD and RAH since the spectra consisted of mainly 
one set of resonances. Moreover, the aromatic ring of the 
RAH selectively penetrates into the p-CD cavity driven by 
hydrophobic interactions 
Guangdong Key Laboratory of Marfn« Matsria Medica, South Chiru 
S M Institute of Ocunotogy, ChirwM Academy ol Scl«ncM, 
Ouangzhou. P.R. CMna 
A new triterpenold: taraxerol-3^0-tr)decyl ether 
from Dorrls triofollata 
Lu-RONO Xu, S I ZHANQ, JUN W U , SHU-HUA Q I , JIAN*SHE 
HUANG. ZHI-HUI XIAO, DAO-JINO ZHANG, J IN YANG, VAN TIAN 
Received January 12, 2004. accepted February 20. 2004 
Si Zhang, Guangdong Key Laboratory of Marine Materi-
al Medico, South China Sea Institute of Oceanohgy. 
Chinese Academy of Sciences. 164 West Xingang Road, 
Guangzhou, 5W30I, P.R. China, 
zhsirnd® scsio.ac.cn 
Pharmazie 59: 655-656 (2004) 
Rtfcrencts 
Aittukl K. Stirinivu \JH (1996) PhytKOChemical ftudy of ciprofloxxnii 
wid) ^ D . Phttmi Sci 2: 431-4S3. 
Bender ML (19S8) Enzynw Mechanismt, Royal Society of ChemLury. 
Leichnonh, p. 1. 
Beneii HA, Hildebrand JH (1949) Interaciion of 1 with uonutic hydrocar-
bon. J An) Cbem Soc 71: 2703-2707. 
BuBcnm "U, Howan 1< U ^ 6 ) '^^ nwkciiW diipoution ot sodium p-ni-
trophenolaie in the cavities of cyclohepiaamylose and cyclohexaamyloM 
in solution. Bioorg. Chem. S: 423-436. 
FrOnuning K, Szejtii J (1994) Cyclodextrin in phannacy, Kluwer Academic 
Dordrecht, p. 1, 
Komiyama M, Hirai H (1980a} Time averaged confonnation of the inclu-
sion complexei of p-cyckxlextrin with ten-butylptienols. Oiem Lea 12: 
1467-1470. Komiyama M, Hitai H (1980b) RelatiiMuhip between the 
cyclodextrin catalysis in the cleavages of phenyl acetates and the time 
averaged confonntfion of the inclusion complexes. Oiem Leu 12: 
1471-1474. 
Meiwd FA, Dcdhiya MG, Rhodes CT (1990) Physicochcmical aspcca of 
the complexation of some dni^ with cyclodextrins. Dnig Dev Ind 
Phaim 16:91-113. 
Murdoch D (1991) Roxatidine acetate: a review of its phaimacodynamic 
and pharmacokinedc ptopeitie* and its therapeutic potential In peptic 
uker disease and related disorder. Diugs 42: 240-60. 
Qi ZH, Male V, Diaz U Orant DM, Chang O (1991) Molecular Recogni-
tion: a-cydodexuin and petucilUn V inclusion complexatioiL J Org 
Chem 56: 1337-1542. 
ReUianky MV, Goldben RN, Schwm FP. Hwari YB. Ross PD, Yama-
ihoji Y. Inoue Y (19^) Thennodynamic and Nuclear Magnetic Reso-
nance study of the InttnctwAS ^ a- and ^-cyckidcxtna wi& laodet 
substances. Fhenylethylamine, ephedrins and related subatances. J Am 
C3MmSoc 117:8830-8840. 
Schneider H/. Hacket P, Rudiger V (1998) NMR soidies of cyclodextrins 
and cyclodextrin con^lexes. Chem Rev 98: 1733-1785. 
Siecd JW, Atwood JL (2000) Supramolecular Chemistry, VTiley-VCn, 
Weinchim, p. 1. 
Wimmer R. Aachmann PL, Larsen KL, Petersen SB (2002) NMR diffu-
siM) M a novel tool for measuring the association constant between cy-
clodextrin. Carfoohydr Res 337: 841-849. 
The new triterpenold taraxerol-3-^-0-trid&cyl ether was 
isolated from the aerial part of Denis trioMiata. The 
stnjcture was established on the basis of spectral data. 
The genus Derris (Leg-urrnnous farmliy) is -misYf spread 
in soutiieast Asia. It is employed for pest control in horti-
culture, agriculture and in poultry (Gupta etal. 1999). 
Some species are also used in folk, medicine (Sekine et al. 
1999; Mahidol el al. 1997). D. triofoliata, a woody clim-
ber growing in the coastal forest throughout south east 
Asia, is used for poisoning fish by local people. The 
whole plant is also used as a stimulant, antispasmodic, 
and counter-irritant (Ramachandran etal. 1986). Previous 
investigations of leaves of Derris trifoliata have yielded 
hydrocarbons, wax esters (Misra etal. 1987), sterols, 
amyrin, lupeol (Ghosh etal. 1985), and two flavonol gly-
cosides: rhamnetin-3-O-P-neohesperidoside and quercedn-
3-0-3-neohesperidoside (Ramachandran etal. 1986). We 
have investigated tiie chemical constitiients of the aerial 
parts of P. triofoliata, and report here the isolation and 
characterization of a new etherified triteipenoid. 
Compound 1, piismy crystalline (CHCna-CHjOH). was 
fonnulatcd as C43H76O from ESI-MS (m/z &M\M + k]+. 
631 [M-I-Na]+). Its 'H and ' ^ NMR spectra showed 
great similarity to tiiat of taraxerol (Sakurai etal. 1987). 
In H^ NMR, eight tertiary metiiyls at 6 1.09 (3H, s). 0.98 
(3H, s), 0.95 (3H, s), 0.93 (3H, s), 0.91 (6H. s), 0.82 
(3 H, 8) and 0.80 (3 H, s) were typical for triterpenc; an 
oxymetiiine proton at 6 3.20 (1 H, dd, J = 11.0, 4.6 Hz, 
H'3) was observed; a downfield one proton double doub-
let centered at 6 5.53 (J ^ 11.3, 3.2 Hz, H-I5) indicated 
the presence of an olefinic bond, and was assigned to the 
olefmic proton at C-15 of the taraxerane skeleton (Tala-
patra etal. 1981); T\vo geminal methylene protons at 6 
1.92 (1H. dd, J = 14.7, 2.9 Hz, H-16a) and 2.03 (1 H, m. 
H-16b) could be discerned in the 'H NMR spectra; Che-
mical shifts for one oxymetiiine carbon at 6 79.08 (C-3), 
olefinic cartwns at 6 158.10 (C-14) and 116.88 (C-15) 
were all observed. Thus, die carbocyclic nucleus of com-
pound 1 proved to be that of a typical taraxerol. Addi-
tional signals as one oxymethylene carbon at 5 63.11, one 
terminal ntethyl carbon at 6 14.11, multiple methylene 
cartwn signals at 6 29.34 ^ 29.70 indicated that the by-
droxyl of taraxol was substituted by a long alkane. And 
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Fexofenadine hydrochloride (FFN), (±>-4-[]-hydroxy-4-
[4-(hydroxydiphcnylmcihyl)-l-piperidinyl]-butyl]-a;(>di-
meihyl bcnzeneacetic acid hydrochloride, is a second 
generation antihistamine that is used to treat allergies.' It is a 
racemate and exists as zwitter ion in aqueous media at 
physiological pH. It belongs to the group of amine 
compounds bearing diphenylmethyl tunctionality. Like other 
members of this group, the drug IK highly hydrophobic and 
slightly soluble in water. 
The study of inclusion complexes of cyclodextrins (CDs) 
is a subject of great inlcrest.''^  CDs are oligosaccharides 
composed of six to eight glucopyranose units bound by 0(1-
4) linkages that are commoniy named o, 0-, and ^ D , 
respectively. y$CD, in particular, has an internal cavity shap-
ed like a truncated cone. The interior of the cavity is 
relatively hydrophobic while the outer surface is quite 
hydrophilic because of the presence of numerous hydroxyl 
groups. CDs can accommodate a variety of guests into its 
cavity through non-covalent interactions. These complexes 
serve as models to mimic enzyme activity' and to provide 
understanding of the molecular recognition.' Moreover, the 
physical properties, such as solubility, stability, volatility, 
sublimation, etc, of the guest molecule are modified upon 
complexation with CDs, and the resulting inclusion com-
plexes have found numerous practical applications in 
pharmaceutical sciences and in several other areas of 
chemistry ranging from analytical to synthetic chemistry.** 
Inclusion complexes of phaimaceutical compounds with 
CDs have been extensively studied and utilized to improve 
the solubility.^  dissolution rale" and bioavailability of poorly 
water-soluble drugs.' Other ^plications of CD complexes 
of pharmaceuticals include elimination of undesirable drug 
properties, such as irritation and unplcasaiii odor or taste. 
C[>s have also been used to stabilize and protect degradation 
of unstable compoimds. In addition, they have shown a 
potential for improving the stability of tight and oxygen 
sensitive drugs.'" 
Various techniques are used to study the CD inclusion 
complexes but l^^R spectroscopy has been found to be 
most useful in this type of studies." Evidence for the inclu-
sion of the guest into the CD-caviiy is obtained by simple 
NMR titration experiments. NMR spectra of mixtures of CD 
nnd guest molecule arc recorded and changes in the 
citcmical shilb uf biiih iltc IHIM iind gucsi arc studied. The 
foTmation of the inclusion complex results in upfield shift 
changes in the CD protons situated inside the cavity, lutmety 
H-3' and H-5'. On the other hand, guest protons generally 
experience downfield shift changes but sometimes upfield 
shifts are also obsa^ed. These shift changes are attributed to 
the anisotropic ring current effect of the aromatic guests. 
Moreover, the magnitude of the chemical shift changes X<x 
the CD-cavity [notons have been shown to be a qualitative 
measure of the stability of the complex while their ratio, 
A6ri.y/A6ii.r. gives information about the depth of penetra-
tion.'^  Also, .information regarding the mode of penetration 
of the guest into the cavity, i.e. from narrower or wider rim 
side, can be obtained from these shift changes. A typical 
inference is that A6iw > ASiw- if the guest enters the cavity 
from narrower side and vice versa^^ but there are exceptions 
and these o»ictusions can only be drawn when only (me 
complex in formed while in cases where multiple equilibria 
exist these shift changes can only be used as an evidence for 
the formati(»i of inclusion complexes. Information r^uding 
the stoichiometry and association and/or dissociation con-
stant of the cnnplcx oan also be obtained by the treatment of 
simple 'H NMR titration data.'^  
2D NMR spectroscopy has recently become an important 
tool for the investigation of the intaactions between CDs 
and guest molocule5"''*since the NOE cross peaks between 
the protons that are closer than 4 A in space are observed in 
ROESY spectrum. The relative intensities of those cross 
peaks depend on the spaces between the corresponding 
Ixx>tons. The height and the diameter of the >5CD cavi^ are-
about 7.9 ± 0.1 A and 6.0-6.5 A. respectively'* Therefore, 
while the guest molecule is included into the ^ D cxvity, 
NOE correlation peaks between the protons of the guest arid 
protons of the 0CD cavity (H-3' and H-S") are observed by 
means of ROESY experimeni. According to the idatjw 
intensities of these cross peaks, it is possible to estimate the 
orioitation of the guest molecule within the CD cavity. 
In continuation of our work on the NMR studies of 
inclusion complexes of pharmaceutical compounds with ^ 
CD."*" we report herein our results on the detailed SDitfy of 
the complexation between fexofenadine hydrochknde 
(FFN) and y?CD in aqueous solution using high resolution 
NMR spectroscopy. 
Results and Discussion 
All the NMR spectra were recorded on an Inova SOO 
2062 Bull. Korean Oicm. Soc. 2005. Vol. 26. No. 12 Notes 
itKiruinciii in D;0 ai 25 "C. The chemical shift values, 
n:pt»riL\t in rf(ppni). were calculated with reference to HDO 
peak ai 4.76. T\K coiiccniraiion of the guest was kept 
con.suiiii ai .V7x |0 "M whilcihc concentration of the ^ D 
was varied lW>iii 2.5 x 10''to 9.1 x 10'^ M. The [^CD]/ 
[FFN] molar ratios were calculated by direct integration of 
apprtipriaic siynals. .Ml ilie spectra coTLsist of (me set of 
conccniraiion dependent resonances for each proton or 
group of equivaleni protons, indicating a fast reversible 
exchange between free and complexed drug on the NMR 
lime scale. 
AJI examination of ilie ^CD proton signals in the 'H 
NMR spectra of mixtures of FFN and ^ C D revealed 
significant upfield shili changes in the H-3' and H-5' proK>n 
resonances, which arc positioned inside the fiCD cavity, 
compared to pure >5CD. This clearly indicates the fonnation 
of FFN/^CD complex in solution, in analogy to previous 
reports. Figure 1 shinv's the expansions of the 'H NMR 
spectral regions containing 0CD proton signals, in the 
absence as well as in the presence of FFN. 
To have an insight into the detailed structure of the 
complex, the investigation of the chemical shift changes in 
the signals for the guest protons in the presence of /7CD is 
necessary and thus tlw unambiguous resonance assignment 
of tSx guest protons is required. The assignment of reso-
nances of guest protons was made with help of COSY and 
ROESY spectral daia. Tlie signal appearing in the lowest 
field as a doublei at 7,482 was assigned to H-3 as it showed 
correlation peaks with H-6. The cross peaks between H-2 
and H-11 and between H-1 and CHj support the resonance 
assignment for the/vsiibstituied aromatic ring protons. The 
H-1 appeared relatively downfield compared to H-2 signal. 
In the presence o f ^ C D , significant shift changes were 
observed in the signals for protons of all the three aromatic 
rpn i i i i i i i ( i i i | n i r ; nn j i !n iTn rpMt [ tn rp r r 
3 90 3 80 3.70 3-60 3.50 
Fexofenadine (FFN) 
Tabic 1. 'H NMR chemical shin change data of studied protons of 
FFN, in the f>«sence of ^ D 
[fiCDWFt^ 
2.46 
1.76 
1.27 
1.15 
1.12 
0.68 
H-I 
-0.060 
-0.058 
-0.042 
-0.040 
-0.044 
-0.030 
H-2.4 
-0.023 
-0.028 
-0.014 
-0.011 
-0.017 
-0.010 
H.3 
0.109 
0.089 
0.060 
0.052 
0.047 
0.026 
H-5 
-0.003 
-0.004 
0.001 
0.000 
-0.005 
-0.004 
CH)-13 
0.068 
0.038 
0.053 
0.052 
0.039 
0.030 
Negative vsJues indicate upfield shil^  changes 
rings of FFN (Table 1) confirming the penetration of all the 
aromatic rings into the ^ C D cavity driven by hydrophobic 
intfflactions. The signals for H-1 and H-2 of p-^ubsdtuted 
ring and H-4 of ring B exhibited upfield shifts while H-3 of 
aromatic ring B showed downfield shiA. Moreover, the H-3 
signal showed splitting in the presence of j9CD suggesting 
that both the B rings are not identical which is because the 
guest has a chiral center. The magnitude of the ASH-I was 
greater than Afiin which means that the entry of the phenyl 
ring into the ^D cavity is favored compared to p-
substitutedring. The involvement of all the aromatic rings in 
Figure I. Pan of ihf 500 MHz 'H NMR specua showing ^ D 
protons of the (a) 1 : 1. 15 FFN/^D mixmre In comparison to (b) 
pure/tCD. 
F ^ r e 2. A pan of 'H NMR specuum (500 MHz) showing 
aromatic protons of fexofenadine hydrochloride (FFN) in the 
absence as well as in the presence of varying amounts otfiCD. 
yofi's Bull. Koivon Chciii Soc. 2005. Vol 26. No. 12 2063 
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Figure .^ . Mok ratio dtaer$m of the chemical shiA changes of FFN 
proton tliiriii^  tiiration with /K^D in D2O. The concentration of ihe 
FFN v^as V.epi conslani ai 3.7 x 10"'' M. 
complexmion po'mts to (he existence ofmultiple equilibria in 
soluiion.'"'"" Pan of the spectra showing aromatic protons of 
UK FFN. in ihe absence as well as in the presence of ^ D . 
are shown in Fijiure 2. 
The stoichiometry of the complex was dciemiined by 
nioJc rath nwjJiod. Ihoufh Job's pJol is considered bencr. 
because of poor solubility of FFN in DjO. Figure 3 
illustrates plot of A6 VS mole ratio ([)?CD]/[FF>^) for H-3 
of rings B. The ^5 values Increase in a linear fashion till [/^  
CD]/1FFN]=I suggesting I : I stotchiometiy but since A6 
does not become constant and still keeps increasing even 
l}$ ^ 
M 
B 
7 1 
•7.2 
•73 
•7.4 
• 7 6 
h7.6 
3.0 2.5 2.0 1 5 
Figur* 4. r.xp;in.iK«i of ihe 500 MHz ROESY spwirum recorded 
with rn/=.>00 ms showing cross peaks of methyl and all the three 
aromatic ring protons with ^ X> protons. 
when (/?-C0J/fFFMJ>l jjHpJies ibai ihe sloichiomeiry is not 
simply t : I but a combination of 1 : I and I : 2 (guest/host) 
complexes. The fonnatioi\ of 1 :2 complex is favored when 
[ /K:D] / [FFN]>I . 
ROESY spectrum was recorded for a mixture of FFN and 
^ D having molar ratio equal to 1.15 in DiO to ascenain 
COOH 
,CO0H 
Figure 5. Schematic representation of all the possible inclusion complexes fomied in 0:0 hetween FFN and ^ CD. 
20f>4 liiill. Kniean Chain. SiH\ 2<KI?. Vol, 2ft. Nn. 12 Notes 
ihc cNisicncc nfiiiuliiplc cqui'libri;! in s<iluiion nnd lo have an 
insiyhi inu» ihc nuMic of pcnciraiion .mJ oricniation of the 
aromiUit riiiL! intit ihv /f-CD cavity. ,\s sliimii in the Figure 
A. the l«)i:SY spectrum displiual a*iTeliiiioii peaks 
be[v\'eeii proions of all llic aromaiie rinsj proioiis with H-3' 
and 11-5" of /J-CD siiuaied inside the ca\ iiy ilius eonfinning 
bcyovKl tlQuht. the involvement of all tUe aroiTiailc rings in 
the complcxaiion. The cross peaks beuveen II-3 of FFN and 
M-2'.4' of/J-CD, situated near wider rim clearly indicate that 
phenyl riny penetrates the cavity from wider rim side while 
/^substituted ring penetrates from iwrrower rim side since 
H-1 is showing cross peak with I[-2'.-4' of/K-'D. Figure 5 
show s the prnp<Ked stnieiurcs for all the [xissihle FFN/yJOD 
inclusion complexes present in solution. 
Conclusion 
'M NMR titration studies of fexofenadine liydrochloride 
(FFN) with >3H:yclodexirin ( ^ D ) in D:0 conJlmied the 
presence of several inclusion complexes involvint^ all the 
three aromatic rings. The structures for all the possible 1 : I 
and 1 : 2 complexes have been proposed taking into account 
the sioichiomeiry and ROESY speciral data. The mode of 
penetration has been clearly established. 
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COMPLEXATION OF ENALAPRIL MALEATE WITH p-CYCLODEXTRlN: NMR SPECTROSCOPIC STUPY IN 
SOLUTION 
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A (leuikd NMR ('H .COSY. ROESY) ipectrwcopic itwly ofcomplMalioaof enalopril maleate with ^yckxlcxlrin was earned ouL 
ITK 'H NMR .spccinim uf enulapril nuleste conrimicd the existence oi cis-lmu equilibrium in solution, pouibly due (o hindered 
ruutiim along [he umide bond. The cis-inuu ratio itnuined almost the ume in the presence of ^yclodextrin but in one case it was 
found sit-nificunily diffeicm which utggcMS a utlatytic role of -^cyckxlexvrin in the ikumeriu^on. 'H NMR liiratton ^ udica corlinncd 
ihc rormjiion of an cnalapril-p-i:ycttxlcxlrin inclusion complex as evidenced by chemical shift vanMions in the pn<ton resonances uf 
both (he host and ihc gunt. The stoichiomctiy of the complex was determined to be 3;! (guest: host)- The mode of pcnetntiioii of the 
guest iniii the p-vyckKlcMriii cavity as well as the stricture of the complex were established using ROESY spectroscopy. 
Keyword:.: enalapril maleate; |l-cyclodexuini NMR spectroscopy. 
INTRODUCTION 
Enalapril malcaic and its analogs arc highly effective 
aniihypcitensivc agents which act as angiotensin converting enzyme 
(ACE) inhibitors. ACE inhibitors prevent conversion of angiotensin 
1 to II and act lo widen the blood vessels resulting in easier pumping 
of blood by the heart. They are, therefore, used for the treatment of 
hypcnension, congestive heart failure and to alleviate strain on heart 
damaged by heart attack''. The solubility of enalapril maleate in 
water is poor but it is highly soluble in methanol. 
The study of inclusion complex of pharmaceuticals with 
cyclodcxlrins (CD^) is a subject of great interest. Such studies 
Involve siniciurc deicnninnlion of the complex besides the 
energetics of the complex formation. CD, are doughnut shaped 
molecules composed of 6, 7 or 8 a-D-glucose units, linked throu^ 
a-1.4 bonds, called a. ^ and y-CD, respectively. The t^iimary 
hydroxy! groups are located at the narrow rim while wider rim is 
lined with secondary hydroxyl groups. The exterior of the CD, is 
fairly hydrophilk due to the presence of hydrox-yl groups white 
CD cavity is relatively hydrophobic. By vinue of their shape and 
hydrophobic nature of cavity. CD, accommodate a variety of 
hydrophobic molecules, or part'of it, inside their cavity through 
non-covaleni interactions lo form inclusion complexes^. 
Inclusion of the guesi into the CD cavity results in altered 
physico-chemical properties of llie guest like water solubility, 
bioavailabilly, stability and volatility etc*. The majority of drug 
molecules arc poorly water soluble and their biological absorption 
is, consequently, slow and far from being complete. Most drug 
molecules arc ideal guests for CD, because their polarity, size 
and structure enable them lo penetrate into the cavity. Moreover, 
the inclusion complexes of pharmaceutical compounds v ^- CD, 
have several desirable properties. This is the reason why major 
portion of CD related studies is dedicated to pharmaceutical 
*(r-tnujt: sma^ hluMKluIt9ya)HX>-C(itn 
applications. A variety of techniques ore used, for characteriution 
of inclusion complexes in terms of geometry and configurational 
preferences, of which solid state and high resolution NMR 
spectroscopy are most important^. 
The formation of inclusion complex results in the shift changes 
in resonances of both the CDs and the guest protons'. The magni-
tude of AS is a critical function of position of proton in the molecule, 
size of CD cavity as well as host/guest ratio. In general, the inclusion 
of an aromatic ligand into the CD cavity causes major upfield shiils 
in the H-3' and H-5' of CD, situated inside the cavity, which is 
attributed to the ring current effect of the aromatic ring. The protons 
located outside cavity show negligible or trivial changes. Contrary 
to the upfield shift changes experienced by the CD protons, situated 
inside the cavity as a result of coniplexation. all the guest protons, 
and not only those irKtuded inside the CD cavity, generally show 
downfield shift changes upon complexation. This has been 
attributed, besides the shielding effect of the cavity, to o'her facton 
like changes in the mtcroenvironment or conformational changes\ 
Ttw preferred niode of penetration of guest into Uie cavity is from 
wider rim side but complexes in which the entry of the gue::l takes 
place from narrower rim side ore also known'. 
Simple 'H NMR titration studies between CD, and the guest 
confirmed the Fonnalion of inclusion coinplex. Moreover, valuable 
inframaiion regarding mode of penetration of guest into CD cavity, 
i.e. from narrower or wider rim side, siotduometry and stability of die 
complex can be obtained by the treatment of 'H NMR titratitm data*. 
Advanced 2D NMR techmques like NOESY and ROESY prove very 
helpful in unambiguous assignment of slrtjcture of the complex. 
In continuation of our work on the NMR studies of inclusion 
complexes of j^armaceutical ccxnpounds with ^•CD '^*', we r^xxt 
herein our results on the study of complexatioi of enal^iril msleale 
with P-CD in solution by NMR spectroscopy. 
EXPERIMFJJTAL PART 
Enalapril maleate was obtained from Nebula Health Care Ltd. 
India, while p-CD was obtained from Ccrcster, Belgium, and these 
All el d. Quim. Nova 
were used without further purification. 'H NMR spectra were 
recorded on a JEOL 400 MHz instrument in D , 0 at 25 "C. The 'H 
NMR measurements were carried out with 4 s relaxation delay. 
0.73275969 Hz resolution and 16384 data points. 2D ROESY 
measurements were made with the experimental conditions n< 
follows: scans 32. acquisition time 0.1470 s, pulse delay 2.3530 i 
and data points 512. The concentration o f ' - C D was kept constant 
at 10 mM while the concentration of enalapril maleate was varied 
from 11,4 to 52.6 mM. The H/G molar raiios were calculated by 
direct integration of appropriate signals. The chemical shift values, 
reported in fi (ppm). were calculated with reference to HDO peak 
at 4.7846. 
in the case of pure enalapril maleule. In the presence of |3-CD, 
this signal merged with {S-CD protons and, therefore, lis chemical 
shift changes could not be determined. The structures for the 
two isomers could be established by comparative study of the 
H - t 3 , 1 4 and 16 signals. The major isomer was assigned structure 
(A) since H-13 and 14, being in close proximity of oxygen of -
COOH group should appear downfield compared to signals for 
the same protons of the minor isomer (B) which is in good 
agreement with earlier obse^vatio^'^ As expected, the signal 
for H - I 6 for major i somer (A) appears relat ively upfield 
compared to (hat of minor isomer. 
RESULTS AND DISCUSSION 
Two diastcreomeric fonns, (SSS)- and (RSS)-, of enalapril 
maleaic, chemically known as l - |N-«S) - I -e ihoxycarbonyl -3-
phenylpropyl]-L-atanyl-L-priiline maleate. are known of which 
only (SSS)-diastercomcr is used as drug". 'H NMR spectra of 
enalapril maleate (SSS-diastereomer), in the absence as well as 
in the presence of P-CD, showed that two geometrical isomers 
are in equilibrium in solution. Cis-trans isomerism is possible 
in the case of enalapril maleate due to hindered rotation along 
amide bond' ' . The spectral assignment for the major (A) and 
minor (B) isomers was made with the help of COSY spectrum. 
The chemical shift data of the studied protons for pure enalapril 
maleate and enalapril maleatc-P-CD mixtures is given in T^ble 
I. The signals for the protons of three methylenic groups, for 
two isomers, at C-8. 17, 18 were found resonating as multipleti 
centered at 2.2700 (3H^+4H„), 1.9600 (3H^+1H,) and 1.7200 
(IHg). The signal for H^-19 was observed resonating at 3.5328 
A; EnnlMpril rnkk-aiu (Major) B: EuUptll mi luie (Minor) 
As expected, changes in the shapes as well as chemical shifts 
of enalapril maleate jHOlons were observed in the presence of ^ 
CD. All the [KOtons, except H-11, exhibited downfield shift changes. 
The highfield shift in the H-ll signal may be due to hydrogen 
bonding between the hydrogen of the rim hydroxyl and -COOCjH, 
group. The fiignal for H-ll. which appeared as a quartet at 4.2321 
in the spectrum of pure enalapril maleate, became complex in the 
presence of P-CD making it difficult to calculate chemical shift 
changes. The AS values for all the studied protons of the enalapril 
maleate ore given in Ibble 1. 
Table 1. 'HNMR (400 MHz) Chemical shift (5. ppm) data for Enalapril maleate (G) and chemical shift change (^S) values for the studied 
protons o)' Enalapril maleaic in ibc presence of ^-cyclodestrin (H) in DjO 
Proton 
H.-I2 
H,-I2 
H,-14 
H.-14 
H..-7 
H,-I9 
H^ -*^  
H^-9 
H,-I3 
H^-13 
H^-16 
H,-16 
H..*2,4.6 
H..,*3.5 
ffcould not 
[C] 
1.2490 
1.2490 
1.4910 
1.5368 
2.7600 
3.4000 
3.8700 
3.9100 
4.0380 
4.2620 
4,3800 
4.4200 
7.2550 
7.3360 
be determined. 
Tubl(! 2. 'HNMR (400 MH/.) 
A/B' 
73:27 
6{t.40 
61:39 
.•59:41 
M36 
|H|/(G1 
0.875 
0.750 
0.560 
0.3.15 
D.IW 
[H]/[G)=0.875 
0.0092 
0.0183 
0.0302 
0.0275 
0.0700 
0.0300 
0.0530 
0.0608 
# 
0.0360 
0.(M36 
0.0130 
0.0250 
0.0140 
[H1/(G]=0.750 
0.0110 
0.0202 
0.0284 
0.0257 
0.0620 
0.0200 
0.0476 
0.0517 
0.0290 
0.0333 
0.0300 
0.0100 
0.0200 
0.0140 
chemical shift change (A6) values for 
H - l ' 
-0.0055 
-0.0073 
-0.0091 
-0.012K 
-«.t)201 
H-2' 
0.0100 
0.0064 
0.0046 
0.0046 
0.1X)37 
[H]/IG]=0.560 
0.0110 
0.0202 
0.0247 
0.0232 
0.0500 
0.0150 
0.0421 
0.0462 
0.0250 
0.0296 
0,0280 
0.0080 
0.0150 
0.0100 
[HJ/[G]=0.335 [H]/[G]=0.190 
p-cyclodextrin protons in d u 
H-3-
-0.0402 
•0.0403 
-0.0439 
-0.0567 
-0.0751 
H.4-
-0.0019 
-0.0037 
-0.0055 
-0.t)092 
-0.0147 
0.0128 
0.0202 
0.0229 
0.0211 
0.0450 
0.0100 
0.0312 
0.0388 
0.0220 
0.0280 
0.0262 
0.0050 
0.0)20 
0.0090 
0.0092 
0.0147 
0.0174 
0.0156 
0.0350 
0.0020 
0.0310 
0.0278 
0.0170 
0.0220 
0,0230 
0.0015 
0.0080 
0.0040 
presence of Enalapril maleate in D p 
H-5' 
-0.0730 
-0.0738 
-0.0798 
-0.0998 
-0.1428 
H.6' 
-0.0073 
-0,0091 
-0.0128 
-0.0183 
-0.0311 
ffcis / iniiis r.iiii> of cnii1;ipi'il niiilcitic. Negative values indicate high field shift. 
W)/. XY. No. OO Coinplexalion of BAalapril Maleaie wiih ^ y c l o d c x m n 
H-r A"*' '"^ *^ '" °-^" H.2' "*^ ' 
[H]/IG]« 0J35 
yvyWU 
[H] H-Z 
n n 
H4' 
f = F 'l I I 1 - ^ 
3,7 3.6 3'5 
Ftjun i. Puriiuf 'H NMH |4flOMH:} i;>ecir(i jfinwing sigmUfor IheprOioni 
offi-CD (HI in the ahxence us well us in the presence of varying amounts of 
eimiainil maleaie IGJ. Noie the large upfield shifts uf H-3'tuut H-5'in sharp 
idiiiroif ((I [h« MiuiH sAi/i chonj-fj obs,tniidfor H-2', H-4'andH-<i' 
'H NMR spetim ol p-CD in (he presenix orcnalapril malealc 
JispKiyccI sigDificyiit highfieliJ shil't clumges in ihe signal for H-3' 
and H-S' wtiile Ihe peaks for other prutons showed negligible AS. 
The A5 data lor all the P-CD protons compared to pure P-CD has 
been given in Table 2. The progressive upfield shift of H-3' and H-
5' resonances in the presence of varying amounts of cnalapril 
maleaic are shown in Figure 1 which shows the part of the 'H NMR 
spectra containing p-CD signals. 
^.06 
-0.04 
•010 
•0.12 
-0.1* 
•0.16 
0.0 0.3 0.4 o.a o j 
[D-COy (Enaiaprll maleatt] 
Figure 2. Mole iviio plni of fhernkal shift change for H-S' (A5^^ of P~CD 
durinii tiirtiiitin with fiutlapril maUale 
The upHetd ihtfts obKrved for the signali of H-3' and H*5'. 
situated inside the p-CD cavity, and concomitant downfteld ihifl 
changes for cnalapril malealc protons in the 'H NMR spectra of 
mixtures of cnalapril maleate and p-CD are a clear indication of 
complexation between cnalapril maleate and p-CD, in analogy to 
previous studies^-*. Furthermore, the magnitude of shift changes 
of these p-CD protons increased with the increase in the 
concentration of cnalapril maleate. The stoichiometry of the 
complex was determined by mole ratio method'*. The plot A5j„. 
vs H/G (Figure 2) shows flattening of the slop of the curve at a 
molar ratio of around O.S suggesting a 1:2 stoichiometry for the 
i-CD-cnalapril maleate complex. 
iLii.,.-.....,. 
7 ^ i 
H-I708>H.3' 
n-3.S/H-5'^ 
H-2.4.6m-19 
H-2.4MI.5' 
t_. 
Figurt 3. 2D ROESY spectrum (4(X) MHz) of mature of p-CD IHJ and 
entdapril maleate Id UHt/(GI=0.H07). The marked cross peaks support 
sirvcturefor 1:2 ^Ct> etutlapril maleaie complex 
ROESY'' .spectrum {Figure 3) was recorded for a mixture of 
cnalapril maleate and P-CD llHyC^O.807) to study the mode of 
penetration of two guest inol^culcs into a p-CD cavity, 
fniermolecular cross peaks ob.scrved between the aromatic 
protons of the guest and H-5' of P-CD and no cross peaks 
ob.scrved between the aromatic protons and H-3' confirm the 
shallow penetration of the aromatic ring into the P-CD cavity 
from narrower rim side". Moreover, Cross peak between H-19 
and H-2, 4, 6 of cnalapril maleate confirmed that aromatic ring 
of one guest molecule and S-mcmbered ring of another molecule 
share the sanw p-CD cavity which is in agreenwnt with the 1:2 
hostiguesi stoichiometry of the complex. Cross peak between 
H-17 (18) and H-3' was also observed which connrms that 5-
mcmbered ring enters the p-CD cavity from wider rim side. Fi-
gure 4 shows an expanded region of the ROESY spectrum 
containing cross peaks between the P-CD and cnalapril maleate 
protons. The proposed structure for the 1:2 P-CD-cnalapril 
maleate complex is shown in Figure 5. 
It is important to mention here that though the cis-trans ratio 
for cnalapril maleaie, as determined from the integration of 14-
CH, doublet, remained almost unchanged, in the presence of P-
CD, in four samples. However, there was a significant change 
observed in one of the sample (Table 2). This can only be explained 
in terms of catalysis by the p-CD. However, this needs further 
investigation, 
All tl al. Quim. Nava 
H - l l / H - J ' - - ' * 
H-l7()l)m-3' 
H-II/H.I9 
' ^ 
H-2,M/H-19 
FIgurt 4. Expansion of pan 2D HOESY sptctnan showing crpssptaks between 
tiudapril maleatr and P-CD 
FigurtS. PniimsedMruttitrr fur 1:2 h-vytliKlctUiii-enalafrrilmtileaie 
CONCLUSION 
Enaiapril maleaie, which exists in two geometrical forms in 
solulion. rorms a I: 2 host>guest inclusion comqilex with ^-CD in 
the concentration range studied. The aiomaiic ring of one guest 
molecule enters the ^-CD cavity from narrower rim side while 3-
member«d ring penetrates throu^ wider rim side at evidenced by 
ROESY speclnim. The nructure for the complex has been [vt^ xised-
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Atittnct 
'HNMR spectroscopic study in D^ O of mixtures of [}-(-)-chIoramphenicol (guest), present in tvfo tautomeric forms in solution, and 
P-cyclodcxirin (host) revealed the formation of 1:1 inclusion complex in which aromatic ring of the guest is tightly held by the host cavity. 
There seems no discrimination between the aromatic rings of two tautomers by the host. 
O 2004 Elsevier SAS. All rights reserved. 
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1. Introduction 
Cyclodextrins (CDs) are among the most widely used 
hosts for their ability to bind organic molecules in aqueous 
solution and in the crystalline state by non-covalent interac-
tions [11. The internal diameter of their torus shaped cavity 
and size of the guest molecule are of primary significance for 
the formation of inclusion complexes. The ability of CDs to 
hold a variety of guests into their hydrophobic cavity has 
rendered them very useful models for studying topochemis-
try and catalytic mechanism of enzymes [2]. Inclusion com-
pounds have difTereni physico-chemical properties, such as 
altered solubility, reduced volatility, reduced/enhanced sta-
bility, modified chemical reactivity and altered bio-
availability as compared to free molecule, and that is why 
CDs are widely used in pharmaceutical applications as a 
vehicle for drug delivery of poorly water-soluble drugs 13,4]. 
NMR spectroscopy is the most reliable technique [5], of all. 
for the study of inclusion phenomenon because both the host 
and guest molecules are observed simultaneously. NMR 
studies of CD-complexes in solution generally show rapid 
exchange of guest molecule between the hosts resulting in 
averaged shifts and no distinct species on the NMR time-
scale. However, valuable information regarding the inclusion 
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of the guest into the CD-cavity, their stoichiomeiry and 
stability can be extracted through treatment of the data from 
simple ' H N M R experiments through the variation of the 
chemical shifts for different protons [6-8]. Extensive studies 
on the inclusion complexes of pharmaceutical compounds 
with p-CD have been reported [3,4,91, In continuation with 
our work on the complexation behaviour of pharmaceuticals 
with P-CD [10], we report here our results on the study of 
inclusion complex of D-(-)-chloramphenicol, an antibacterial 
drug having a wide spectrum of activity against gram positive 
and gram negative cocci and bacilli (including anaerobes) 
[11], with P-CD in solution by NMR spectroscopy. 
2. Results 
'HNMR spectra were recorded on a 300 MHz instrument 
at 25 "C for five samples with |H]/(G] molar ratios ranging 
from 2.31 to 1.27 which were determined by direct integra-
tion of the NMR signals. The anomcric proton (H-1) of p-CD 
was used as internal reference throughout this work. The use 
of this proton signal as a reference is justified because the 
water signal is too wide; H-3, H-5 signals show largest 
chemical shift changes on complexaUon; H-2, H-4 signals 
may also be affected though situated outside the cavity. The 
location of anomeric proton ensures the smallest (if any) 
induced shift. 
The signals for the protons of the drug and p-CD did not 
interfere with each other in any of the spectrum. 'HNMR 
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Spectrum of each sample denoted largest chemical shift 
changes (A )^ for H-3 and H-5 protons of the p-CD while the 
other protons of the ^-CO showed negligible deviations in 
the presence of guest. The chemical shift change (A )^ data 
for various protons of the p-CD in the presence of varying 
amounts of drug is given in Table 1. Part of the NMR spectra 
of samples A-E containing signals for the protons of P-CD is 
shown in Fig. 1. The progressive upfield shift in the signals 
for H-3 and H-5 protons of P-CD with the increase in the 
concentration of guest, is quite prominent. 
A cursory examination of the signals for drug protons, in 
the abwnce as well as in the presence of P-CD, clearly 
indicates that two tautomeric foims, namely kelo and enol, 
are present In solution in the approximate ratio of 3:2, as 
determined by the integration of NMR signals appearing 
separately for the two tautomers. 
3'CHaOH o 
a M cHcij 
To" 
D-(-)<Cblaf*aiph«alcaI 
The presence of two tautomers of drug molecule was 
evident from the signal for H-1'proton which integrated for 
two-third of a proton. Moreover, the sigiuls for H-3' and H-4' 
protons appeared separately for the two uutomers while 
aromatic protons were observed together as a pair of doublets 
having AB pattern. In the presence of P^D, signal for 
H-5',8' aromatic protons of drug moved progressively down-
field with the increase in the concentration of P-CD while an 
upfield shift in the H-6',7' aromatic protons signal was ob-
served, though small in nuignitude. The multiple! for H-2' 
proton also exhibited large downfleld shift in the presence of 
p-CD while H-3' signal did not show any appreciable devia-
tion. The signal for H-4' of kelo form also moved downfield 
but no significant change for the same proton of enol form 
was observed. T^ble 2 shows the chemical shift change (Ai$) 
data for the D-(-)-chloramphenicol protons and part of the 
NMR spectra showing the chemical shift changes for various 
protons of the drug in the presence as well as absence of 
P-CD is given in Fig. 2. 
Tibk 1 
'HNMR Chemical sitift changes (A5) of 0-cyclodextrin protons in UK presence of IK-)-<:hlonmphenicol 
3-8 3.6 TT 
F « . I. Pan of 'HNMR spectra (300 MHz) coauinitiK signals for ^-CD 
proton in the presence of l>-(-)>chloramphenK(ri (A>E) and 'HNMR 
<500 MHz) spectnim of ^ D . 
3. Discussion 
P-Cyclodextrin is a truncated right cylindrical cone 
shaped molecule, 7.9 x \0'^ cm high, with a hollow upered 
cavity whose top and bottom dimensions are 6.5 x 10"* and 
6.0 X 10~^cm [12]. The most likely modeof complexation of 
the guest involves insertion of the less polar ptHtion into the 
cavity of the P-CD from the wider side resulting in major 
upfield shifts in the signals for H-3 and H-S protons of P-CD, 
since these are positioned inside the cavity. This is attributed 
Sample 
A 
B 
C 
D 
E 
[HMO] 
2.31 
1.95 
1.55 
1.38 
1.27 
H-2 
0.002 
-0.002 
0.003 
-0.003 
0.004 
H.3 
-0.041 
-0.043 
-0.054 
-0.061 
-0.071 
H-4 
0.004 
-0.003 
0.001 
-0.002 
-0.00! 
H-S 
-0.051 
-0.054 
-O.069 
-0.081 
-0.098 
H-6 
0.000 
-0,001 
-0.002 
-O.002 
0.006 
H-5/H-3 
1.24 
1.20 
1.27 
1.33 
1.40 
Negative values indicau high field shift. 
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Rg. 2. Pwi of 'HNMR ipeclra (300 MHz) conlaining signals for iH-)-
chlorunpttenicol protoiu in the presence (A'E) and absence of p-CD. 
to the ring current of the aromatic ring of the guest molecule 
that is included into the cavity [I3,]4]. The other p-CD 
protons located outside the cavity show either no or negli-
gible changes in their chemical shifts upon complexation. On 
the other hand, signals for most of the guest protons show 
downfield shift changes upon complexation with p-CD but 
the magnitude of the shifts is much smaller compared to 
^CD protons. In a detailed thermodynamic and NMR spec-
troscopic study of the inter«;tion of CDs with a variety of 
model substrates, Rekharsky et al. [IS] demonstrated that the 
(HMG) 
Fig. 3. 
magnitude of the upfield shifts in the signals for H-5 and H-3 
protons of CDs, A(i(H-5) and A^H-3), and their relative 
ratios, &3{H-5)/63{H-3), can be used as a quantitative mea-
sure of the stability of the complex and the depth of inclusion 
of the guesl into the cavity, respectively. 
It can be argued, in analogy to earlier reports [ 15-17], that 
the observed highfietd shifts in the signals for H-5 (domi-
nant) and H'3 (subordinate) protons are clearly indicative of 
the penetration of the aromatic ring into the ^ C D cavity 
from the wider side, and the formation of a tight-fitting 
complex between the guest and p-CD as evidenced by high 
4<5(H-5) and ^H-3) values. Also, the values (1.20-1.40) for 
A(5(H-5)/A<5(H-3) ratios (Table I) are suggestive of deep 
insertion of the aromatic ring of the guest into the host cavity 
[15]. The stoichiometry of the complex was determined by 
plotting A5(H-5) and A^(H-3) vs. [H]/[G] which gave 
slightly curved lines. However, a modified Benesi and Hilde-
brand [181 plot of chemical shift changes for H-3 and H-5 
protons in the fonn of ([Hl/[G])/4(5CH-3 or 5) vs. [H]/[GI 
gave excellent linear fits (Fig. 3) supporting 1:1 complex-
ation. There seems no discrimination by the host between the 
two tautomeric forms of the guest as the signals for aromatic 
prototis of both the tautomers appear together as a pair of 
doublets in the presence as well as in the absence of host. The 
chemical shift changes that take place in die signals for 
aromatic protons, upon complexation with ^-CD, also give 
valuable information regarding the depth of penetration be-
side Uie values for Atf(H-5)/AJ(H-3) ratios. All the aromatic 
lU>)c2 
'HNMR chemicaJ shift changes (A5) for various f^Mons of o-(-)-chloramphenicol in the presence of p-CD 
Sample 
A. 
B 
C 
D 
E 
[HWG] 
2.31 
1.95 
1.56 
1.38 
1.27 
H-2' 
0.130 
0.128 
0.115 
0.108 
0.086 
H-3' 
Keio 
0.009 
0.006 
0.005 
0.004 
0.003 
Enoi 
0.023 
0.022 
0,022 
0.021 
0.020 
H-4' 
Keto 
0.161 
0.154 
0.134 
0.123 
0.105 
Enol 
0.032 
0.029 
0.026 
0.024 
0.020 
H-5'.8' 
0093 
0.086 
0.082 
0.079 
0.078 
H-6'.7' 
-0.028 
-0.027 
-0.025 
-0.022 
-0.021 
Negative values indicate high field shift. 
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protons of the phenyl ring show downfield shift upon com-
plexation [16]. but when a polar group, present at para-
position of the aromatic ring, enters the hydrophobic cavity 
of f}-CD it passes through the cavity and protrudes out of the 
smaller rim. In such cases, the aromatic protons oitho to 
polar group exhibit upfield shift while those in meta position 
move downfield [19]. The chemical shift changes in the 
aromatic protons of the guest, in our case, also point to the 
nttro group protruding out of the smaller rim and exposed to 
solvent. The difference in the chemical shift changes for H-4' 
proton of keto and enol forms of the guest molecule may be 
due to different environment but is not clearly understood. 
Finally, the ' H N M R spectroscopic study, in solution of 
D-(-)-chloramphenicol with varying amounts of P-CD re-
vealed the formation of a 1:1 tight fitting Inclusion complex 
formed by the inclusion of the aromatic ring into the hydro-
phobic cavity of the P-CD. There is no evidence of discrimi-
nation by the host between the two tautomeric forms of the 
guest. 
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Abslracl 
A proton magnetic resonance spectroscopic study in D,0 of mixtures of fluoxetine hydrochloride (guest) with ^yclodextrin (host) 
revealed the existence of two dilTerent equilibria for I: I inclusion complexes in which -CF^ substituted ring of the guest is more tightly held 
by the host cavity. The struaures of the two complexes have been proposed which are supported by 2DR0ES Y spearal data. The dissociation 
constant was also deurmined. 
0 2005 Elsevier SAS. All rights reserved-
K'e.vHtifrfj; ItKiuswjn complexes; P-Cyclodexirin; Ruonetine hydrochloride;' H NMR; ROESY 
1. Introduction 
Cyclodextrins (CDs) are polymeric carbohydrates (cyclic 
oligomers) dItTering from one another in number of glucopy-
ranose units in their structure and are referred as a*, ^ and 
Y'CD having 6-^ units, respectively [ I ]. Due (o formation of 
a>l,4>glycosidic linkage, CDs are doughnut shaped mol-
ecules, possessing hollow cavities which can accommodate a 
variety of guests in aqueous solution and in the crystalline 
state by non-covalent interactions [2]. The presence of 
hydroxyl groups on the exterior surface of CDs make them 
fairly polar while the interior of the cavity is relatively non-
polar. The slightly hydrophobic character of the inner cavity 
provides a driving force for host-guest complexation with 
similarly apolarguesi molecules. The study of inclusion com-
plexes of pharmaceuticals with CDs have received consider-
able attention due to altered physical and chemical properties 
of the included guest molecules [3]. Several drugs are already 
approved and marketed in CD-complexed form and consid-
ering the strict tequirements for approval of a new chemical 
entity, the study of inclusion complexes of drug molecules 
with CDs has become a subject of great interest [4}. 
In continuation of our work on the NMR spectroscopic 
studies of ^-CD-complexes of pharmaceutical compounds 
* Comsponding auihor. 
E-ntailuddrexf: smashhoodaIi<S'yahoo.com (S,M. Ali). 
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[5,6], we report here our results on the study of inclusion 
complex of racemic fluoxetine hydrochloride (G) with P-CD 
(H). Fluoxetine hydrochloride, commercially known as 
'Prozac', is an antidepressant, antiobsessional and antibu-
Umic drug. It is a potent and selective inhibitor of serotonin 
uptake. This uptake inhibition by fluoxetine hydrochloride 
enhances serotonergic function. As a consequence the sero-
tonin receptors are desensitized or down regulated after long-
term filuoxetirie hydrochloride admimsvraiion. It does t\oi 
appear to cause down regulation of post synaptic beta-
adrenei:gic receptors or a decrease in beta-adrenergic-
stimulalcd cyclic adenosine monophosphate generation as do 
other antidepressant medications [7]. 
2. Results 
All the NMR spectra were recorded on a 500 MHz Bruker 
instrument at 25 "C in D^O. The H-1' signal of ^-CD is used 
as a reference throughout this work [81 and chemical shifi 
values are reponed in ppm. ' H NMR spectra for five mix-
tures of fluoxetine hydrochloride and p-CD, having [Hl/fG] 
molar ratios ranging from 0.40-1.40, as determined by the 
integration of appropriate signals, were recorded. The amount 
of guest was kept constant (I x 10"^ mmol) while amount of 
P-CD was varied. These samples were then dissolved in 0.5 ml 
D2O. ROESY (500 MHz) experiment was performed on a 
44(> SM. Mi fliil. /fl l\in,Hi,i' N> {2iH)5\ 44;i^4» 
MTL 
7.10 3.(0 
sample having (H1/[G1 molar ratio as 0.45 wiih a mixing lime 
of 225 msat25 °C. All (he spectra contained one set of reso-
nances suggesting a fast equilibrium between free and the 
completed state, on the NMR time scale. 
The signals for the protons of fluoxetine hydrochloride and 
P-CD did not interfere in any of the spectra. 'H NMR spectra 
of fluoxetine hydrochloride, in the absence of 3-CD, exhib-
ited a pair of doublets, each integrating for two protons and 
showing AjB; pattern, at 7.091 (7= 8.95 Hz) and 7.573 
{7 = 8.75 Hz) which were assignable to H-2,3 and H-1,4, 
respectively, of the trifluoromethyl substituted aromatic ring. 
The signal for H-8 of phenyl ring appeared as a triplet at 7.393 
(J = 7.20 Hz) while signals for remaining phenyl ring pro-
tons appeared merged in the region 7.4.30-7.505. A singlet at 
2.779 for three protons was due to N-CHj. A doublet of dou-
blet (7, ^J2 = 4.25 Hz) at 5.618 was ascribable to benzylic 
proton (H-5). A pair of multiplets centered at 2.364 and 2.463. 
each integrating for one proton, was assigned to methylenic 
protons (H-11) while signals for methylenic H-12 were found 
resonating as a pair of multiplets centered at 3.261 and 3.346. 
Prominent changes in the nature and position of signals 
for most of the protons of fluoxetine hydrochloride were 
observed in the presence of P-CD which Increased with the 
increase in the concentration of p-CD. The signals for the 
phenyl ring protons moved downfield and became complex 
making it difficult to calculate chemical shift change values 
in the presence of ^-CD. The signals for H-2,3 of trifluorom-
ethyl substituted aromatic ring exhibited downfield shifts with 
the Increase In the concentration of P-CD and signals for two 
enantiomers started separating. A very significant upfield shift 
was observed in the H-1.4 proton signal in the presence of 
|3-C0. The peaks for H-5 proton of the two enantiomers also 
separated in the presence of p-CD. Downfield shift changes 
were also observed in the signals for two methylenic groups 
of the drug in the presence of P-CD. Part of spectra contain-
ing studied signals of fluoxetine hydrochloride are shown in 
Fig. I while chemical shift change values for various protons 
of the guest are given in Table 1. 
In all the specu-a of mixtures of fluoxetine hydrochloride 
and p-CD, the signals for H-5' and H-3', situated inside the 
p-CD cavity, exhibited high field shifts compared to pure 
P-CD: the H-5' shifts being dominant while H-3' shifts as 
subordinate. The signal for the H-2' proton moved signifi-
cantly downfield In the presence of fluoxetine hydrochloride. 
Though signals H-4' and H-6' also displayed downfield shifts, 
these were not very significant. The chemical shift change 
{M) values for P-CD protons are given in Table 2. The pat-
tern of the spectral region containing P-CD signals, in the 
spectra of mixtures of fluoxetine hydrochloride and P-CD, 
Table 1 
'H NMR (500 MHz) chemical shift change (&^) values for various procons of fluoxetine hydrochloride in the presence of |3-CD in D.O at 25 "C 
Sample [H1/[G1 H-1.4 H-2.3 H.5 H-lla H-llb H-I2a H-I2b H-I.l 
A 
B 
C 
D 
E 
1.40 
1.05 
0.88 
0.4.S 
0.40 
-0.1:^ 8 
-0.115 
-0.102 
-0.060 
-0.0.56 
0.047 
0.040 
0.038 
0.016 
-0.00.1 
-0.021 
-0.019 
-fl.018 
-0,01.3 
-0.016 
0.131 
0,119 
0.112 
0,050 
0.02.^  
0.093 
0.088 
0.082 
0.035 
0.013 
0.005 
0.060 
0,041 
0,022 
0.104 
0.040 
0.047 
0.038 
0,016 
0,005 
0.050 
0.042 
0.041 
0.010 
0.010 
Negative values indicate upheld shift. 
Table! 
'H NMR (.500 MHzKbemicat shift change (A4) data for p-CD protons in ihe presence or fluoxeiine hydrochloride in D^Oat 25''C 
Sample (H]/(G] 
A 1.40 
B 1.05 
C 0,88 
D 0,45 
E 0.40 
H-3' 
0.0.54 
0.057 
0.0.57 
0.059 
0.057 
H-3' 
-O.038 
-0.048 
-0.0.50 
-0.0.56 
-0.059 
H-4' 
0.022 
0,023 
0.021 
0.022 
0.020 
H-.5' 
-0.291 
-0.310 
-0..W8 
-0.319 
-0.315 
H-6' 
0.028 
0.020 
0.017 
0,009 
0,009 
A<iH-5'/A^H-.V 
7.66 
646 
6.16 
5.70 
5..U 
Negative values indicate upfietd shift. 
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more or less remained unchanged because concentration of 
the guest was kept constant. 
3. Discussion 
CDs have played major rote in the development of su-
pramolecular chemistry. Most of the CD related studies 
involve structural elucidation of the inclusion complex besides 
the energetics of the complex formation. The results of these 
studies suggest that the mode of complexation of the guest 
with CDs, Involve Insertion of the less polar (non-polar) por-
tion of the guest into the CD cavity. They act as one site llgand 
meaning that the penetration mostly lakes place from the 
wider rim side of cavity. Though these observations are mainly 
based on the studies of a-CD complexes but have mostly been 
found w e for ^ CD complexes. In the case of iarger CDs the 
entry of guest may take place from either side, as in the case 
ofY-CD[l]. 
NMR spectroscopy has proved to be the most useful tech-
nique for the study of ^-CD Inclusion complexes because of 
its sensitivity [9]. The host-guest interactions are clearly 
reflected in changes on various NMR spectral parameters. 
The structure of an Inclusion complex is determined by an 
energetic balance between the maximal inclusion of non-
polar portion of guest into the ^-CD cavity and optimal mutual 
orientations of host and guest to permit interactions of polar 
portions of the guest with ^ D or solvent. 
Demarko and Thakkar first observed the variations in 
chemical shifts of H-3' and H-5' of p-CD in the presence of 
various substrates and inferred thai inclusion In cavity has 
taken place since these protons are situated Inside the cavity 
[ 10]. This type of evidence has since been widely collected. 
The development of new NMR techniques has further con-
tributed to better understanding of structures of CD com-
plexes {11 ]. A typical structural inference is that if only H-3' 
signal undergoes a shift in the presence of a substrate then 
cavity penetration Is shallow, a deep peneu^tion results in 
H-5' shift also (121. The magnitude of shift changes for H-3' 
and H-5' have been shown lo be related to the stability of 
inclusion complex: higher values of AJ^ H-.V and A^H-S' mean-
ing higher stability of the complex. Moreover, the ratio for 
the induced shift changes for these protons, A^'H.^ 7A5H..I'< has 
been correlated to the depth of inclusion of the guest Into the 
CD cavity 113]. 
Contrary to the upfield shift changes experienced by (he 
protons situated inside the CD cavity, all the protons of the 
guest, generally, show downlield shirt changes on complex-
ation and not only the proion/s included in the CD cavtiy 
which has been attributed, besides the shielding effect by the 
cavity, to other factors like changes in the microenvironment 
and guest conrormalional changes upon complexation. The 
downfield shift changes in protons of the guest ore smaller in 
magnitude compared to CD protons and have mostly been 
neglected though these may be useful, using advanced NMR 
techniques, in identification of the part of the guest that is 
included in the CD cavity [ 111. 
0.14-t 
o.iH 
I 
I 
9M 
OM-
Remarkable upfield shift variations observed in the reso-
nances of H-3'and H-5'of p-CD In the presence of fluoxet-
ine hydrochloride clearly indicate the inclusion of aromatic 
part of the guest into the CD cavity due to hydrophobic Inter-
action, in analogy to earlier studies [5.6,101. As expected, 
most of the guest protons exhibited concomitant downfield 
shifts which increased with increasing [HI. exhibiting type of 
saturation curvature (Fig. 2). A modified Hlldebrand-BenesI 
plot of H-1,4 of trifluoromethyl substituted aromatic ring in 
the form of (Hj/iW vs. [H] gave excellent linear fits (Fig. ^ ) 
which supports 1:1 complex formation[141.The higher mag-
nitude for ^ ^.y compared to AI)'H-.V values may be due to 
either the penetration of aromatic guest from the narrow rim 
of P-CD [IS] or deep penetration of the guest from wider 
side [131. The observations that protons belonging to both 
the aromatic rings exhibit shift changes (though the chemical 
1.6 2.0 2.4 
(H]«IO-'(M) 
Fif. .1. 
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shift changes of phenyl ring coutd not be calculated because 
of their comple;(ity). taking into account the 1:1 stoichiom-
etry of the complex, indicates that two equilibria may exist in 
solution. The separation of signals of H-5 of two enanti-
omers in the presence of ^CD (Fig. I), may be attributed to 
the fact that diastereomeric complexes formed from two enan-
tiomers are structurally different from each other. 
To have an insight into the mode and depth of penetration, 
confirm the existence of multi-equilibria in solution and 
detailed structure of complex/es. ROES Y experiment was per-
formed on a mixture of fluoxetine hydrochloride-P-CD. The 
presence of strong cross peaks between H-2,3 and H-1,4 of 
(rifluoromethyl substituted aromatic ring with H-3' and H-5' 
of p-CD and relatively weak cross peaks between H-3' of 
I^CD and phenyl ring protons of guest (Fig. 4), confirmed 
the presence of two equilibria in solution. Several topologies 
may arise for' each aromatic ring because enuy may occur 
through either the larger or smaller rim of M^D and the pen-
etration may be either shallow or deep. The 2DR0ESY spec-
trum confirms binding mode-I for CF^i-substituted ring with 
^>CD in which the guest enters from wider rim and pen-
etrates deep so that the -CF3 group protrudes outside the cav-
ity and ii\teracls with 6'-0H. This assumption is supported 
by the fact that H-1,4 showed upfield shifts in the presence of 
P-CD, which may be explained in terms of close proximity 
of these protons with fluorine in free state while in com-
plexed state these F atoms may form H'bonds with 6'-0H, 
thus weakening the Interaction between F and H-1,4. In this 
mode, these H-l,4 come in sizable contact with only H-5' 
while H-2,3 of guest are in the proximity of both H-3' and 
H-5' of P-CD. The cross peaks between phenyl ring protons 
with only H-3' of ^CD, which is near the witter rim, support 
the mode-II of various probable topologies nKaning the pen-
3 4 
7.5-
7,0-
H-3'Jt.2,3 
^NHCH, 
|l-QrctodixtriK 
Model 
NKCHt 
Mode II 
Scheme 1. 
Fig. 4. 
etration of the phenyl ring is also from wider side but only a 
part of the ring enters the cavity. The deep penetration wouid 
bring some of the phenyl protons near the H-5'. A schematic 
representation of the inclusion equilibria is shown in Scheme 
1. The dissociation constant, K^, of the complex was calcu-
lated to be }.4 X 10'^ Mby a least-square fitting procedure 
from the ptou (Figs. 2 and 3) [14,16]. 
In conclusion, 'H NMR and 2DR0ESY spectroscopy of 
mixtures of fluoxetine hydrochloride and ^-CD in D^O at 
25 "C revealed the existence of two 1:1 diasiereomeric inclu-
sion complexes formed by the penetration of aromatic rings 
of guest Into the ^-CD cavity from wider rim side and that 
CFs'Substituted ring penetrates deep while inclusion of phe-
nyl ring is shallow. The dissociation constant. K^, for the com-
plex was determined. 
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4f> 
Fluvastatin sodium (FLU) helps in preventing^eart 
disease, angina, strolte and heart attacks by reduci^fe^ 
chol»terol and certain other fatty s u b s t a n ^ i n ^ ^ 
blood [I, 2]. It is a competitive inhibitor ' ^ ' ^ i ^ i ^ y ^ ' 
methylglutaryl-coenzyme A ( H M a - C o A ) - m ^ ^ ^ a j i d 
lowers the overall blood cholesterol MoH^" 
LDL (bad) cholesterol levels, w h i d i i s ^ ^ n s i b f e for 
coronary artery diseases. FLU is lignraeo$fim%nd its 
solubility in vrttei is 1.91 mg/ml. ,^ "Hi-,*! 
Complexation of pharmaceutii»{ compounds with 
cyclodextrins (CDs) leads ta'-^teredJfpj^iicochcmicul 
properties of the guest. Inclusiol^^bipplexes of phar-
maccuticul compounds with^JGD|» th^^fore. have been 
extensively studied and i^lizedTd^prove the solubility 
(31. dis-wlulion rate [41t^nd bio^VailabiUty of poorly 
water-soluble drugs ^$)«n^'0ih^,r^esirable properties [6J. 
CDs ure cyclic oUgomeni of >-o-glucose linked 
through glycosidic;^-l.4-bohds resulting in the forma* 
tion oC d o u ^ u t ^ ^ ' ' M o l e c u l e s having one rim 
(narrow) lined with n'^Kmary hydroxyl groups while 
the other rim. ^wd«>»lined with 2n secondary hydr-
oxyl groups. Yhc H-3'. H-5' and glycosldic oxygen are 
located inside the cavity which is relatively hydrophobic. 
The CDs. therefore, act as hosts for a variety of non-
polar molecules (7-9]. 
• AultiiM for auraponi'Ofn. r.-ti^;ttl', «muhhoo(k)ltl;U'yih(X>.Gom 
NMR spectroscopy is an important tool lo stiuly CD 47 
inclusion complexes [10]. 'H NMR .spectra of iniMures 48 
of CD and guest molecule are recorded and changcx in 49 
the chemical shifts (Ad) of both the host as well as guest 50 
are studied. The formation of the inclusion complex is 51 
indicated by highfield shift changes in the CD protons 52 
situated inside the cavity, namely H-3' and H-5' and 53 
downfield shift changes in the guest protons. The 54 
chemical shift change data can be used for the deter- 55 
mination of stoichiometry. binding constant and mode 56 
of penetration of the guest into the CD cavity. ROESY 57 
[11] spectroscopy is particularly useful in the situdy of 58 
inclusion complexes. NOE correlation peaks ob^rved 59 
between the protons of the included part of the guest 60 
and ^-CD cavity protons give direct evidence for the 61 
fonnation of Inclusion complex and provide very useful 62 
information regarding the structure of the complex. 63 
We are interested in the study of the inclusion com- M 
plexes of pharmaceutical compounds with ^-CD in 65 
solution [12, 13] and report herein our results on the 66 
detailed NMR spectroscopic study of P-CD-fluvnst;\iin 6? 
sodium complexation. gg 
Results and discussion 69 
AU the ' H NMR spectra were recorded on a Varian 70 
Mercury Plus-300 instrument while COSY, DEPTO 71 
and ROESY experiments were performed on a JEOL 72 
^ 
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7.t 3-41X1 MHz instrumeni in DjO at room lempcrature and 
74 the chemicul shift values (6) are reported in ppm. No 
75 exiernal indicator was used and HDO signal at 4.800 
76 was used as internal reference throughout this work. 'H 
77 NMR spectra Tor live samples of FLU and ^ C D with 
78 ^-CO'FLU molar ratios ratigins from 0.2 to l.t were 
79 recorded. The concentration of the FLU was kept con* 
80 stant at 1.6 x I0~' M while that of fi-CD was varied. 
81 Distinct peaks for bound and free form of the FLU were 
82 not observed indicating the rapid exchange of FLU 
83 between free and bind slate on the NMR time scale. 
84 'H NMR spectra of mixtures of FLU and fi-CD 
85 displayed highfield shin changes in the H<3' and H-S' of 
86 the /J-CD, located inside the cavity, while insignificant 
HI shift changes were observed for other ^-CD protons. 
88 Expansions of part of the spectra showing J3-CD pro-
89 tons, in the presence as well as in the absence of FLU, 
<K) are $hown in Figure I. These high field shift changes in 
91 ihe ^-CD cavity protons can only be explained in term 
92 of ring current effect of aromatic ring penetrating 
9} the /f-CD cavity and thus confirm the formation of 
94 FLU /i-CD complex, in analogy to previous siudies.[IO. 
95 14]. This is also supported by concomitant downfield 
V6 shift changes in the aromatic protons of the FLU in the 
T FLU It-CD mixtures compared to pure FLU (14]. 
98 To clearly establish whether both or either of the two 
99 rings h involved in compkxalion. an unambiguous 
ItK) resonance assignment of FLU protons was required. A 
101 cursory examination of the aromatic region of the FLU. 
102 specirtt. in the presence us wet) as in the absence t^ f 
Jl p-CD/Fl_U-0.^ 
fi-CD. points to the presence of two isomeric forms of 
FLU. The COSY. ROESY and DEPTO experiments 
were performed on a mixture of FLU/J3-C^ which 
proved very helpful in resonance assignment<'of4he two 
isomers. Only the signals for the F-substit 
ring appeared separaleiy for the two isotaen'. 
blet at 7.5634 (/-6.88 Hz) was assi 
one of the isomers. This signal showed cross 
COSY spectrum, with the multiple 
that H-2 of one isomer is meri 
It was confirmed by the D 
signals for the protons of th| 
merged in the multiple! at 7.1 
(J-6.88HZ) and triplet,. 
assignable tn H-l and^H-
isomer. The cross peaks'! 
7.1048. observed in.CGS 
the imciaction bei»«en'H-2 a' ,. .... 
COSY (Figure 2^hd DEPTO (Figure 3) spectra of a 
FLU/^-CO nitixture, showing aromatic regions, support 
K4 
atic 
u-
of 
in the 
lesting 
ugnal. 
ments that 
rings are 
ubiet at 7.3876 
6.S8 Hz) were 
lively, of the other 
ignals at 6.9742 and 
rum, may arise due to 
H-3. Expansions of the
34 
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Figun 2. Pan of IhcCOSY ipccirum (400 MHz) ofa mixture o.'FLU 
iin<l ^ C D showing inicradion of aromutic protons. 
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Figia-e I. pBrtioT^ H NMR tp«xlni {300 MHz) ihowini upfidd ihift of Fixure J. Part of DEPTO ipcctrum showing that HO ii merged wiih 
ihc /(-CD prmnns wtih increasing nmouni of FLU H-3.5. 
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Fig¥re 6. Expanded region or ROESY tpccinim of /KD/FLU mix-
lure showing cross peaks of F-subsiiluled sronuiic ring proioni with 
/(•CD cavily protons. 
ihe ^-CE>*€av^^show downfield shift changes upon 
complej^^n wifffiCDs [15]. 
lliie sroKhioin«ry of tht complex was detennined 
usiijg Scott's edification [16] of Benesi-Hildebrand 
eqMti6nw.[n Scott's equation 
•>;[Gb],/A5ob, = (CD],/A<Sc + l7Ar,A<Sc 
12.^  ihe assignment of TLU aromatic proton resonani 
124 beyond doubl. i ' 
tiS In the presence of /(rCD, all the aromatic protons 
126 sijiniticantly shifted downfield but the shift for t l |^ sig-
127 nals of the F-substituted aromatic ring was moi 
128 nounced (Figure 4). these observutjons ctea^^ndv 
129 that atleait F'Substituted aromatic ring is 
130 the ^-CD cavity but whether other ring if a 
131 in complexation is not clear because, g< 
132 protons of the guest, and not only t^'p&S that inters 
I, is the molar concentration of the CDs, Aioh. is the 
olH^ed chemical shift difference for a given [CD], 
concentration. Ai, is the chemical shift difference bc-
tyeen a pure sample of complex and the free component 
the saturation. The plot of chemical shift changes {tiS) 
"or the FLU protons against [/J-CD] in the form of 
([^•CDl/A^,. versus [^-CD] gave excellent linear fit 
(Figure 5) confirmimg 1:1 stoichiometry for the com-
plex. The slope of the plot of [CD] is thus equal to l/A^^  
and the intercept with Ihe vertical axis to l/AT^ A^ c 
allowing the estimation of X.. The binding constant (AT.) 
was determined to be 340 M~'. 
In order to clearly establish the structure of the 
complex. ROESY experiment was performed on a 
ONa 
(P-CD]xlO"''M 
Figure S. Scoti's plot showing l:t itoichiomciry o{ Ibc JI-CD/FLU Flgurt 7. Pluusibic siruciure or the l:i /l-CD/Fluvusuiin sodium 
complex. complex. 
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I>.^  FLU /J-CD niixiure under spin lock comliiions. The 
154 result is displayed in Figured; a acl of cross peaks 
155 connects H-3' and H-5' resonances of ^-CD lo the 
15ft signals for the F-substituted aromatic ring. The signals 
157 Tor the other aromatic ring did not show any cross peaks 
15ii with ^-CD cavity protons confirming beyond doubt the 
15<^ peneiralion of onty F'Substituted aromtitic ring into the 
160 It-CD cavity. The intensity of the cross peaks for the two 
16! isomers was not identical suggesting chirfll diHerentia-
162 tion by the ^-CD cavity [\7]. Moreover, the H-l of the 
163 F-subslituted aromatic ring also showed cross connec-
164 tion peaks with H<2' and 4' protons, which are situated 
165 near the wider rim. This implies that aromatic ring 
166 penetrates deep from the narrower rim side [18] and H-l 
167 i<; located near wider rim in the c o m p l e x . The plaus i -
168 ble structure for the FLU/^-CD complex is shown in 
169 Figure?. 
170 In conclusion, the detailed NMR spectroscopic study 
171 of FLU in solution in the presence of ^-CD confirmed 
172 the formation of 1:1 inclusion complex resulting by the 
173 penetration of the F-substituted aromatic ring into the 
174 ^-CD cavity from narrower rim side. FLU is a mixture 
)75 of two isomers and ^-CD seems to play a role in their 
176 chiral differentiation by favourably binding to one of the 
177 isomers. The structure for the ^-CD-fluvaslatin sodium 
\ 7s complex has been proposed. 
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